Citations

Citations to this article as recorded by  

• Histology of subepithelial lesions (SELs) in the gastrointestinal tract-resected endoscopic: a database study of 4901 patients
  Zhipeng Qi, Enpan Xu, Shuchang Xu, Leiming Xu, XiaoBo Li, Liang Zhong, Dongli He, Pinghong Zhou, Zhendong Jin, Yunshi Zhong
  Gut.2025; : gutjnl-2024-333150.     CrossRef
• Overall survival and margin status in resected gastric GI stromal tumors
  Fiyinfoluwa O. Abraham, Tarrant McPherson, Leslie Blackshear, Yuan Liu, Theresa Gillespie, Preeyanka Sundar, Vaishali Patel, Jordan Orr, Saurabh Chawla, Steven A. Keilin, Field F. Willingham
  iGIE.2025;[Epub]     CrossRef
• Advancements in Endoscopic Treatment for Gastric Subepithelial Tumors
  Osamu Goto, Kazutoshi Higuchi, Eriko Koizumi, Katsuhiko Iwakiri
  Gut and Liver.2025; 19(2): 151.     CrossRef
• Rapidly Growing Gastrointestinal Stromal Tumor on the Esophagus
  Ji Hye Park, Sung Eun Kim, Seun Ja Park, Moo In Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Myung Hun Lee
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2025; 25(1): 64.     CrossRef
• Clinical importance of tumor rupture in gastrointestinal stromal tumor
  Toshirou Nishida, Naoto Gotouda, Tsuyoshi Takahashi, Hui Cao
  Journal of Digestive Diseases.2024; 25(9-10): 542.     CrossRef
• Gastric gastrointestinal stromal tumors: therapeutic strategies and long-term prognosis
  Chunhui Shou, Zhou Chen, Zhijian Li, Weili Yang, Qing Zhang, Hao Bai, Jiren Yu
  Scandinavian Journal of Gastroenterology.2024; 59(2): 239.     CrossRef
• Pimitespib for the Treatment of Advanced Gastrointestinal Stromal tumors and Other Tumors
  Toshihiko Doi, Noboru Yamamoto, Shuichi Ohkubo
  Future Oncology.2024; 20(9): 507.     CrossRef
• Endoscopic resection for the treatment of gastric gastrointestinal stromal tumors: a retrospective study from a large tertiary hospital in China
  Zhengting He, Chen Du, Bingqian Cheng, Jiancong Feng, Nanjun Wang, Yan Ma, Longsong Li, Bo Zhang, Hongbin Wang, Ping Tang, Ningli Chai, Enqiang Linghu
  Surgical Endoscopy.2024; 38(3): 1398.     CrossRef
• Comparative Analysis of Enbloc or Piecemeal Removal After Enbloc Resection of Gastrointestinal Stromal Tumors
  Jing-wen Zhang, Chang-qing Guo, Shan-shan Zhu, Ghulam Nabi, Nan Dai, Xiao-yu Wan, Ping Liu, Fang-bin Zhang, Yang Fu, Xin-gung Cao
  Digestive Diseases and Sciences.2024; 69(5): 1755.     CrossRef
• Automatically optimized radiomics modeling system for small gastric submucosal tumor (<2 cm) discrimination based on EUS images
  Mingyan Cai, Baohui Song, Yinhui Deng, Pingting Gao, Shilun Cai, Ayimukedisi Yalikong, Enpan Xu, Yunshi Zhong, Jinhua Yu, Pinghong Zhou
  Gastrointestinal Endoscopy.2024; 99(4): 537.     CrossRef
• English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology
  Seiichi Hirota, Ukihide Tateishi, Yuji Nakamoto, Hidetaka Yamamoto, Shinji Sakurai, Hirotoshi Kikuchi, Tatsuo Kanda, Yukinori Kurokawa, Haruhiko Cho, Toshirou Nishida, Akira Sawaki, Masato Ozaka, Yoshito Komatsu, Yoichi Naito, Yoshitaka Honma, Fumiaki Tak
  International Journal of Clinical Oncology.2024; 29(6): 647.     CrossRef
• Efficacy and Safety of Endoscopic Resection for Gastric Gastrointestinal Stromal Tumors Originating from the Muscularis Propria
  Ji Li, Dong Xu, Wei-Feng Huang, Shao-Kun Hong, Jin-Yan Zhang
  Digestive Diseases and Sciences.2024; 69(6): 2184.     CrossRef
• Clinical outcomes of endoscopic resection for the treatment of intermediate- or high-risk gastric small gastrointestinal stromal tumors: a multicenter retrospective study
  Enpan Xu, Qiang Shi, Zhipeng Qi, Bing Li, Huihui Sun, Zhong Ren, Shilun Cai, Dongli He, Zhengtao Lv, Zhanghan Chen, Liang Zhong, Leiming Xu, Xiaobo Li, Shuchang Xu, Pinghong Zhou, Yunshi Zhong
  Surgical Endoscopy.2024; 38(6): 3353.     CrossRef
• Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative)
  Johnn Henry Herrera Kok, Luigi Marano, Jan Willem van den Berg, Preethi Shetty, Yogesh Vashist, Laura Lorenzon, Beate Rau, Richard van Hillegersberg, Giovanni de Manzoni, Andrea Spallanzani, Won Jun Seo, Hiromi Nagata, Clarisse Eveno, Stefan Mönig, Karen
  European Journal of Surgical Oncology.2024; 50(7): 108387.     CrossRef
• Efficacy of real-time artificial intelligence-aid endoscopic ultrasonography diagnostic system in discriminating gastrointestinal stromal tumors and leiomyomas: a multicenter diagnostic study
  Zhixia Dong, Xiangyun Zhao, Hangbin Zheng, HanYao Zheng, Dafan Chen, Jia Cao, Zili Xiao, Yunwei Sun, Qian Zhuang, Shan Wu, Jie Xia, Min Ning, Binjie Qin, Hui Zhou, Jinsong Bao, Xinjian Wan
  eClinicalMedicine.2024; 73: 102656.     CrossRef
• Clinical and Biomarker Analysis of a Phase I/II Study of PDR001 Plus Imatinib for Advanced Treatment-Refractory Gastrointestinal Stromal Tumors
  Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Changhoon Yoo, Sung-Joo Kim, Yoon-Koo Kang
  Clinical Cancer Research.2024; 30(13): 2743.     CrossRef
• Optimal management options for esophageal gastrointestinal stromal tumors (E-GIST)
  Shanshan Zhu, Changqing Guo, Jingwen Zhang, Nan Dai, Saif Ullah, Ping Liu, Yang Fu, Ge Zhang, Fangbin Zhang, Shengang Zhang, Xinguang Cao
  European Journal of Surgical Oncology.2024; 50(9): 108527.     CrossRef
• Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors
  Tadayoshi Hashimoto, Yoshiaki Nakamura, Yoshito Komatsu, Satoshi Yuki, Naoki Takahashi, Naohiro Okano, Hidekazu Hirano, Koushiro Ohtsubo, Takashi Ohta, Eiji Oki, Tomohiro Nishina, Hisateru Yasui, Hisato Kawakami, Taito Esaki, Nozomu Machida, Ayako Doi, Sh
  BJC Reports.2024;[Epub]     CrossRef
• Impact of systemic steroids on the efficacy of first line imatinib treatment of patients with advanced gastrointestinal stromal tumors (GISTs)
  Sejin Kim, Hyung-Don Kim, Eo Jin Kim, Min-Hee Ryu, Yoon-Koo Kang
  BMC Cancer.2024;[Epub]     CrossRef
• Unraveling Gastric and Small Intestine Gastrointestinal Stromal Tumors: A Review of Our Current Knowledge
  Panagiotis Eskitzis, Vasiliki Michou, Rodoula Theoti, Antonia Antoniou, Drosos Tsavlis, Doxakis Anestakis
  Gastrointestinal Disorders.2024; 6(4): 842.     CrossRef
• Mean platelet volume/platelet count ratio can predict the recurrence-free survival rate of patients after complete resection of gastrointestinal stromal tumors
  Xinlian Du, Xinxin Zang, Hanbo Zhang, Lijia Liu, Ying Xu, Xuedong Li, Ruishu Mou, Haitao Xu, Jiuxin Zhu, Rui Xie
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Genotypical analysis of gastrointestinal stromal tumors using next-generation sequencing
  Trupti V. Deshpande, Pranav Dorwal, Akshay A Anikhindi, Nishant Tiwari, Dharmendar Jain, Simmi Mehra, Ashok Vaid, Vimarsh Raina
  Indian Journal of Cancer.2024; 61(3): 477.     CrossRef
• Diagnostic and Therapeutic Challenges in the Management of Acute Massive Overt Bleeding of Jejunal Gastrointestinal Stromal Tumours: Case Series
  Satish Subbiah Nagaraj, Sriram Deivasigamani, Amresh Aruni, Hemanth Kumar, Anurag Sachan, Jayanta Samanta, Amanjit Bal
  Journal of Gastrointestinal Cancer.2023; 54(1): 316.     CrossRef
• Splenic capsulitis associated with gastric GIST
  Soumya Hariswamy, Sam Alhayo, Yasser Farooque
  ANZ Journal of Surgery.2023; 93(4): 1104.     CrossRef
• Counting mitoses in gastrointestinal stromal tumours (GISTs): variable practices in the real-world setting and their clinical implications
  Michela Campora, Michele Paudice, Alessandro Gambella, Danila Comandini, Paola Parente, Marta Sbaraglia, Angelo Paolo Dei Tos, Federica Grillo, Luca Mastracci
  Virchows Archiv.2023; 482(3): 589.     CrossRef
• Pure endoscopic resection versus laparoscopic assisted procedure for upper gastrointestinal stromal tumors: Perspective from a surgical endoscopist
  Hon Chi Yip, Jun Liang Teh, Anthony Y. B. Teoh, Philip Chiu
  Digestive Endoscopy.2023; 35(2): 184.     CrossRef
• Gastrointestinal stromal tumor of jejunum misdiagnosed as uterine leiomyoma: A case report
  Min Yu, Miaomiao Sun, Shanwei Guo, Fangfang Nan
  Asian Journal of Surgery.2023; 46(3): 1457.     CrossRef
• A Rare Gastric Subepithelial Lesion Removed through Submucosal Tunneling Endoscopic Resection: Case Report and Literature Review
  Mu-Ming Chien, Yun-Ho Lin, Chun-Chao Chang, Hsi-Yuan Chien
  Life.2023; 13(1): 179.     CrossRef
• Clinical Efficacy and Safety of Endoscopic Treatment of Gastrointestinal Stromal Tumors in the Stomach
  Moon Kyung Joo, Jong-Jae Park, Yeon Ho Lee, Beom Jae Lee, Seong Min Kim, Won Shik Kim, Ah Young Yoo, Hoon Jai Chun, Sang Woo Lee
  Gut and Liver.2023; 17(2): 217.     CrossRef
• Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours
  Yoichi Naito, Toshirou Nishida, Toshihiko Doi
  Gastric Cancer.2023; 26(3): 339.     CrossRef
• Interruption of imatinib in advanced gastrointestinal stromal tumor after prolonged imatinib maintenance in the absence of gross tumor lesions
  Yoon-Koo Kang, Hyung-Don Kim, Hyun Jin Kim, Young Soo Park, Mo-Youl Beck, Min-Hee Ryu
  Gastric Cancer.2023; 26(4): 604.     CrossRef
• Risk factors of perforation in gastric stromal tumors during endoscopic resection: a retrospective case–control study
  Muhan Ni, Dehua Tang, Wei Ren, Rui Meng, Jinping Yang, Peng Yan, Xiwei Ding, Guifang Xu, Ying Lv, Min Chen, Hua Yang, Lei Wang
  Gastric Cancer.2023; 26(4): 590.     CrossRef
• Clinical outcomes of endoscopic resection for the treatment of esophageal gastrointestinal stromal tumors: a ten-year experience from a large tertiary center in China
  Jia-Xin Xu, Tian-Yin Chen, Yan-Bo Liu, Xiao-Yue Xu, Wei-Feng Chen, Quan-Lin Li, Jian-Wei Hu, Wen-Zheng Qin, Ming-Yan Cai, Yi-Qun Zhang, Ping-Hong Zhou
  Surgical Endoscopy.2023; 37(8): 5883.     CrossRef
• Efficacy of post‐first‐line agents for advanced gastrointestinal stromal tumors following imatinib failure: A network meta‐analysis
  Kehan Hu, Hu Zhang, Mingrong Shu, Xingyue Wang
  Cancer Medicine.2023; 12(11): 12187.     CrossRef
• A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours
  Hyung-Don Kim, Changhoon Yoo, Min-Hee Ryu, Yoon-Koo Kang
  British Journal of Cancer.2023; 129(2): 275.     CrossRef
• Endoscopic resection for the treatment of non-gastric gastrointestinal stromal tumors: A retrospective study from a large tertiary hospital in China
  Chen Du, Zhengting He, Longsong Li, Bo Ning, Bo Zhang, Yaqi Zhai, Yan Ma, Ke Han, Hongbin Wang, Ping Tang, Ningli Chai, Enqiang Linghu
  Clinics and Research in Hepatology and Gastroenterology.2023; 47(7): 102152.     CrossRef
• Gastrointestinal Stromal Tumor of Small Intestine
  Hyo Yeop Song, Geom Seog Seo, Hoon Gil Jo
  The Korean Journal of Gastroenterology.2023; 81(6): 276.     CrossRef
• Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach
  Seong-Ho Kong, Yukinori Kurokawa, Jeong-Hwan Yook, Haruhiko Cho, Oh-Kyoung Kwon, Toru Masuzawa, Kyung Hee Lee, Sohei Matsumoto, Young Soo Park, Hiroshi Honda, Seung-Wan Ryu, Takashi Ishikawa, Hye Jin Kang, Kazuhito Nabeshima, Seock-Ah Im, Toshio Shimokawa
  Gastric Cancer.2023; 26(5): 775.     CrossRef
• Non-exposed endoscopic wall-inversion surgery with one-step nucleic acid amplification for early gastrointestinal tumors: Personal experience and literature review
  Francesco Crafa, Serafino Vanella, Aristide Morante, Onofrio A Catalano, Kelsey L Pomykala, Mario Baiamonte, Maria Godas, Alexandra Antunes, Joaquim Costa Pereira, Valentina Giaccaglia
  World Journal of Gastroenterology.2023; 29(24): 3883.     CrossRef
• Transgastric endoscopic ultrasound‐guided fine needle biopsy for diagnosing gastrointestinal stromal tumor of the jejunum
  Yuichi Takano, Fumitaka Niiya, Masatsugu Nagahama
  Digestive Endoscopy.2023;[Epub]     CrossRef
• Simple Scoring Model Based on Enhanced CT in Preoperative Prediction of Biological Risk of Gastrointestinal Stromal Tumor
  Yating Wang, Genji Bai, Hui Zhang, Wei Chen
  Technology in Cancer Research & Treatment.2023;[Epub]     CrossRef
• Goldilocks principle of minimally invasive surgery for gastric subepithelial tumors
  Wei-Jung Chang, Lien-Cheng Tsao, Hsu-Heng Yen, Chia-Wei Yang, Hung-Chi Chang, Chew-Teng Kor, Szu-Chia Wu, Kuo-Hua Lin
  World Journal of Gastrointestinal Surgery.2023; 15(8): 1629.     CrossRef
• Comparison of Safety and Outcomes between Endoscopic and Surgical Resections of Intermediate-Risk Primary Gastric Gastrointestinal Stromal Tumors
  Ximei Ren, Muhan Ni, Tingting Zhu, Jinping Yang, Jinyan Liu, Shahzeb Hassan, Xiaoping Zou, Guifang Xu, Lei Wang
  Digestive Diseases.2023; 41(2): 187.     CrossRef
• A giant gastric stromal tumor with dizziness as the main complaint: A case report and literature review
  Dongdong Zhang, Shuk Ying WONG, Jixiang Wu, Limin Guo
  International Journal of Surgery Case Reports.2023; 110: 108747.     CrossRef
• Survival outcome of local versus radical resection for jejunoileal gastrointestinal stromal tumors: a propensity score-matched population-based analysis
  Shangcheng Yan, Wei Peng, Ming Cheng, Jingyu Zhang, Tianhua Liu, Mengchao Sheng, Rui Ren, Qiang Chen, Wei Gong, Yongyou Wu
  International Journal of Colorectal Disease.2023;[Epub]     CrossRef
• CT features of calcified micro-gastric gastrointestinal stromal tumors: a case series
  Li-Jun Chen, Yue-Dong Han, Ming Zhang
  BMC Medical Imaging.2023;[Epub]     CrossRef
• Rapidly Growing, High-Risk Gastrointestinal Stromal Tumor of the Stomach: A Case Report
  Sung Jin Lim, Han Mo Yoo, Seung-Woo Lee, Hae Joung Sul, Dong Soo Lee
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(4): 306.     CrossRef
• Factors associated with gastrointestinal stromal tumor rupture and pathological risk: A single-center retrospective study
  Jia-Zheng Liu, Zhong-Wen Jia, Ling-Ling Sun
  World Journal of Radiology.2023; 15(12): 350.     CrossRef
• Clinical outcomes of endoscopic resection for the treatment of gastric gastrointestinal stromal tumors originating from the muscularis propria: a 7-year experience from a large tertiary center in China
  Chen Du, Ningli Chai, Enqiang Linghu, Huikai Li, Yaqi Zhai, Longsong Li, Xiaowei Tang, Hongbin Wang, Ping Tang
  Surgical Endoscopy.2022; 36(2): 1544.     CrossRef
• Radiomics Nomogram Based on Contrast-enhanced CT to Predict the Malignant Potential of Gastrointestinal Stromal Tumor: A Two-center Study
  Yancheng Song, Jie Li, Hexiang Wang, Bo Liu, Chentong Yuan, Hao Liu, Ziwen Zheng, Fanyi Min, Yu Li
  Academic Radiology.2022; 29(6): 806.     CrossRef
• Impacts of SNPs on adverse events and trough concentration of imatinib in patients with gastrointestinal stromal tumors
  Keiko Maekawa, Masahiro Yamamura, Atsushi Matsuki, Takashi Ishikawa, Toshihiro Hirai, Yoshiyuki Yamaguchi, Yoshiro Saito, Tatsuo Kanda
  Drug Metabolism and Pharmacokinetics.2022; 43: 100441.     CrossRef
• Clinical Course of Small Subepithelial Tumors of the Small Bowel Detected on CT
  Seohyun Kim, Seung Joon Choi, Su Joa Ahn, So Hyun Park, Young Sup Shim, Jeong Ho Kim
  Journal of the Korean Society of Radiology.2022; 83(3): 608.     CrossRef
• Clinical outcomes of endoscopic treatment for gastric gastrointestinal stromal tumors: a single-center study of 240 cases in China
  Deqiong Wang, Qiang Ding, Li Cao, Xinxia Feng, Zerui Zhang, Panpan Lu, Xiaoyu Ji, Lili Li, Dean Tian, Mei Liu
  Scandinavian Journal of Gastroenterology.2022; 57(8): 996.     CrossRef
• The Diagnosis of Small Gastrointestinal Subepithelial Lesions by Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy
  Masanari Sekine, Takeharu Asano, Hirosato Mashima
  Diagnostics.2022; 12(4): 810.     CrossRef
• A Huge Malignant Gastric Gastrointestinal Stromal Tumor in a Young Patient
  Yun Jin Jeong, Hyun Seung Hwang, Yong Eun Park, Kyung Han Nam, Sung Jin Oh
  The Korean Journal of Gastroenterology.2022; 79(4): 177.     CrossRef
• Advancements in the Diagnosis of Gastric Subepithelial Tumors
  Osamu Goto, Mitsuru Kaise, Katsuhiko Iwakiri
  Gut and Liver.2022; 16(3): 321.     CrossRef
• Adjuvant Imatinib Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor: A Retrospective Analysis
  Sora Kang, Min-Hee Ryu, Yeong Hak Bang, Hyung-Don Kim, Hyung Eun Lee, Yoon-Koo Kang
  Cancer Research and Treatment.2022; 54(4): 1167.     CrossRef
• The analysis of prognostic factors of primary small intestinal gastrointestinal stromal tumors with R0 resection
  Hui Qu, ZhaoHui Xu, YanYing Ren, ZeZhong Gong, Ri Hyok Ju, Fan Zhang, Shuai Shao, XiaoLiang Chen, Xin Chen
  Medicine.2022; 101(25): e29487.     CrossRef
• Clinical outcomes and prognostic factors for patients with high‐risk gastrointestinal stromal tumors treated with 3‐year adjuvant imatinib
  Yeong Hak Bang, Min‐Hee Ryu, Hyung‐Don Kim, Hyung Eun Lee, Yoon‐Koo Kang
  International Journal of Cancer.2022; 151(10): 1770.     CrossRef
• Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study
  Zhou Zhao, Xiao-Nan Yin, Jian Wang, Xin Chen, Zhao-Lun Cai, Bo Zhang
  World Journal of Gastroenterology.2022; 28(27): 3476.     CrossRef
• Therapeutic Effects of 4 Surgical Approaches for Small Gastrointestinal Stromal Tumors: A Network Meta-analysis
  Zhiyuan Yu, Huaiyu Tu, Chen Liang, Shuzhong Qiu, Xiaoyu Dong, Yonghui Zhang, Chao Ma, Peiyu Li
  Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2022;[Epub]     CrossRef
• Necessity of Individualized Approach for Gastric Subepithelial Tumor Considering Pathologic Discrepancy and Surgical Difficulty Depending on the Gastric Location
  Sung Gon Kim, Bang Wool Eom, Hongman Yoon, Myeong-Cheorl Kook, Young-Woo Kim, Keun Won Ryu
  Journal of Clinical Medicine.2022; 11(16): 4733.     CrossRef
• Laparoscopic versus open resection for the treatment of gastric GIST: a retrospective 10-year single-center experience
  Andrea LOCATELLI, Daniele CARZANIGA, Pierluigi CARZANIGA, Andrea COSTANZI
  Minerva Surgery.2022;[Epub]     CrossRef
• Case report: 10-year survival of a patient with a primary hepatic gastrointestinal stromal tumor
  Jie Lian, Meiyan Feng, Shumei Zhang, Haibo Lu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Clinical outcomes of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor
  Hiroyuki Hanayama, Masanori Katagata, Takahiro Sato, Hiroshi Nakano, Takuro Matsumoto, Takeshi Tada, Yohei Watanabe, Suguru Hayase, Hirokazu Okayama, Tomoyuki Momma, Tsunetaka Kato, Minami Hashimoto, Jun Nakamura, Takuto Hikichi, Zenichiro Saze, Koji Kono
  FUKUSHIMA JOURNAL OF MEDICAL SCIENCE.2022; 68(3): 169.     CrossRef
• Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan
  Yuichi Ichinose, Yi-Hsin Yang, Hui-Jen Tsai, Ru-Yu Huang, Takahiro Higashi, Toshirou Nishida, Li-Tzong Chen
  Scientific Reports.2022;[Epub]     CrossRef
• Gastrointestinal stromal tumor of the small intestine of high malignant potential
  Aleksandar Mladenović, Miljan Jovančević, Zoran Milošević
  PONS - medicinski casopis.2022; 19(1): 33.     CrossRef
• Development and validation of a novel diagnostic model for initially clinical diagnosed gastrointestinal stromal tumors using an extreme gradient-boosting machine
  Bozhi Hu, Chao Wang, Kewei Jiang, Zhanlong Shen, Xiaodong Yang, Mujun Yin, Bin Liang, Qiwei Xie, Yingjiang Ye, Zhidong Gao
  BMC Gastroenterology.2021;[Epub]     CrossRef
• Incidence of gastrointestinal stromal tumor in Chinese urban population: A national population‐based study
  Lu Xu, Yanpeng Ma, Shengfeng Wang, Jingnan Feng, Lili Liu, Jinxi Wang, Guozhen Liu, Dianrong Xiu, Wei Fu, Siyan Zhan, Tao Sun, Pei Gao
  Cancer Medicine.2021; 10(2): 737.     CrossRef
• Malignant solitary fibrous tumor of the greater omentum: A case report and review of literature
  Yu-Chen Guo, Li-Yu Yao, Zhi-Sen Tian, Bing Shi, Ying Liu, Yuan-Yi Wang
  World Journal of Clinical Cases.2021; 9(2): 445.     CrossRef
• A Case of Liver Metastasis from Small Intestinal Gastrointestinal Stromal Tumor 25 Years after Surgery including Autopsy Findings
  Yuichi Takano, Masataka Yamawaki, Jun Noda, Tetsushi Azami, Takahiro Kobayashi, Fumitaka Niiya, Eiichi Yamamura, Naotaka Maruoka, Kuniyo Gomi, Yuichiro Kuroki, Yorimasa Yamamoto, Tomoko Norose, Nobuyuki Ohike, Masatsugu Nagahama, Marcel Cerqueira Cesar Ma
  Case Reports in Gastrointestinal Medicine.2021; 2021: 1.     CrossRef
• Gastrointestinal stromal tumours
  Jean-Yves Blay, Yoon-Koo Kang, Toshiroo Nishida, Margaret von Mehren
  Nature Reviews Disease Primers.2021;[Epub]     CrossRef
• A modified endoscopic full thickness resection for gastric subepithelial tumors from muscularis propria layer: Novel method
  Jung Min Lee, In Kyung Yoo, Sung Pyo Hong, Joo Young Cho, Young Kwan Cho
  Journal of Gastroenterology and Hepatology.2021; 36(9): 2558.     CrossRef
• Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors
  Toshirou Nishida, Shigetaka Yoshinaga, Tsuyoshi Takahashi, Yoichi Naito
  Cancers.2021; 13(13): 3158.     CrossRef
• Diagnosis of gastric submucosal tumors and estimation of malignant risk of GIST by endoscopic ultrasound. Comparison between B mode and contrast-harmonic mode
  Christine Lefort, Vikas Gupta, Andrea Lisotti, Laurent Palazzo, Pietro Fusaroli, Bertrand Pujol, Rodica Gincul, Fabien Fumex, Maxime Palazzo, Bertrand Napoléon
  Digestive and Liver Disease.2021; 53(11): 1486.     CrossRef
• Gastrointestinal Stromal Tumors—A Mini Review
  Gina Gheorghe, Nicolae Bacalbasa, Gabriela Ceobanu, Madalina Ilie, Valentin Enache, Gabriel Constantinescu, Simona Bungau, Camelia Cristina Diaconu
  Journal of Personalized Medicine.2021; 11(8): 694.     CrossRef
• Controversies in EUS: Do we need miniprobes?
  Hans Seifert, Pietro Fusaroli, PaoloGiorgio Arcidiacono, Barbara Braden, Felix Herth, Michael Hocke, Alberto Larghi, Bertrand Napoleon, Mihai Rimbas, BogdanSilvio Ungureanu, Adrian Sãftoiu, AnandV Sahai, ChristophF Dietrich
  Endoscopic Ultrasound.2021; 10(4): 246.     CrossRef
• Convolutional neural network‐based object detection model to identify gastrointestinal stromal tumors in endoscopic ultrasound images
  Chang Kyo Oh, Taewan Kim, Yu Kyung Cho, Dae Young Cheung, Bo‐In Lee, Young‐Seok Cho, Jin Il Kim, Myung‐Gyu Choi, Han Hee Lee, Seungchul Lee
  Journal of Gastroenterology and Hepatology.2021; 36(12): 3387.     CrossRef
• The Value of Endoscopic Ultrasonography in the Endoscopic Resection of Gastrointestinal Stromal Tumors
  Jian-Wei Mi, Jia-Qi Wang, Jie Liu, Li-Xian Zhang, Hong-Wei Du, Dong-Qiang Zhao
  International Journal of General Medicine.2021; Volume 14: 5149.     CrossRef
• Factors predicting technical difficulties during endoscopic submucosal excavation for gastric submucosal tumor
  Jia Liu, Yuyong Tan, Deliang Liu, Chenjie Li, Meixian Le, Hejun Zhou
  Journal of International Medical Research.2021;[Epub]     CrossRef
• Endoscopic Resection of Gastrointestinal Stromal Tumor: Is It Safe?
  Moon Kyung Joo
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(3): 180.     CrossRef
• Endoscopic Resection for Gastric Subepithelial Tumor with Backup Laparoscopic Surgery: Description of a Single-Center Experience
  Wei-Jung Chang, Lien-Cheng Tsao, Hsu-Heng Yen, Chia-Wei Yang, Joseph Lin, Kuo-Hua Lin
  Journal of Clinical Medicine.2021; 10(19): 4423.     CrossRef
• Successful Endoscopic Resection of a Rectal Gastrointestinal Stromal Tumor Larger Than 5 cm
  Seong Jung Kim, Yun Jung, Ran Hong, Jun Lee
  The Korean Journal of Gastroenterology.2021; 78(4): 235.     CrossRef
• A Nomogram for Predicting Laparoscopic and Endoscopic Cooperative Surgery during the Endoscopic Resection of Subepithelial Tumors of the Upper Gastrointestinal Tract
  Shun-Wen Hsiao, Mei-Wen Chen, Chia-Wei Yang, Kuo-Hua Lin, Yang-Yuan Chen, Chew-Teng Kor, Siou-Ping Huang, Hsu-Heng Yen
  Diagnostics.2021; 11(11): 2160.     CrossRef
• Building Radiomics Models Based on Triple-Phase CT Images Combining Clinical Features for Discriminating the Risk Rating in Gastrointestinal Stromal Tumors
  Meihua Shao, Zhongfeng Niu, Linyang He, Zhaoxing Fang, Jie He, Zongyu Xie, Guohua Cheng, Jian Wang
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Gastrointestinal stromal tumor of the rectum resected by transanal total mesorectal excision after neoadjuvant imatinib treatment: A case report
  Takuya Yano, Masahiro Nakahara, Hiroshi Okuda, Toshihiko Nishidate, Ichiro Takemasa, Masahiko Fujimori, Hirofumi Nakatsuka, Hironobu Amano, Hideki Ohdan, Toshio Noriyuki
  Asian Journal of Endoscopic Surgery.2020; 13(4): 574.     CrossRef
• Wedge gastrectomy: Robot-assisted with a hand-sewn repair versus a laparoscopic linear stapler technique for gastric subepithelial tumors
  Chairat Supsamutchai, Thitipong Setthalikhit, Chumpon Wilasrusmee, Pornraksa Ovartchaiyapong, Jakrapan Jirasiritham, Pattawia Choikrua, Pitichote Hiranyatheb
  Laparoscopic, Endoscopic and Robotic Surgery.2020; 3(1): 17.     CrossRef
• Impact of l-carnitine on imatinib-related muscle cramps in patients with gastrointestinal stromal tumor
  Heejung Chae, Min-Hee Ryu, Jungeun Ma, Moyeol Beck, Yoon-Koo Kang
  Investigational New Drugs.2020; 38(2): 493.     CrossRef
• Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors
  Jian Wang, Yuan Yin, Chaoyong Shen, Xiaonan Yin, Zhaolun Cai, Lin Pu, Wei Fu, Yaxuan Wang, Bo Zhang
  Medicine.2020; 99(9): e19275.     CrossRef
• Multiple Intra-abdominal Leiomyosarcoma in a Single Patient
  Rajshekhar C. Jaka, N. Chandra Mouli, T. Ravi Kumar, Akshay V. Gokak
  Indian Journal of Surgical Oncology.2020; 11(S1): 63.     CrossRef
• Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors
  Caiyue Ren, Shengping Wang, Shengjian Zhang
  Cancer Imaging.2020;[Epub]     CrossRef

• Gastrointestinal Stromal Tumors of the Small Intestine: Progress in Diagnosis and Treatment Research

  
  Fangxing Peng, Yao Liu
  Cancer Management and Research.2020; Volume 12: 3877.     CrossRef
• Comparison of endoscopic versus laparoscopic resection for gastric gastrointestinal stromal tumors: A preliminary meta‐analysis
  Hanlong Zhu, Si Zhao, Ruonan Jiao, Jian Zhou, Chunmei Zhang, Lin Miao
  Journal of Gastroenterology and Hepatology.2020; 35(11): 1858.     CrossRef
• Laparoscopy‑assisted endoscopic full‑thickness resection of upper gastrointestinal subepithelial tumors: A single‑center early experience
  Prasit Mahawongkajit, Pakkavuth Chanswangphuvana
  Molecular and Clinical Oncology.2020;[Epub]     CrossRef

• Skin Metastasis of Gastrointestinal Stromal Tumors: A Case Series and Literature Review

  
  Peng Liu, Fengbo Tan, Heli Liu, Jie Ge, Sheng Liu, Tianxiang Lei, Xianhui Zhao
  Cancer Management and Research.2020; Volume 12: 7681.     CrossRef
• Laparoscopic Transabdominal Dissection and Transection of the Distal Rectum Followed by Local Excision Through the Anus for Rectal Gastrointestinal Stromal Tumor
  Shin Emoto, Takashi Akiyoshi, Koji Fukata, Toshiya Nagasaki, Yosuke Fukunaga
  Diseases of the Colon & Rectum.2020; 63(11): e542.     CrossRef
• Laparoscopic resectional oesophago-gastroplasty: a novel technique for minimally invasive treatment of large high gastric lesser curve GIST involving gastroesophageal junction
  Mang Yik Foo, Baldwin P M Yeung, Jeremy T H Tan
  Journal of Surgical Case Reports.2020;[Epub]     CrossRef
• Clinical features of multiple gastrointestinal stromal tumors: A pooling analysis combined with evidence and gap map
  Chen Li, Ke-Lu Yang, Quan Wang, Jin-Hui Tian, Yang Li, Zhi-Dong Gao, Xiao-Dong Yang, Ying-Jiang Ye, Ke-Wei Jiang
  World Journal of Gastroenterology.2020; 26(47): 7550.     CrossRef
• Application of NOTES combined with ESD for the treatment of an exogenous gastric stromal tumor: A case report and review of the literature
  Xiao-Bo Liu, Zi-Ye Gao, Sandeep Pandey, Bao-Zhen Shan, Ping Liu, Chuan-Tao Sun, Sheng-Bao Li, Shu Jin
  World Academy of Sciences Journal.2020;[Epub]     CrossRef
• Laparoscopic versus open resection of gastrointestinal stromal tumors: survival outcomes from the NCDB
  Colette S. Inaba, Austin Dosch, Christina Y. Koh, Sarath Sujatha-Bhaskar, Marija Pejcinovska, Brian R. Smith, Ninh T. Nguyen
  Surgical Endoscopy.2019; 33(3): 923.     CrossRef
• Gastric sub-epithelial tumors: identification of gastrointestinal stromal tumors using CT with a practical scoring method
  Ming Liu, Liheng Liu, Erhu Jin
  Gastric Cancer.2019; 22(4): 769.     CrossRef
• Per oral endoscopic tumor (POET) resection for treatment of upper gastrointestinal subepithelial tumors
  Philip Wai Yan Chiu, Hon Chi Yip, Anthony Yuen Bun Teoh, Vivien Wai Yin Wong, Shannon Melissa Chan, Simon Kin Hung Wong, Enders Kwok Wai Ng
  Surgical Endoscopy.2019; 33(4): 1326.     CrossRef
• Long‐term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14‐year, single‐center experience
  Jwa Hoon Kim, Min‐Hee Ryu, Changhoon Yoo, Heejung Chae, Hana Na, Moyoul Beck, Beom Su Kim, Moon‐Won Yoo, Jeong Hwan Yook, Byung Sik Kim, Ki‐Hun Kim, Chan Wook Kim, Yoon‐Koo Kang
  Cancer Medicine.2019; 8(3): 1034.     CrossRef
• PRE-OPERATIVE GASTRIC GIST DOWNSIZING: THE IMPORTANCE OF NEOADJUVANT THERAPY
  João Bernardo Sancio Rocha RODRIGUES, Renato Gomes CAMPANATI, Francisco NOLASCO, Athos Miranda BERNARDES, Soraya Rodrigues de Almeida SANCHES, Paulo Roberto SAVASSI-ROCHA
  ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo).2019;[Epub]     CrossRef
• Value of contrast‐enhanced harmonic endoscopic ultrasonography in differentiating between gastrointestinal stromal tumors: A meta‐analysis
  Jia Yue Tang, Ke Gong Tao, Li Yuan Zhang, Kai Ming Wu, Jian Shi, Xin Zeng, Yong Lin
  Journal of Digestive Diseases.2019; 20(3): 127.     CrossRef
• Future of full thickness resection – Devices, indications, robotics, what is missing
  Philip WY Chiu
  Techniques in Gastrointestinal Endoscopy.2019; 21(1): 48.     CrossRef
• Clinicopathological Features and Prognosis of Small Gastric Gastrointestinal Stromal Tumors (GISTs)
  Mincong Wang, Anwei Xue, Wei Yuan, Xiaodong Gao, Min Fu, Yong Fang, Li Wang, Ping Shu, He Li, Yingyong Hou, Kuntang Shen, Yinghong Sun, Xinyu Qin
  Journal of Gastrointestinal Surgery.2019; 23(11): 2136.     CrossRef
• Intra-abdominal desmoid tumors mimicking gastrointestinal stromal tumors —8 cases: A case report
  Jwa Hoon Kim, Min-Hee Ryu, Young Soo Park, Hyun Jin Kim, Hyojung Park, Yoon-Koo Kang
  World Journal of Gastroenterology.2019; 25(16): 2010.     CrossRef
• Primary hepatic gastrointestinal stromal tumor with right adrenal gland invasion
  Liangliang Xu, Ming Zhang, Mingqing Xu
  Medicine.2019; 98(20): e15482.     CrossRef
• Endoscopic full-thickness resection for a gastrointestinal stromal tumor in a liver transplant recipient
  Man Xie, Wei Rao, Peng Zhang, Qingxi Zhao, Zibin Tian
  Medicine.2019; 98(31): e16669.     CrossRef
• Association of Hepatic Nuclear Factor 4 Alpha Gene Polymorphisms With Free Imatinib Plasma Levels and Adverse Reactions in Chinese Gastrointestinal Stromal Tumor Patients
  Hanmei Chen, Jing Liu, Yuhong Zhou, Yingyong Hou, Guo Ma, Weimin Cai
  Therapeutic Drug Monitoring.2019; 41(5): 582.     CrossRef
• Value of CT-Based Texture Analysis in Preoperative Prediction of the Grade of Gastrointestinal Stromal Tumors Compared to Conventional CT Imaging
  Caiyue Ren, Shengping Wang, Shengjian Zhang, Zhaoxia Jiang
  Iranian Journal of Radiology.2019;[Epub]     CrossRef
• Excision of a Large Gastrointestinal Stromal Tumour Following 16 Months of Neoadjuvant Therapy with Imatinib (Case Report)
  Fousséni Alassani, Boyodi Tchangai, Aklesso Bagny, Ablavi A. Adani-Ife, Kossigan A. Amavi, Tchin Darre, Komla Attipou
  Oncology and Therapy.2019; 7(2): 159.     CrossRef
• Clinical Relevance of the Location of Gastric Gastrointestinal Stromal Tumors
  Eun Jeong Gong
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2019; 19(3): 143.     CrossRef
• Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses
  Hyungwoo Cho, Min-Hee Ryu, Yongjune Lee, Young Soo Park, Ki-Hun Kim, Jwa Hoon Kim, Yangsoon Park, Sun Mi Lee, Chan Wook Kim, Beom Soo Kim, Moon-Won Yoo, Yoon-Koo Kang
  The Oncologist.2019; 24(12): e1443.     CrossRef
• Gastrointestinal stromal tumors: Do we follow the current guidelines? A self-critique
  MohammadEzzedien Rabie, Abdelelah Hummadi, Mohammad Bazeed, Ismail El Hakeem, AbdullaSaad Al Qahtani, Hesham Haroon, Abbas Al Zain
  Saudi Surgical Journal.2019; 7(3): 100.     CrossRef
• Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib
  Jae-Joon Kim, Min-Hee Ryu, Changhoon Yoo, Mo Youl Beck, Jung Eun Ma, Yoon-Koo Kang
  The Oncologist.2019; 24(11): e1212.     CrossRef
• The fourth space surgery: endoscopic subserosal dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria layer
  Fei Liu, Song Zhang, Wei Ren, Tian Yang, Ying Lv, Tingsheng Ling, Xiaoping Zou, Lei Wang
  Surgical Endoscopy.2018; 32(5): 2575.     CrossRef
• Robotic Gastrotomy With Intracorporeal Suture for Patients With Gastric Gastrointestinal Stromal Tumors Located at Cardia and Subcardiac Region
  Jian Zhao, Gang Wang, Zhiwei Jiang, Chuanwei Jiang, Jiang Liu, Jiahui Zhou, Jieshou Li
  Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2018; 28(1): e1.     CrossRef
• Subepitheliale Raumforderungen
  N. Glaser, R. Thimme, A. Schmidt
  Der Gastroenterologe.2018; 13(2): 113.     CrossRef
• Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours
  Simone Mocellin, Sandro Pasquali, Luca Campana, Yuhong Yuan, Alessandro Gronchi, Ewen Griffiths, Ravinder Vohra
  Cochrane Database of Systematic Reviews.2018;[Epub]     CrossRef
• Using the recurrence risk score by Joensuu to assess patients with gastrointestinal stromal tumor treated with adjuvant imatinib
  Jianwei Tang, Rui Zhao, Xiaobo Zheng, Liangliang Xu, Yong Wang, Lei Feng, Shengsheng Ren, Peng Wang, Ming Zhang, Mingqing Xu
  Medicine.2018; 97(29): e11400.     CrossRef
• A Novel Pathological Prognostic Score (PPS) to Identify “Very High-Risk” Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST)
  Xuechao Liu, Haibo Qiu, Zhiming Wu, Peng Zhang, Xingyu Feng, Tao Chen, Yong Li, Kaixiong Tao, Guoxin Li, Xiaowei Sun, Zhiwei Zhou
  Journal of Gastrointestinal Surgery.2018; 22(12): 2150.     CrossRef
• Inhibition of stromal‐interacting molecule 1‐mediated store‐operated Ca2+ entry as a novel strategy for the treatment of acquired imatinib‐resistant gastrointestinal stromal tumors
  Ziyi Yang, Lijia Pan, Shilei Liu, Fengnan Li, Wenjie Lv, Yijun Shu, Ping Dong
  Cancer Science.2018; 109(9): 2792.     CrossRef
• Standard Approach to Gastrointestinal Stromal Tumors - Differences between China and Europe
  Lin Tu, Peter Hohenberger, Heike Allgayer, Hui Cao
  Visceral Medicine.2018; 34(5): 353.     CrossRef
• Gastric ectopic pancreas mimicking a gastrointestinal stromal tumour: A case report
  Zdravko Štor, Jurij Hanžel
  International Journal of Surgery Case Reports.2018; 53: 348.     CrossRef
• Tumor rupture of gastric gastrointestinal stromal tumors during endoscopic resection: a risk factor for peritoneal metastasis?
  Shiyi Song, Wei Ren, Yi Wang, Shu Zhang, Song Zhang, Fei Liu, Qiang Cai, Guifang Xu, Xiaoping Zou, Lei Wang
  Endoscopy International Open.2018; 06(08): E950.     CrossRef
• Drill needle aspiration biopsy for submucosal tumors in an experimental study
  Masaya Uesato, Tomohide Tamachi, Naoyuki Hanari, Yorihiko Muto, Akiko Kagaya, Ryuma Urahama, Yukiko Ogura, Hiroshi Suito, Akira Nakano, Mizuho Aikawa, Takashi Oide, Hisahiro Matsubara
  Gastric Cancer.2017; 20(3): 475.     CrossRef
• Tumor del estroma extragastrointestinal primario hepático gigante
  Ana María Carrillo Colmenero, Mario Serradilla Martín, Manuel de Dios Redondo Olmedilla, Francisco Manuel Ramos Pleguezuelos, Pedro López Leiva
  Cirugía Española.2017; 95(9): 547.     CrossRef
• Cancer biology of small gastrointestinal stromal tumors (<2 cm): What is the risk of malignancy?
  K. Søreide
  European Journal of Surgical Oncology (EJSO).2017; 43(7): 1344.     CrossRef
• An unexpected cause of gastric submucosal lesion
  Rachid Guimarães Nagem
  Einstein (São Paulo).2017; 15(1): 112.     CrossRef
• Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST)
  Mónica Ballesteros, Nadia Montero, Antonio López-Pousa, Gerard Urrútia, Ivan Solà, Gabriel Rada, Hector Pardo-Hernandez, Xavier Bonfill
  BMC Medical Research Methodology.2017;[Epub]     CrossRef
• Laparoscopic management of gastric gastrointestinal stromal tumors: A retrospective 10-year single-center experience
  Guan-Qun Liao, Tao Chen, Xiao-Long Qi, Yan-Feng Hu, Hao Liu, Jiang Yu, Guo-Xin Li
  World Journal of Gastroenterology.2017; 23(19): 3522.     CrossRef
• Current research and treatment for gastrointestinal stromal tumors
  Kheng Tian Lim, Kok Yang Tan
  World Journal of Gastroenterology.2017; 23(27): 4856.     CrossRef
• Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16 Ink4A /p14 ARF gene expressions: An in vivo and in vitro study
  Jiang-Li Wang, Jiang-Hong Wu, Cai Hong, Ya-Nong Wang, Ye Zhou, Zi-Wen Long, Ying Zhou, Hai-Shu Qin
  Pathology - Research and Practice.2017; 213(12): 1542.     CrossRef
• Giant Primary Extra Gastrointestinal Stromal Tumor of the Liver
  Ana María Carrillo Colmenero, Mario Serradilla Martín, Manuel de Dios Redondo Olmedilla, Francisco Manuel Ramos Pleguezuelos, Pedro López Leiva
  Cirugía Española (English Edition).2017; 95(9): 547.     CrossRef
• Adjuvant imatinib for patients with high-risk gastrointestinal stromal tumors: a retrospective cohort study
  Rui Zhao, Yong Wang, Yuqian Huang, Yaping Cui, Lin Xia, Yi Chen, Wen Zhuang, Yong Zhou, Xiaoting Wu
  Scientific Reports.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• An open, multicenter, exploratory study of apatinib mesylate maintenance therapy for recurrent/metastatic head and neck squamous cell carcinoma (ChiCTR1800019375)
  Jinlong Wei, Jing Su, Jianfeng Wang, Xiaojing Jia, Qin Zhao, Weiyan Shi, Huanhuan Wang, Zhuangzhuang Zheng, Xin Jiang
  Head & Neck.2024; 46(4): 915.     CrossRef
• The Prognostic Role of Perineural Invasion for Survival in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
  Zhuo-Ying Tao, Guang Chu, Yu-Xiong Su
  Cancers.2024; 16(14): 2514.     CrossRef
• Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review
  Sam Dowthwaite, James Jackson, Marcin Dzienis, Eric Khoo, Mathew Cronin, Emily Guazzo
  Current Oncology Reports.2023; 25(5): 501.     CrossRef
• A Mn-doped calcium phosphate nanoparticle-based multifunctional nanocarrier for targeted drug delivery and cellular MR imaging
  Chaohui Zhou, Shenglei Hou, Chusen Huang, Nengqin Jia
  Journal of Nanoparticle Research.2022;[Epub]     CrossRef
• Importance of lymph node ratio in HPV-related oropharyngeal cancer patients treated with surgery and adjuvant treatment
  Kyu Hye Choi, Jin Ho Song, Ji Hyun Hong, Youn Soo Lee, Jin Hyoung Kang, Dong-Il Sun, Min-Sik Kim, Yeon-Sil Kim, Yifei Wang
  PLOS ONE.2022; 17(8): e0273059.     CrossRef
• 18F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer
  Gwenaelle Creff, Franck Jegoux, Xavier Palard, Adrien Depeursinge, Ronan Abgral, Remi Marianowski, Jean-Christophe Leclere, Thomas Eugene, Olivier Malard, Renaud De Crevoisier, Anne Devillers, Joel Castelli
  Journal of Nuclear Medicine.2022; 63(9): 1378.     CrossRef
• Risk stratification of postoperative recurrence in hypopharyngeal squamous-cell carcinoma patients with nodal metastasis
  Hanqing Lin, Tian Wang, Yu Heng, Xiaoke Zhu, Liang Zhou, Ming Zhang, Yong Shi, Pengyu Cao, Lei Tao
  Journal of Cancer Research and Clinical Oncology.2021; 147(3): 803.     CrossRef
• A two-fold interpenetration pillar-layered metal-organic frameworks based on BODIPY for chemo-photodynamic therapy
  Yang Meng, Yingying Du, Yanxin Lin, Yu Su, Ruonan Li, Yaqing Feng, Shuxian Meng
  Dyes and Pigments.2021; 188: 109174.     CrossRef
• Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia
  Chichao Xia, Sile Li, Teng Long, Zigui Chen, Paul K. S. Chan, Siaw Shi Boon
  Cancers.2021; 13(11): 2691.     CrossRef
• Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer
  Gwenaelle Creff, Anne Devillers, Adrien Depeursinge, Xavier Palard-Novello, Oscar Acosta, Franck Jegoux, Joel Castelli
  JAMA Otolaryngology–Head & Neck Surgery.2020; 146(5): 471.     CrossRef
• Sequentially self-assembled polysaccharide-based nanocomplexes for combined chemotherapy and photodynamic therapy of breast cancer
  Yaping Wang, Ming Yang, Junmin Qian, Weijun Xu, Jinlei Wang, Guanghui Hou, Lijie Ji, Aili Suo
  Carbohydrate Polymers.2019; 203: 203.     CrossRef
• Self-assembly of photosensitive and chemotherapeutic drugs for combined photodynamic-chemo cancer therapy with real-time tracing property
  Shengtao Wang, Jingtao Li, Zhou Ye, Jieling Li, Anhe Wang, Jing Hu, Shuo Bai, Jian Yin
  Colloids and Surfaces A: Physicochemical and Engineering Aspects.2019; 574: 44.     CrossRef
• Patterns of recurrence in oral tongue cancer with perineural invasion
  Jennifer R. Cracchiolo, Bin Xu, Jocelyn C. Migliacci, Nora Katabi, David G. Pfister, Nancy Y. Lee, Snehal G. Patel, Ronald A. Ghossein, Richard J. Wong
  Head & Neck.2018; 40(6): 1287.     CrossRef
• Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy
  Yumin Zhang, Fan Huang, Chunhua Ren, Lijun Yang, Jianfeng Liu, Zhen Cheng, Liping Chu, Jinjian Liu
  ACS Applied Materials & Interfaces.2017; 9(15): 13016.     CrossRef

Citations

Citations to this article as recorded by  

• Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis
  Samuel A. Kareff, Kunal Gawri, Khadeja Khan, Deukwoo Kwon, Estelamari Rodriguez, Gilberto de Lima Lopes, Richa Dawar
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum–Based Chemotherapy Failure Setting
  Yu Yang Soon, Wesley Furnback, Jin Kim, Po-Ya Chuang, Gordon Chavez, Christina Proescholdt, Cloe Ying Chee Koh
  JTO Clinical and Research Reports.2023; 4(11): 100579.     CrossRef
• Safety and effectiveness of ramucirumab and docetaxel: a single-arm, prospective, multicenter, non-interventional, observational, post-marketing safety study of NSCLC in Japan
  Yucherng Chen, Soshi Nagaoka, Taeko Katayose, Nobuyuki Sekine
  Expert Opinion on Drug Safety.2022; 21(5): 691.     CrossRef
• Validity of the Cancer and Aging Research Group Predictive Tool in Older Japanese Patients
  Hirotaka Suto, Yumiko Inui, Atsuo Okamura
  Cancers.2022; 14(9): 2075.     CrossRef
• Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan
  Yu Kondo, Tomoya Tachi, Takayoshi Sakakibara, Jun Kato, Aki Kato, Takahito Mizuno, Yoshio Miyake, Hitomi Teramachi
  Supportive Care in Cancer.2022; 30(8): 6775.     CrossRef
• Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)
  Yuankai Shi, Lin Wu, Xinmin Yu, Puyuan Xing, Yan Wang, Jianying Zhou, Airong Wang, Jianhua Shi, Yi Hu, Ziping Wang, Guangyu An, Yong Fang, Sanyuan Sun, Caicun Zhou, Changli Wang, Feng Ye, Xingya Li, Junye Wang, Mengzhao Wang, Yunpeng Liu, Yanqiu Zhao, Yin
  Cancer Communications.2022; 42(12): 1314.     CrossRef
• The Relevance of Docetaxel-related Febrile Neutropenia to Patient-reported Symptoms and the Quality of Life in Japanese, East Asian (Korean, Taiwanese), and Non-East Asian Patients Based on Post-hoc Analyses of Two Randomized Clinical Trials of Docetaxel
  Yukie Omori, Sotaro Enatsu, Alan J.M. Brnabic, Narayan Rajan, Jin-Yuan Shih, Joo-Hang Kim, Keunchil Park, Akira Inoue
  Haigan.2019; 59(7): 1140.     CrossRef
• Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer
  Mark A. Socinski, Coleman Obasaju, David Gandara, Fred R. Hirsch, Philip Bonomi, Paul A. Bunn, Edward S. Kim, Corey J. Langer, Ronald B. Natale, Silvia Novello, Luis Paz-Ares, Maurice Pérol, Martin Reck, Suresh S. Ramalingam, Craig H. Reynolds, David R. S
  Journal of Thoracic Oncology.2018; 13(2): 165.     CrossRef
• Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?
  Stefano Frega, Laura Bonanno, Valentina Guarneri, Pierfranco Conte, Giulia Pasello
  Critical Reviews in Oncology/Hematology.2018; 128: 19.     CrossRef
• Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials
  Chia-Jui Yen, Kei Muro, Tae-Won Kim, Masatoshi Kudo, Jin-Yuan Shih, Keun-Wook Lee, Yee Chao, Sang-We Kim, Kentaro Yamazaki, JooHyuk Sohn, Rebecca Cheng, Yawei Zhang, Polina Binder, Gu Mi, Mauro Orlando, Hyun Cheol Chung
  Journal of Global Oncology.2018; (4): 1.     CrossRef
• Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer
  Makoto Nishio, Dong-Wan Kim, Yi-Long Wu, Kazuhiko Nakagawa, Benjamin J. Solomon, Alice T. Shaw, Satoshi Hashigaki, Emiko Ohki, Tiziana Usari, Jolanda Paolini, Anna Polli, Keith D. Wilner, Tony Mok
  Cancer Research and Treatment.2018; 50(3): 691.     CrossRef
• The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum
  Takumi Fujiwara, Hirotsugu Kenmotsu, Tateaki Naito, Takahisa Kawamura, Nobuaki Mamesaya, Mie Kotake, Haruki Kobayashi, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Tetsuhiko Taira, Haruyasu Murakami, Katsuhiro Omae, Keita Mori, Masahiro E
  Cancer Chemotherapy and Pharmacology.2017; 79(6): 1229.     CrossRef
• The safety and efficacy of ramucirumab in combination with docetaxel in the treatment of lung cancer
  Valérie Paulus, Virginie Avrillon, Maurice Pérol
  Expert Review of Anticancer Therapy.2016; 16(11): 1119.     CrossRef
• Recommendations of the Austrian Working Group on Pulmonary Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
  Helmut H. Popper, Ulrike Gruber-Mösenbacher, Georg Hutarew, Maximilian Hochmair, Gudrun Absenger, Luka Brcic, Leonhard Müllauer, Gerhard Dekan, Ulrike Setinek, Dagmar Krenbek, Michael Vesely, Robert Pirker, Wolfgang Hilbe, Rainer Kolb, Gerald Webersinke,
  memo - Magazine of European Medical Oncology.2016; 9(4): 191.     CrossRef

Citations

Citations to this article as recorded by  

• Radiotherapy in the management of lung oligometastases
  V. Bourbonne, A. Lévy, J. Khalifa, D. Antoni, E. Blais, J. Darréon, C. Le Péchoux, D. Lerouge, P. Giraud, A. Marguerit, N. Pourel, F.-G. Riet, S. Thureau
  Cancer/Radiothérapie.2024; 28(1): 36.     CrossRef
• Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer
  Kyungmi Yang, Jae Myoung Noh, Hye Yun Park, Hongseok Yoo, Sun Hye Shin, Hongryull Pyo
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC) Therapy
  Zixuan Lyu, Chiming Wei
  Cancer Research Journal.2024; 12(2): 27.     CrossRef
• Accelerated Hypofractionated Radiotherapy for Centrally Located Lung Tumours Not Suitable for Stereotactic Body Radiotherapy or Chemoradiotherapy
  K.L. Zeng, I. Poon, Y. Ung, M. Tsao, L. Zhang, A. Cumal, A.V. Louie, P. Cheung
  Clinical Oncology.2023; 35(2): e173.     CrossRef
• An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
  Izabela Zarębska, Maciej Harat
  Thoracic Cancer.2023; 14(28): 2813.     CrossRef
• Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer
  Kyungmi Yang, Yang-Gun Suh, Hyunju Shin, Hongryull Pyo, Sung Ho Moon, Yong Chan Ahn, Dongryul Oh, Eunah Chung, Kwanghyun Jo, Jae Myoung Noh
  Life.2022; 12(2): 292.     CrossRef
• Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis
  Jae Myoung Noh, Hongseok Yoo, Woojin Lee, Hye Yun Park, Sun Hye Shin, Hongryull Pyo
  Cancers.2022; 14(6): 1445.     CrossRef
• Hypofractionated Postoperative Radiation Therapy for Breast Cancer – Do We Need More Evidence or Adapted Reimbursement Policies?
  Monica-Emilia Chirilă, Ivica Ratosa, Gustavo Nader Marta, Philip Poortmans
  Journal of Medical and Radiation Oncology.2021; 1(1): 83.     CrossRef
• Radiotherapy for Lung Cancer During the COVID Pandemic – A Narrative Review of Practical Recommendations
  Prasenjit Chatterjee, Jibak Bhattacharya, Tanmay Ghosh, Biplap Sarkar, Monica-Emilia Chirilă, Sushmita Roy Chowdhury, Syamasis Bandyopadhyay, Jayaprakash Agarwal
  Journal of Medical and Radiation Oncology.2021; 1(1): 99.     CrossRef
• Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic
  C. Faivre-Finn, J.D. Fenwick, K.N. Franks, S. Harrow, M.Q.F. Hatton, C. Hiley, J.J. McAleese, F. McDonald, J. O'Hare, C. Peedell, T. Pope, C. Powell, R. Rulach, E. Toy
  Clinical Oncology.2020; 32(8): 481.     CrossRef
• Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak
  Zhongxing Liao, Eleonor Rivin del Campo, Ahmed Salem, Qingsong Pang, Hui Liu, Jose Luis Lopez Guerra
  Lung Cancer.2020; 146: 230.     CrossRef
• Radiation dose intensity and local tumour control of non-small cell lung cancer: A radiobiological modelling perspective
  M Alaswad, C Kleefeld, M Foley
  Journal of Physics: Conference Series.2019; 1248(1): 012071.     CrossRef

Citations

Citations to this article as recorded by  

• P4HA1 is highly expressed in gastric cancer and promotes proliferation and metastasis of gastric cancer cells
  PeiYao Gao, HengJin Tian, KunPeng Ge, FeiFan Wang, YanMing Zhao, JiWen Sun, Qiang Zhang
  Discover Oncology.2025;[Epub]     CrossRef
• Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer
  Peng Chen, Amit Sharma, Hans Weiher, Ingo G.H. Schmidt-Wolf
  Journal of Experimental & Clinical Cancer Research.2024;[Epub]     CrossRef
• Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma
  Xuebing Zhou, Yuan Li, Chunyu Yang, Dan Chen, Tong Wang, Tesi Liu, Wendi Yan, Zhaoxia Su, Bosen Peng, Xiangshan Ren
  Life Sciences.2023; 327: 121698.     CrossRef
• ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway
  Min Wu, Ruixue Li, Jianyan Qin, Ziyuan Wang, Jiasen Guo, Fenghong Lv, Guoqin Wang, Youguang Huang
  Journal of Molecular Histology.2023; 54(6): 621.     CrossRef
• Identification of novel small molecule inhibitors for endoplasmic reticulum oxidoreductase 1α (ERO1α) enzyme: structure-based molecular docking and molecular dynamic simulation studies
  Hussam Albassam, Chetan H. Mehta, Usha Y. Nayak
  Journal of Biomolecular Structure and Dynamics.2022; 40(23): 13218.     CrossRef
• MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha
  Gang Chen, Qihao Wang, Kunyu Wang
  Bioengineered.2022; 13(4): 10061.     CrossRef
• ERO1L promotes the proliferation and metastasis of lung adenocarcinoma via the Wnt2/β‐catenin signaling pathway
  Jinbao Xie, Guoliang Liao, Zhi Feng, Bo Liu, Xu Li, Minglian Qiu
  Molecular Carcinogenesis.2022; 61(10): 897.     CrossRef
• Current therapeutic options for gastric adenocarcinoma
  C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
  Saudi Journal of Biological Sciences.2021; 28(9): 5371.     CrossRef
• circ‑ACACA promotes proliferation, invasion, migration and glycolysis of cervical cancer cells by targeting the miR‑582‑5p/ERO1A signaling axis
  Dandan Huang, Cuimei Li
  Oncology Letters.2021;[Epub]     CrossRef
• Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients
  Li Li, Xiaodong Yin, Hai Meng, Juanyu Hu, Zhengqing Yu, Jianyong Xu
  Yonsei Medical Journal.2020; 61(1): 15.     CrossRef
• Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities
  Zifeng Song, Martin C. Pearce, Yuan Jiang, Liping Yang, Cheri Goodall, Cristobal L. Miranda, Milan Milovancev, Shay Bracha, Siva K. Kolluri, Claudia S. Maier
  Scientific Reports.2020;[Epub]     CrossRef
• Role of the ERO1-PDI interaction in oxidative protein folding and disease
  Andrea G. Shergalis, Shuai Hu, Armand Bankhead, Nouri Neamati
  Pharmacology & Therapeutics.2020; 210: 107525.     CrossRef
• Perineural Invasion and Postoperative Adjuvant Chemotherapy Efficacy in Patients With Gastric Cancer
  Qing Tao, Wen Zhu, Xiaohui Zhao, Mei Li, Yongqian Shu, Deqiang Wang, Xiaoqin Li
  Frontiers in Oncology.2020;[Epub]     CrossRef
• ERO1L promotes NSCLC development by modulating cell cycle‐related molecules
  Xiujuan Shi, Jiawen Wu, Yi Liu, Yuxiong Jiang, Changjiang Zhi, Jue Li
  Cell Biology International.2020; 44(12): 2473.     CrossRef
• ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells
  Yuanyuan lei, Ruochuan Zang, Zhiliang Lu, Guochao Zhang, Jianbing Huang, Chengming Liu, Zhanyu Wang, Shuangshuang Mao, Yun Che, Xinfeng Wang, Sufei Zheng, Lingling Fang, Nan Sun, Jie He
  Cell Death & Disease.2020;[Epub]     CrossRef
• Hypoxia and Reactive Oxygen Species as Modulators of Endoplasmic Reticulum and Golgi Homeostasis
  Daniela Mennerich, Sakari Kellokumpu, Thomas Kietzmann
  Antioxidants & Redox Signaling.2019; 30(1): 113.     CrossRef
• Endoplasmic reticulum proteostasis control and gastric cancer
  Yu Wang, Kai Wang, Yang Jin, Xia Sheng
  Cancer Letters.2019; 449: 263.     CrossRef
• Analysis of the characteristics and expression profiles of coding and noncoding RNAs of human dental pulp stem cells in hypoxic conditions
  Ruitang Shi, Haoqing Yang, Xiao Lin, Yangyang Cao, Chen Zhang, Zhipeng Fan, Benxiang Hou
  Stem Cell Research & Therapy.2019;[Epub]     CrossRef
• A2ML1and otitis media: novel variants, differential expression, and relevant pathways
  Eric D. Larson, Jose Pedrito M. Magno, Matthew J. Steritz, Erasmo Gonzalo d.V. Llanes, Jonathan Cardwell, Melquiadesa Pedro, Tori Bootpetch Roberts, Elisabet Einarsdottir, Rose Anne Q. Rosanes, Christopher Greenlee, Rachel Ann P. Santos, Ayesha Yousaf, Sv
  Human Mutation.2019;[Epub]     CrossRef
• ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
  Anastasiya V. Snezhkina, Anna V. Kudryavtseva, Olga L. Kardymon, Maria V. Savvateeva, Nataliya V. Melnikova, George S. Krasnov, Alexey A. Dmitriev
  Oxidative Medicine and Cellular Longevity.2019; 2019: 1.     CrossRef
• Control of Protein Homeostasis in the Early Secretory Pathway: Current Status and Challenges
  Daria Sicari, Aeid Igbaria, Eric Chevet
  Cells.2019; 8(11): 1347.     CrossRef
• ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer
  Nikhil Gupta, Jung Eun Park, Wilford Tse, Jee Keem Low, Oi Lian Kon, Neil McCarthy, Siu Kwan Sze
  Oncotarget.2019; 10(57): 5970.     CrossRef
• Polyamine Metabolism and Oxidative Protein Folding in the ER as ROS-Producing Systems Neglected in Virology
  Olga A. Smirnova, Birke Bartosch, Natalia F. Zakirova, Sergey N. Kochetkov, Alexander V. Ivanov
  International Journal of Molecular Sciences.2018; 19(4): 1219.     CrossRef
• Combined expression of protein disulfide isomerase and endoplasmic reticulum oxidoreductin 1‑α is a poor prognostic marker for non‑small cell lung cancer
  Kyoung Kim, Ae An, Ho Park, Kyu Jang, Woo Moon, Myoung Kang, Yong Lee, Ja Ku, Myoung Chung
  Oncology Letters.2018;[Epub]     CrossRef
• High expression of IRE1 in lung adenocarcinoma is associated with a lower rate of recurrence
  Toshio Sakatani, Keita Maemura, Noriko Hiyama, Yosuke Amano, Kousuke Watanabe, Hidenori Kage, Masashi Fukayama, Jun Nakajima, Yutaka Yatomi, Takahide Nagase, Daiya Takai
  Japanese Journal of Clinical Oncology.2017; 47(6): 543.     CrossRef
• Omics technologies in diagnostics of lung adenocarcinoma
  S.E. Novikova, L.K. Kurbatov, M.G. Zavialova, V.G. Zgoda, A.I. Archakov
  Biomeditsinskaya Khimiya.2017; 63(3): 181.     CrossRef
• Omics technologies in diagnosis of lung adenocarcinoma
  S. E. Novikova, L. K. Kurbatov, M. G. Zavialova, V. G. Zgoda, A. I. Archakov
  Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry.2017; 11(4): 309.     CrossRef
• Expression of ERO1L in gastric cancer and its association with patient prognosis
  Bo Zhou, Gongping Wang, Shegan Gao, Ye Chen, Canhui Jin, Zengfang Wang, Yantong Yang, Zhikun Ma, Wei Zhang, Xiaoshan Feng
  Experimental and Therapeutic Medicine.2017; 14(3): 2298.     CrossRef
• Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma
  Hongzhe Li, Xinjing Wang, Yuan Fang, Zhen Huo, Xiongxiong Lu, Xi Zhan, Xiaxin Deng, Chenghong Peng, Baiyong Shen
  Oncotarget.2017; 8(32): 52571.     CrossRef

Citations

Citations to this article as recorded by  

• Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights
  Geetika Kaur, Bipradas Roy
  Biomedicines.2024; 12(4): 827.     CrossRef
• Current trends in the characterization and monitoring of vascular response to cancer therapy
  Binita Shrestha, Noah B Stern, Annie Zhou, Andrew Dunn, Tyrone Porter
  Cancer Imaging.2024;[Epub]     CrossRef
• Role of advanced imaging techniques in the evaluation of oncological therapies in patients with colorectal liver metastases
  Martina Caruso, Arnaldo Stanzione, Anna Prinster, Laura Micol Pizzuti, Arturo Brunetti, Simone Maurea, Pier Paolo Mainenti
  World Journal of Gastroenterology.2023; 29(3): 521.     CrossRef
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Monoclonal Antibody Tumor Disposition
  Brandon M. Bordeau, Joseph Ryan Polli, Ferdinand Schweser, Hans Peter Grimm, Wolfgang F. Richter, Joseph P. Balthasar
  International Journal of Molecular Sciences.2022; 23(2): 679.     CrossRef
• The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids
  Sarah Line Bring Truelsen, Nabi Mousavi, Haoche Wei, Lucy Harvey, Rikke Stausholm, Erik Spillum, Grith Hagel, Klaus Qvortrup, Ole Thastrup, Henrik Harling, Harry Mellor, Jacob Thastrup, Christina L. Addison
  PLOS ONE.2021; 16(7): e0253258.     CrossRef
• [18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer
  Rohini Sharma, Pablo Oriol Valls, Marianna Inglese, Suraiya Dubash, Michelle Chen, Hani Gabra, Ana Montes, Amarnath Challapalli, Mubarik Arshad, George Tharakan, Ed Chambers, Tom Cole, Jingky P. Lozano-Kuehne, Tara D. Barwick, Eric O. Aboagye
  European Journal of Nuclear Medicine and Molecular Imaging.2020; 47(5): 1239.     CrossRef
• Combination of DCE‐MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma
  Changmin Liu, Roger Sun, Jing Wang, Fangling Ning, Zhenbo Wang, Judong Luo, Shaoshui Chen, Shuanghu Yuan, Enzo Terreno
  BioMed Research International.2020;[Epub]     CrossRef
• Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging
  Pier Paolo Mainenti, Arnaldo Stanzione, Salvatore Guarino, Valeria Romeo, Lorenzo Ugga, Federica Romano, Giovanni Storto, Simone Maurea, Arturo Brunetti
  World Journal of Gastroenterology.2019; 25(35): 5233.     CrossRef
• Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients
  Matteo Morotti, Prashanth Hari Dass, Adrian L. Harris, Simon Lord
  European Journal of Drug Metabolism and Pharmacokinetics.2018; 43(2): 137.     CrossRef
• Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial
  Loïc Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Isabelle Ray-Coquard, Axel Le Cesne, Emmanuelle Bompas, Jean-Yves Blay, Antoine Italiano, Olivier Mir, Thomas Ryckewaert, Yves Toiron, Luc Camoin, Anthony Goncalves, Nicolas Penel, Marie-Cécile
  BMC Cancer.2018;[Epub]     CrossRef
• Functional Parameters Derived from Magnetic Resonance Imaging Reflect Vascular Morphology in Preclinical Tumors and in Human Liver Metastases
  Pavitra Kannan, Warren W. Kretzschmar, Helen Winter, Daniel Warren, Russell Bates, Philip D. Allen, Nigar Syed, Benjamin Irving, Bartlomiej W. Papiez, Jakob Kaeppler, Bosjtan Markelc, Paul Kinchesh, Stuart Gilchrist, Sean Smart, Julia A. Schnabel, Tim Mau
  Clinical Cancer Research.2018; 24(19): 4694.     CrossRef
• Dynamic Contrast-Enhanced Ultrasound of Colorectal Liver Metastases as an Imaging Modality for Early Response Prediction to Chemotherapy
  Marie Mogensen, Martin Hansen, Birthe Henriksen, Thomas Axelsen, Ben Vainer, Kell Osterlind, Michael Nielsen
  Diagnostics.2017; 7(2): 35.     CrossRef
• Nano-sized and other improved reporters for magnetic resonance imaging of angiogenesis
  Simonetta Geninatti Crich, Enzo Terreno, Silvio Aime
  Advanced Drug Delivery Reviews.2017; 119: 61.     CrossRef

Citations

Citations to this article as recorded by  

• Colorectal adenosquamous carcinoma: clinicopathologic analysis of two large cohorts and literature review confirm poor prognosis and reveal prognostic aspects
  Raul S Gonzalez, Rachel K Horton, Xuchen Zhang, Rondell P Graham, Teri A Longacre, Anupamjit Mehrotra, Daniela S Allende, Kelsey E McHugh, Jinru Shia, Maria Westerhoff, Amitabh Srivastava, Wei Chen, Jennifer Vazzano, Paul E Swanson, Deyali Chatterjee, Has
  Histopathology.2025;[Epub]     CrossRef
• Usefulness of Elastica van Gieson staining and the number of samples prepared for venous invasion of colorectal cancer (pT2–pT4)
  Kota Nakashima, Jun Akiba, Shinji Mizuochi, Masamichi Nakayama, Naohiro Yoshida, Kenichi Koushi, Takefumi Yoshida, Fumihiko Fujita, Hitoshi Obara, Tatsuyuki Kakuma, Yoshito Akagi, Hirohisa Yano
  Human Pathology Reports.2023; 31: 300690.     CrossRef
• Routine elastin staining improves venous invasion detection in colorectal carcinoma
  Hisham F. Bahmad, Ferial Alloush, Ali Salami, Rachel Sawah, Ciara Lusnia, Ekim Kilinc, Tyson Sutherland, Sarah Alghamdi, Robert J. Poppiti
  Annals of Diagnostic Pathology.2023; 66: 152170.     CrossRef
• The Usefulness of Elastin Staining to Detect Vascular Invasion in Cancer
  Jeffrey Gonzalez, Hisham F. Bahmad, Stephanie Ocejo, Alvaro Abreu, Meagan Popp, Samantha Gogola, Vielka Fernandez, Monica Recine, Robert Poppiti
  International Journal of Molecular Sciences.2023; 24(20): 15264.     CrossRef
• Reevaluation of Venous Invasion with Elastic Tissue Stain in Colorectal Cancers
  Ebru AKAY, Serdal Sadet ÖZCAN, Merve DOĞAN, Fatoş TEKELİOĞLU, Saliha KARAGÖZ EREN, Hatice KARAMAN
  Sakarya Medical Journal.2022;[Epub]     CrossRef
• Addition of V-Stage to Conventional TNM Staging to Create the TNVM Staging System for Accurate Prediction of Prognosis in Colon Cancer: A Multi-Institutional Retrospective Cohort Study
  Jung Hoon Bae, Ji Hoon Kim, Jaeim Lee, Bong-Hyeon Kye, Sang Chul Lee, In Kyu Lee, Won Kyung Kang, Hyeon-Min Cho, Yoon Suk Lee
  Biomedicines.2021; 9(8): 888.     CrossRef
• Feasibility and Performance of Elastin Trichrome as a Primary Stain in Colorectal Cancer Resection Specimens
  Sameer Shivji, Ipshita Kak, Stephanie L. Reid, Jennifer Muir, Sara Hafezi-Bakhtiari, Hector Li-Chang, Ardit Deliallisi, Ken J. Newell, Andrea Grin, James Conner, Richard Kirsch
  American Journal of Surgical Pathology.2021; 45(10): 1419.     CrossRef
• Comparison of Vascular Invasion With Lymph Node Metastasis as a Prognostic Factor in Stage I-III Colon Cancer: An Observational Cohort Study
  Jung Hoon Bae, Ji Hoon Kim, Bong-Hyeon Kye, Abdullah Al-Sawat, Chul Seung Lee, Seung-Rim Han, In Kyu Lee, Sung Hak Lee, Yoon Suk Lee
  Frontiers in Surgery.2021;[Epub]     CrossRef
• Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion
  Seung-Mo Hong, DongJun Jung, Ashley Kiemen, Matthias M. Gaida, Tadashi Yoshizawa, Alicia M. Braxton, Michaël Noë, Gemma Lionheart, Kiyoko Oshima, Elizabeth D. Thompson, Richard Burkhart, Pei-Hsun Wu, Denis Wirtz, Ralph H. Hruban, Laura D. Wood
  Modern Pathology.2020; 33(4): 639.     CrossRef
• Prognostic significance of venous invasion in node‐negative head and neck squamous cell carcinoma
  Arun Gopinath, Aysha Mubeen, Brett Baskovich, Ibraheem Mohammed, Raafat Makary, Erica S. Hoy, Roi Dagan, Carmen Smotherman, Shiva Gautam, Rui P. Fernandes, Anthony M. Bunnell, Phillip Pirgousis, Ahmad Alkhasawneh
  Journal of Oral Pathology & Medicine.2020; 49(2): 150.     CrossRef
• Comparison of the efficiency of transgelin, smooth muscle myosin, and CD31 antibodies for the assessment of vascular tumor invasion and free tumor deposits in gastric, pancreatic, and colorectal adenocarcinomas
  Betul Ogut, Ozgur Ekinci, Bulent Celik, EmelRodoplu Unal, Ayse Dursun
  Indian Journal of Pathology and Microbiology.2020; 63(1): 25.     CrossRef
• Elastin and collagen IV double staining: A refined method to detect blood vessel invasion in breast cancer
  Masayoshi Fujisawa, Masako Omori, Hiroyoshi Doihara, Ye‐Min Than, Hnin Wint Wint Swe, Teizo Yoshimura, Akihiro Matsukawa
  Pathology International.2020; 70(9): 612.     CrossRef
• Incidence of extramural venous invasion in colorectal carcinoma as determined at the invasive tumor front and its prognostic impact
  Klaus Dirschmid, William Sterlacci, Ewald Wöll, Peter Tschann, Michaela Rhomberg, Felix Offner
  Human Pathology.2019; 86: 102.     CrossRef
• Why is pancreatic cancer so deadly? The pathologist's view
  Ralph H Hruban, Matthias M Gaida, Elizabeth Thompson, Seung‐Mo Hong, Michaël Noë, Lodewijk AA Brosens, Martine Jongepier, G Johan A Offerhaus, Laura D Wood
  The Journal of Pathology.2019; 248(2): 131.     CrossRef
• Rectal cancer and the pathologist
  Mariana Berho, Pablo A. Bejarano
  Minerva Chirurgica.2018;[Epub]     CrossRef
• Identifying molecular contributors to autofluorescence of neoplastic and normal colon sections using excitation-scanning hyperspectral imaging
  Joshua Deal, Sam Mayes, Craig Browning, Shante Hill, Paul Rider, Carole Boudreaux, Thomas C. Rich, Silas J. Leavesley
  Journal of Biomedical Optics.2018; 24(02): 1.     CrossRef

Citations

Citations to this article as recorded by  

• Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects
  Young Jun Kim, Junhong Min
  Analytical and Bioanalytical Chemistry.2024; 416(9): 2065.     CrossRef
• Diagnostic value of expressions of cancer stem cell markers for adverse outcomes of hepatocellular carcinoma and their associations with prognosis: A Bayesian network meta‑analysis
  Zhengrong Ou, Shoushuo Fu, Jian Yi, Jingxuan Huang, Weidong Zhu
  Oncology Letters.2024;[Epub]     CrossRef
• Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment
  Francesca Carissimi, Matteo Nazzareno Barbaglia, Livia Salmi, Cristina Ciulli, Linda Roccamatisi, Giuseppe Cordaro, Venkata Ramana Mallela, Rosalba Minisini, Biagio Eugenio Leone, Matteo Donadon, Guido Torzilli, Mario Pirisi, Fabrizio Romano, Simone Famul
  World Journal of Gastrointestinal Surgery.2021; 13(9): 967.     CrossRef
• Fabrication of Formalin-Fixed, Paraffin-Embedded (FFPE) Circulating Tumor Cell (CTC) Block Using a Hydrogel Core-Mediated Method
  Tae Hee Lee, Young Jun Kim, Woo Sun Rou, Hyuk Soo Eun
  Micromachines.2021; 12(9): 1128.     CrossRef
• Isolation and morphology of circulating tumor cells by cell block technique in breast cancer
  Nandini Agrawal, Rajpal S. Punia, Uma Handa, Ashok K. Attri
  Indian Journal of Pathology and Microbiology.2021; 64(2): 329.     CrossRef
• Circulating tumor cells in the clinical cancer diagnosis
  P. Zhang, H. Zhou, K. Lu, Y. Wang, T. Feng
  Clinical and Translational Oncology.2020; 22(3): 279.     CrossRef
• A microfluidic system based on the monoclonal antibody BCMab1 specifically captures circulating tumor cells from bladder cancer patients
  Yunchao Wang, Qing Liu, Tongyi Men, Ye Liang, Haitao Niu, Jianning Wang
  Journal of Biomaterials Science, Polymer Edition.2020; 31(9): 1199.     CrossRef
• The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy
  Feiyu Chen, Zhangfeng Zhong, Hor-Yue Tan, Ning Wang, Yibin Feng
  Cancers.2020; 12(7): 1734.     CrossRef
• The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis
  Theresa D. Ahrens, Sara R. Bang-Christensen, Amalie M. Jørgensen, Caroline Løppke, Charlotte B. Spliid, Nicolai T. Sand, Thomas M. Clausen, Ali Salanti, Mette Ø. Agerbæk
  Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
• Efficient Detection and Single-Cell Extraction of Circulating Tumor Cells in Peripheral Blood
  Rui Li, Zhiyi Gong, Kezhen Yi, Wei Li, Yichao Liu, Fubing Wang, Shi-shang Guo
  ACS Applied Bio Materials.2020; 3(9): 6521.     CrossRef
• Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer
  Ruizan Shi, Linhong Liu, Fengge Wang, Yifan He, Yanan Niu, Chang Wang, Xuanping Zhang, Xiuli Zhang, Huifeng Zhang, Min Chen, Yan Wang
  Cellular Signalling.2020; 76: 109810.     CrossRef
• Cell blocks in cytopathology: An update
  Aruna Nambirajan, Deepali Jain
  Cytopathology.2018; 29(6): 505.     CrossRef
• Cytopathological Study of the Circulating Tumor Cells filtered from the Cancer Patients’ Blood using Hydrogel-based Cell Block Formation
  Yoon-Tae Kang, Young Jun Kim, Tae Hee Lee, Young-Ho Cho, Hee Jin Chang, Hyun-Moo Lee
  Scientific Reports.2018;[Epub]     CrossRef
• Dual-patterned immunofiltration (DIF) device for the rapid efficient negative selection of heterogeneous circulating tumor cells
  Jiyoon Bu, Yoon-Tae Kang, Young Jun Kim, Young-Ho Cho, Hee Jin Chang, Hojoong Kim, Byung-In Moon, Ho Gak Kim
  Lab on a Chip.2016; 16(24): 4759.     CrossRef

Citations

Citations to this article as recorded by  

• Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study
  Christian Möhring, Moritz Berger, Farsaneh Sadeghlar, Xin Zhou, Taotao Zhou, Malte Benedikt Monin, Kateryna Shmanko, Sabrina Welland, Friedrich Sinner, Birgit Schwacha-Eipper, Ulrike Bauer, Christoph Roderburg, Angelo Pirozzi, Najib Ben Khaled, Peter Schr
  Cancers.2025; 17(6): 972.     CrossRef
• Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
  Sojung Han, Do Young Kim, Ho Yeong Lim, Jung-Hwan Yoon, Baek-Yeol Ryoo, Yujeong Kim, Kookhee Kim, Bo Yeon Kim, So Young Yi, Dong-Sook Kim, Do-Yeon Cho, Jina Yu, Suhyun Kim, Joong-Won Park
  Gut and Liver.2024; 18(1): 116.     CrossRef
• Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor
  Po-Ting Lin
  American Journal of Cancer Research.2024; 14(3): 1306.     CrossRef
• Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review
  Florian P. Reiter, Najib Ben Khaled, Liangtao Ye, Changhua Zhang, Max Seidensticker, Mark op den Winkel, Gerald Denk, Andreas Geier, Enrico N. De Toni
  Digestive Diseases.2022; 40(5): 565.     CrossRef
• Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
  Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
  Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
• Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research
  Francesca Negri, Gabriele Missale, Anna Degli Antoni, Camillo Porta
  Translational Oncology.2021; 14(9): 101153.     CrossRef
• Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial
  Beom Kyung Kim, Do Young Kim, Hwa Kyung Byun, Hye Jin Choi, Seung-Hoon Beom, Hye Won Lee, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Jinsil Seong, Kwang-Hyub Han
  International Journal of Radiation Oncology*Biology*Physics.2020; 107(1): 106.     CrossRef
• Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin
  Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Jong Yul Lee, Young Woon Kim, Dong Jae Shim, Sung Won Lee, Jeong Won Jang
  Cancer Control.2020;[Epub]     CrossRef
• Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry
  Young Eun Chon, Han Ah Lee, Jun Sik Yoon, Jun Yong Park, Bo Hyun Kim, In Joon Lee, Suk Kyun Hong, Dong Hyeon Lee, Hyun-Joo Kong, Eunyang Kim, Young-Joo Won, Jeong-Hoon Lee
  Journal of Liver Cancer.2020; 20(2): 135.     CrossRef

• Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

  
  Sojung Han, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Dai Hoon Han, Beom Kyung Kim
  Journal of Hepatocellular Carcinoma.2020; Volume 7: 403.     CrossRef
• Sorafenib: key lessons from over 10 years of experience
  Bernard Escudier, Francis Worden, Masatoshi Kudo
  Expert Review of Anticancer Therapy.2019; 19(2): 177.     CrossRef
• Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
  Hee Chul Nam, Pil Soo Sung, Ho Jong Chun, Dong Goo Kim, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon
  Journal of Liver Cancer.2019; 19(1): 64.     CrossRef
• 18F–fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment
  Pil Soo Sung, Hye Lim Park, Keungmo Yang, Seawon Hwang, Myeong Jun Song, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ie Ryung Yoo, Si Hyun Bae
  European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(3): 384.     CrossRef
• Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial
  Nikhil Chauhan, Janet Bukovcan, Eveline Boucher, David Cosgrove, Julien Edeline, Bonnie Hamilton, Laura Kulik, Fayaz Master, Riad Salem
  JMIR Research Protocols.2018; 7(8): e11234.     CrossRef
• Sorafenib: A Review in Hepatocellular Carcinoma
  Gillian M. Keating
  Targeted Oncology.2017; 12(2): 243.     CrossRef
• Treatment options after sorafenib failure in patients with hepatocellular carcinoma
  Imane El Dika, Ghassan K. Abou-Alfa
  Clinical and Molecular Hepatology.2017; 23(4): 273.     CrossRef
• Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway
  Sung Hoon Choi, Hyemi Kim, Hyun Gyu Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
  Oncotarget.2017; 8(35): 58974.     CrossRef

Citations

Citations to this article as recorded by  

• Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma—Cohort Study
  Su-Hyeong Park, In-Cheon Kang, Seung-Soo Hong, Ha-Yan Kim, Ho-Kyoung Hwang, Chang-Moo Kang
  Cancers.2024; 16(10): 1844.     CrossRef
• Clinical Outcomes of Proton Beam Therapy for Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Retrospective Study
  Ichiro Seto, Hisashi Yamaguchi, Yoshiaki Takagawa, Yusuke Azami, Kanako Takayama, Motohisa Suzuki, Masanori Machida, Yuntao Dai, Nor Shazrina Binti Sulaiman, Yasuhiro Kikuchi, Takahiro Kato, Noriyuki Nishino, Yasushi Teranishi, Masao Murakami
  Advances in Radiation Oncology.2024; 9(10): 101577.     CrossRef
• Predictors of Mortality in Patients with Advanced Cancer—A Systematic Review and Meta-Analysis
  Catherine Owusuaa, Simone A. Dijkland, Daan Nieboer, Agnes van der Heide, Carin C. D. van der Rijt
  Cancers.2022; 14(2): 328.     CrossRef
• Prognostic models to predict survival in patients with pancreatic cancer: A systematic review
  Liane J. Ioannou, Ashika D. Maharaj, John R. Zalcberg, Jesse T. Loughnan, Daniel G. Croagh, Charles HC. Pilgrim, David Goldstein, James G. Kench, Neil D. Merrett, Arul Earnest, Elizabeth A. Burmeister, Kate White, Rachel E. Neale, Sue M. Evans
  HPB.2022;[Epub]     CrossRef
• Development of a Clinical–Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial
  Julie Egea, Julia Salleron, Sophie Gourgou, Ahmet Ayav, Valérie Laurent, Béata Juzyna, Alexandre Harlé, Thierry Conroy, Aurélien Lambert
  Cancers.2022; 14(20): 5068.     CrossRef
• Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade
  Jin Shang, Xiao Han, Haoran Zha, Haitao Tao, Xiaoyan Li, Fang Yuan, Guangying Chen, Lijie Wang, Junxun Ma, Yi Hu
  Frontiers in Oncology.2021;[Epub]     CrossRef
• 71/m in reduziertem Allgemeinzustand mit Sklerenikterus
  M. Schönrock, M. Sinn
  Der Onkologe.2021; 27(S1): 109.     CrossRef
• Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer
  Alisa D. Kjaergaard, Inna M. Chen, Astrid Z. Johansen, Børge G. Nordestgaard, Stig E. Bojesen, Julia S. Johansen
  Cancers.2021; 13(18): 4599.     CrossRef
• Peripheral Blood Cell Variables Related to Systemic Inflammation in Patients With Unresectable or Metastatic Pancreatic Cancer
  Giuseppe Colloca, Antonella Venturino
  Pancreas.2021; 50(8): 1131.     CrossRef
• The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer
  Michael Shusterman, Erin Jou, Andreas Kaubisch, Jennifer W. Chuy, Lakshmi Rajdev, Santiago Aparo, Justin Tang, Nitin Ohri, Abdissa Negassa, Sanjay Goel
  Journal of Gastrointestinal Cancer.2020; 51(3): 868.     CrossRef
• Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores
  Piera Gargiulo, Daniel Dietrich, Richard Herrmann, György Bodoky, Thomas Ruhstaller, Werner Scheithauer, Bengt Glimelius, Simona Berardi, Sandro Pignata, Peter Brauchli
  Therapeutic Advances in Medical Oncology.2019;[Epub]     CrossRef
• Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: A meta-analysis containing 8252 patients
  Yongping Zhou, Qian Wei, Junsheng Fan, Sijin Cheng, Wenzhou Ding, Zhiyuan Hua
  Clinica Chimica Acta.2018; 479: 181.     CrossRef
• A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma
  Irene S. Yu, Winson Y. Cheung
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy
  Lingyun Liu, Wei Wang, Yi Zhang, Jianting Long, Zhaohui Zhang, Qiao Li, Bin Chen, Shaoqiang Li, Yunpeng Hua, Shunli Shen, Baogang Peng
  Cancer Research and Treatment.2018; 50(2): 538.     CrossRef
• Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer
  Marek Sierzega, Marzena Lenart, Magdalena Rutkowska, Marta Surman, Bozenna Mytar, Andrzej Matyja, Maciej Siedlar, Jan Kulig
  Annals of Surgical Oncology.2017; 24(3): 808.     CrossRef
• Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma
  Angélique Vienot, Guillaume Beinse, Christophe Louvet, Louis de Mestier, Aurélia Meurisse, Francine Fein, Bruno Heyd, Denis Cleau, Christelle d’Engremont, Anne-Claire Dupont-Gossart, Zaher Lakkis, Christophe Tournigand, Olivier Bouché, Benoît Rousseau, Ci
  JNCI: Journal of the National Cancer Institute.2017;[Epub]     CrossRef
• Current and future biomarkers for pancreatic adenocarcinoma
  Sven H Loosen, Ulf P Neumann, Christian Trautwein, Christoph Roderburg, Tom Luedde
  Tumor Biology.2017; 39(6): 101042831769223.     CrossRef
• Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis
  Randy C. Bowen, Nancy Ann B. Little, Joshua R. Harmer, Junjie Ma, Luke G. Mirabelli, Kyle D. Roller, Andrew Mackay Breivik, Emily Signor, Alec B. Miller, Hung T. Khong
  Oncotarget.2017; 8(19): 32171.     CrossRef

Citations

Citations to this article as recorded by  

• Computed Tomography-Based Sarcopenia and Pancreatic Cancer Survival—A Comprehensive Meta-Analysis Exploring the Influence of Definition Criteria, Prevalence, and Treatment Intention
  Antonio Jesús Láinez Ramos-Bossini, Antonio Gámez Martínez, David Luengo Gómez, Francisco Valverde-López, Antonio Jesús Morillo Gil, Encarnación González Flores, Ángela Salmerón Ruiz, Paula María Jiménez Gutiérrez, Consolación Melguizo, José Prados
  Cancers.2025; 17(4): 607.     CrossRef
• Looking at or beyond the tumor - a systematic review and meta-analysis of quantitative imaging biomarkers predicting pancreatic cancer prognosis
  Zihe Wang, Liang Zhu, Yitan Wang, Xianlin Han, Qiang Xu, Menghua Dai
  Abdominal Radiology.2025;[Epub]     CrossRef
• Prognostic value of deep learning-derived body composition in advanced pancreatic cancer—a retrospective multicenter study
  J. Keyl, A. Bucher, F. Jungmann, R. Hosch, A. Ziller, R. Armbruster, P. Malkomes, T.M. Reissig, S. Koitka, I. Tzianopoulos, P. Keyl, K. Kostbade, D. Albers, P. Markus, J. Treckmann, K. Nassenstein, J. Haubold, M. Makowski, M. Forsting, H.A. Baba, S. Kaspe
  ESMO Open.2024; 9(1): 102219.     CrossRef
• Body composition measures as a determinant of Alpelisib related toxicity
  Eliya Shachar, Ari Raphael, Uriel Katz, Rivka Kessner, Shlomit Strulov Shachar
  Breast Cancer Research and Treatment.2024; 206(2): 369.     CrossRef
• The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis
  Joshua J. Thompson, Josh McGovern, Campbell S.D. Roxburgh, Joanne Edwards, Ross D. Dolan, Donald C. McMillan
  Critical Reviews in Oncology/Hematology.2024; 199: 104378.     CrossRef
• Prevalence of Sarcopenia Determined by Computed Tomography in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Observational Studies
  Antonio Jesús Láinez Ramos-Bossini, Antonio Gámez Martínez, David Luengo Gómez, Francisco Valverde-López, Consolación Melguizo, José Prados
  Cancers.2024; 16(19): 3356.     CrossRef
• Sarkopenie als unabhängiger Prognosefaktor bei Pankreaskarzinom
  Johanna Mandl, Sebastian Baumer, Bernadette Holtzem, Rainer Theurer, Niels Zorger, Oliver Pech
  Zeitschrift für Gastroenterologie.2023; 61(10): 1365.     CrossRef
• Association between Body Composition and Peripheral Neurotoxicity in Cancer Patients from North China Taking Nab-Paclitaxel
  Jiayuan Guo, Juan Zhao, Ming Gu, Jixiang Hou, Ting Xu, Ying Jiang, Caihong Jiang, Hui Li, Xiaorong Li, Guang Liu, Lanzhen Zhao, Gaowa Jin, Yongzhi Shi, Ting Liu, Zhenhao Li, Zewei Zhang, Quanfu Li
  Nutrition and Cancer.2023; 75(3): 805.     CrossRef
• Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer – a Meta-analysis
  Maximilian Thormann, Mattes Hinnerichs, Felix Barajas Ordonez, Sylvia Saalfeld, Aristoteles Perrakis, Roland Croner, Jazan Omari, Maciej Pech, Marina Zamsheva, Hans-Jonas Meyer, Andreas Wienke, Alexey Surov
  Academic Radiology.2023; 30(8): 1552.     CrossRef
• Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
  Anne-Laure Couderc, Evelyne Liuu, Pascaline Boudou-Rouquette, Johanne Poisson, Maxime Frelaut, Coline Montégut, Soraya Mebarki, Romain Geiss, Zoé ap Thomas, Aurélien Noret, Monica Pierro, Capucine Baldini, Elena Paillaud, Frédéric Pamoukdjian
  Nutrients.2023; 15(5): 1193.     CrossRef
• Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study
  Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Natee Ina, Ply Chichareon
  Scientific Reports.2023;[Epub]     CrossRef
• Prognostic value of pretreatment skeletal muscle index in pancreatic carcinoma patients: A meta-analysis
  Li Yang, Xianghui Liao, Zhong Xie, Haiwen Li
  Medicine.2023; 102(19): e33663.     CrossRef
• Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?
  Marco Cefalì, Isabel Scala, Giuliana Pavone, Daniel Helbling, Saskia Hussung, Ralph Fritsch, Cäcilia Reiner, Soleen Stocker, Dieter Koeberle, Marc Kissling, Vito Chianca, Filippo Del Grande, Sara De Dosso, Stefania Rizzo
  Cancers.2023; 15(17): 4398.     CrossRef
• Sarkopenie als unabhängiger Prognosefaktor bei Pankreaskarzinom
  Johanna Mandl, Sebastian Baumer, Bernadette Holtzem, Rainer Theurer, Niels Zorger, Oliver Pech
  TumorDiagnostik & Therapie.2023; 44(10): 696.     CrossRef
• Gastrointestinal Cancer Patient Nutritional Management: From Specific Needs to Novel Epigenetic Dietary Approaches
  Chiara Cencioni, Ilaria Trestini, Geny Piro, Emilio Bria, Giampaolo Tortora, Carmine Carbone, Francesco Spallotta
  Nutrients.2022; 14(8): 1542.     CrossRef
• Sarcopenia
  Hiroyuki Asama, Makoto Ueno, Satoshi Kobayashi, Taito Fukushima, Kuniyuki Kawano, Yusuke Sano, Satoshi Tanaka, Shuhei Nagashima, Manabu Morimoto, Hiromasa Ohira, Shin Maeda
  Pancreas.2022; 51(2): 148.     CrossRef
• Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab‑paclitaxel: A retrospective study
  Yuichiro Tozuka, Makoto Ueno, Satoshi Kobayashi, Manabu Morimoto, Taito Fukushima, Yusuke Sano, Kuniyuki Kawano, Akane Hanaoka, Shun Tezuka, Hiroyuki Asama, Satoshi Moriya, Soichiro Morinaga, Shinichi Ohkawa, Shin Maeda
  Oncology Letters.2022;[Epub]     CrossRef
• Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review
  Stefania Rizzo, Isabel Scala, Angela Rodriguez Robayo, Marco Cefalì, Sara De Dosso, Stefano Cappio, Genti Xhepa, Filippo Del Grande
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Dynamic changes in the body composition during chemotherapy for gastrointestinal tumors in the context of active nutrition intervention
  Ting Xu, Zhenhao Li, Hui Li, Jixiang Hou, Jingjing Li, Gaowa Jin, Shaohua Li, Quanfu Li
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis
  Emanuele Rinninella, Marco Cintoni, Pauline Raoul, Francesca Romana Ponziani, Maurizio Pompili, Carmelo Pozzo, Antonia Strippoli, Emilio Bria, Giampaolo Tortora, Antonio Gasbarrini, Maria Cristina Mele
  Internal and Emergency Medicine.2021; 16(5): 1341.     CrossRef
• Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study
  In-Ho Kim, Moon Hyung Choi, In Seok Lee, Tae Ho Hong, Myung Ah. Lee
  BMC Cancer.2021;[Epub]     CrossRef
• The impact of body composition on short-term outcomes of neoadjuvant chemotherapy with gemcitabine plus S-1 in patients with resectable pancreatic cancer
  Tsuyoshi Takeda, Takashi Sasaki, Takafumi Mie, Takaaki Furukawa, Yuto Yamada, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira
  Japanese Journal of Clinical Oncology.2021; 51(4): 604.     CrossRef
• Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model
  Hiroki Sato, Takuma Goto, Akihiro Hayashi, Hidemasa Kawabata, Tetsuhiro Okada, Shuhei Takauji, Junpei Sasajima, Katsuro Enomoto, Mikihiro Fujiya, Kyohei Oyama, Yusuke Ono, Ayumu Sugitani, Yusuke Mizukami, Toshikatsu Okumura
  Pancreatology.2021; 21(5): 892.     CrossRef
• Current situation, consensus and controversy of perioperative nutrition management in pancreatic surgery: A narrative review
  Jingyong Xu, Junmin Wei
  Journal of Pancreatology.2021; 4(1): 37.     CrossRef
• Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
  Dong Woo Shin, Minseok Albert Kim, Jong-chan Lee, Jaihwan Kim, Jin-Hyeok Hwang
  BMC Research Notes.2021;[Epub]     CrossRef
• Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer
  Naoto Iwai, Takashi Okuda, Kohei Oka, Junichi Sakagami, Taishi Harada, Tomoya Ohara, Chie Hattori, Masashi Taniguchi, Hiroaki Sakai, Tasuku Hara, Toshifumi Tsuji, Toshiyuki Komaki, Keizo Kagawa, Osamu Dohi, Hiroaki Yasuda, Yoshito Itoh
  Cancers.2021; 13(15): 3860.     CrossRef
• Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma
  Ilaria Trestini, Marco Cintoni, Emanuele Rinninella, Futura Grassi, Salvatore Paiella, Roberto Salvia, Emilio Bria, Carmelo Pozzo, Sergio Alfieri, Antonio Gasbarrini, Giampaolo Tortora, Michele Milella, Maria Cristina Mele
  World Journal of Gastrointestinal Surgery.2021; 13(9): 885.     CrossRef
• Circulating Immunological Biomarkers
  Fleur van der Sijde, Dana A.M. Mustafa, Eveline E. Vietsch, Peter D. Katsikis, Casper H. J. van Eijck
  Pancreas.2021; 50(7): 933.     CrossRef
• Influence of sarcopenia in major pancreatic surgery. A systematic review of the literature
  Raquel Aranzazu Latorre Fragua, Alba Manuel Vázquez, Carmen Ramiro Pérez, Roberto de la Plaza Llamas, José Manuel Ramia Ángel
  Gastroenterología y Hepatología.2020; 43(3): 142.     CrossRef
• Serum miR-338-3p and miR-199b-5p are associated with the absolute neutrophil count in patients with resectable pancreatic cancer
  Fleur van der Sijde, Eveline E. Vietsch, Dana A.M. Mustafa, Yunlei Li, Casper H.J. van Eijck
  Clinica Chimica Acta.2020; 505: 183.     CrossRef
• Influence of sarcopenia in major pancreatic surgery. A systematic review of the literature
  Raquel Aranzazu Latorre Fragua, Alba Manuel Vázquez, Carmen Ramiro Pérez, Roberto de la Plaza Llamas, José Manuel Ramia Ángel
  Gastroenterología y Hepatología (English Edition).2020; 43(3): 142.     CrossRef
• The impact of sarcopenia on patients undergoing treatment for pancreatic ductal adenocarcinoma
  Julia R. Amundson, Jelani K. Williams, Andrew J. Benjamin, Hunter D.D. Witmer, Kevin K. Roggin
  Journal of Pancreatology.2020; 3(2): 59.     CrossRef
• Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients
  Raoul Wochner, Dorothea Clauss, Johanna Nattenmüller, Christine Tjaden, Thomas Bruckner, Hans-Ulrich Kauczor, Thilo Hackert, Joachim Wiskemann, Karen Steindorf, Leonardo A. Peyré-Tartaruga
  PLOS ONE.2020; 15(11): e0242785.     CrossRef
• Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores
  Inhwan Hwang, Jihoon Kang, Hei Nga Natalie Ip, Jae Ho Jeong, Kyu-pyo Kim, Heung-Moon Chang, Changhoon Yoo, Baek-Yeol Ryoo
  Investigational New Drugs.2019; 37(3): 584.     CrossRef
• Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy
  Yusuke Kurita, Noritoshi Kobayashi, Motohiko Tokuhisa, Ayumu Goto, Kensuke Kubota, Itaru Endo, Atsushi Nakajima, Yasushi Ichikawa
  Pancreatology.2019; 19(1): 127.     CrossRef
• Significance of the inflammation-based prognostic score in recurrent pancreatic cancer
  Kenji Nakagawa, Masayuki Sho, Takahiro Akahori, Minako Nagai, Kota Nakamura, Tadataka Takagi, Toshihiro Tanaka, Hideyuki Nishiofuku, Chiho Ohbayashi, Kimihiko Kichikawa, Naoya Ikeda
  Pancreatology.2019; 19(5): 722.     CrossRef
• Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis
  James Bundred, Sivesh K. Kamarajah, Keith J. Roberts
  HPB.2019; 21(12): 1603.     CrossRef
• Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal Cancer
  Sachiyo Onishi, Masahiro Tajika, Tsutomu Tanaka, Yutaka Hirayama, Kazuo Hara, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Yoshitaka Inaba, Takeshi Kodaira, Tetsuya Abe, Kei Muro, Masahito Shimizu, Yasumasa Niwa
  Journal of Clinical Medicine.2019; 8(10): 1647.     CrossRef
• An update on treatment options for pancreatic adenocarcinoma
  Aurélien Lambert, Lilian Schwarz, Ivan Borbath, Aline Henry, Jean-Luc Van Laethem, David Malka, Michel Ducreux, Thierry Conroy
  Therapeutic Advances in Medical Oncology.2019;[Epub]     CrossRef
• Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function
  Yeonjung Ha, Daejung Kim, Seungbong Han, Young Eun Chon, Yun Bin Lee, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
  Cancer Research and Treatment.2018; 50(3): 843.     CrossRef
• The Obesity Paradox in Cancer: How Important Is Muscle?
  Elizabeth M. Cespedes Feliciano, Candyce H. Kroenke, Bette J. Caan
  Annual Review of Nutrition.2018; 38(1): 357.     CrossRef
• Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor
  Sandeep Nadella, Julian Burks, Abdulhameed Al-Sabban, Gloria Inyang, Juan Wang, Robin D. Tucker, Marie E. Zamanis, William Bukowski, Narayan Shivapurkar, Jill P. Smith
  American Journal of Physiology-Gastrointestinal and Liver Physiology.2018; 315(5): G699.     CrossRef
• Prognostic value of pretreatment serum lactate dehydrogenase level in pancreatic cancer patients
  Jianxin Gan, Wenhu Wang, Zengxi Yang, Jiebin Pan, Liang Zheng, Lanning Yin
  Medicine.2018; 97(46): e13151.     CrossRef

Citations

Citations to this article as recorded by  

• Prospective Randomized Controlled Trial Comparing Adjuvant Chemotherapy vs. No Chemotherapy for Patients with Carcinoma of Gallbladder Undergoing Curative Resection
  Sundeep Singh Saluja, Phani Kumar Nekarakanti, Pramod Kumar Mishra, Anurita Srivastava, Kishore Singh
  Journal of Gastrointestinal Surgery.2022; 26(2): 398.     CrossRef
• Adjuvant Therapy for Resectable Biliary Tract Cancer: A Bayesian Network Analysis
  Xiuqiong Chen, Fanqiao Meng, Hua Xiong, Yanmei Zou
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Current standards and future perspectives in adjuvant treatment for biliary tract cancers
  Angela Lamarca, Julien Edeline, Mairéad G McNamara, Richard A Hubner, Masato Nagino, John Bridgewater, John Primrose, Juan W Valle
  Cancer Treatment Reviews.2020; 84: 101936.     CrossRef
• Prognostic factors and patterns of loco-regional failure in patients with R0 resected gallbladder cancer
  Jung Ho Im, Woo Jung Lee, Chang Moo Kang, Ho Kyoung Hwang, Jinsil Seong
  HPB.2020; 22(8): 1168.     CrossRef
• Prognostic Factors for Operated Gallbladder Cancer
  Bala Basak Oven Ustaalioglu, Ahmet Bilici, Mesut Seker, Umut Kefeli, Dincer Aydin, Serkan Celik, Tarik Demir, Burcak Erkol
  Journal of Gastrointestinal Cancer.2019; 50(3): 451.     CrossRef
• Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer
  Abhay K. Kattepur, Shraddha Patkar, Mahesh Goel, Anant Ramaswamy, Vikas Ostwal
  Journal of Gastrointestinal Surgery.2019; 23(11): 2232.     CrossRef
• A systematic review of the effectiveness of adjuvant therapy for patients with gallbladder cancer
  Carlos Manterola, Galo Duque, Luis Grande, Xabier de Aretxabala, Roque Conejeros, Tamara Otzen, Nayely García
  HPB.2019; 21(11): 1427.     CrossRef
• Adjuvant Chemoradiotherapy is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: A Systematic Review and Meta-analysis
  Byoung Hyuck Kim, Jeanny Kwon, Eui Kyu Chie, Kyubo Kim, Young Hoon Kim, Dong Wan Seo, Amol K. Narang, Joseph M. Herman
  Annals of Surgical Oncology.2018; 25(1): 255.     CrossRef
• Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer
  T Ebata, S Hirano, M Konishi, K Uesaka, Y Tsuchiya, M Ohtsuka, Y Kaneoka, M Yamamoto, Y Ambo, Y Shimizu, F Ozawa, A Fukutomi, M Ando, Y Nimura, M Nagino, S Nakamori, T Ajiki, H Baba, R Yamaguchi, M Kawai, H Nagano, F Miura, T Arai, Y Nishiwaki, S Kawasaki
  British Journal of Surgery.2018; 105(3): 192.     CrossRef
• Adjuvant systemic therapy and postoperative outcomes after resection of node positive gallbladder cancer
  Jiong-Jie Yu, Xin-Fei Xu, Tian Yang
  International Journal of Surgery.2018; 54: 307.     CrossRef
• The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer
  Luxi Yin, Qi Xu, Jingjing Li, Qing Wei, Jieer Ying
  Medicine.2018; 97(50): e13570.     CrossRef
• Surgical Management of Gallbladder Cancer
  Gyulnara G. Kasumova, Omidreza Tabatabaie, Robert M. Najarian, Mark P. Callery, Sing Chau Ng, Andrea J. Bullock, Robert A. Fisher, Jennifer F. Tseng
  Annals of Surgery.2017; 266(4): 625.     CrossRef

Citations

Citations to this article as recorded by  

• Prevalence of acute oral mucosal damage secondary to the use of systemic antineoplastics: A systematic review and meta-analysis
  Manuel Eros Rodríguez-Fuentes, Mario Pérez-Sayáns, Carmen Martín Carreras-Presas, Xabier Marichalar-Mendia, Leticia Bagán-Debón, Rafael López-López
  Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2023; 135(3): 385.     CrossRef
• Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function
  Łukasz Mielczarek, Anna Brodziak, Paweł Sobczuk, Maciej Kawecki, Agnieszka Cudnoch-Jędrzejewska, Anna M. Czarnecka
  Cancer Chemotherapy and Pharmacology.2021; 87(6): 723.     CrossRef
• Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study
  Cristina Masini, Maria Giuseppa Vitale, Marco Maruzzo, Giuseppe Procopio, Ugo de Giorgi, Sebastiano Buti, Sabrina Rossetti, Roberto Iacovelli, Francesco Atzori, Laura Cosmai, Francesca Vignani, Giuseppe Prati, Sarah Scagliarini, Annalisa Guida, Annalisa B
  Clinical Genitourinary Cancer.2019; 17(1): e150.     CrossRef
• Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
  Ravi K. Paluri, Guru Sonpavde, Charity Morgan, Jacob Rojymon, Anastasia Hartzes Mar, Radhika Gangaraju
  Oncology Reviews.2019;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Identifying ways to improve diabetes management during cancer treatments (INDICATE): protocol for a qualitative interview study with patients and clinicians
  Laura Ashley, Saifuddin Kassim, Ian Kellar, Lisa Kidd, Frances Mair, Mike Matthews, Mollie Price, Daniel Swinson, Johanna Taylor, Galina Velikova, Jonathan Wadsley
  BMJ Open.2022; 12(2): e060402.     CrossRef
• Annular-shaped stenosis in the ureter: Caution should be taken
  Jie Ming, Yue Wang, Ziliang Su, Chunyang Wang
  Urologic Oncology: Seminars and Original Investigations.2022; 40(6): 274.e7.     CrossRef
• Glycosylated haemoglobin and prognosis in 10,536 people with cancer and pre-existing diabetes: a meta-analysis with dose-response analysis
  Suping Ling, Michael Sweeting, Francesco Zaccardi, David Adlam, Umesh T. Kadam
  BMC Cancer.2022;[Epub]     CrossRef
• Malnutrition management of hospitalized patients with diabetes/hyperglycemia and cancer cachexia
  Rosa Burgos Peláez, José Pablo Suárez Llanos, Jose Manuel García Almeida, Pilar Matía Martín, Samara Palma Milla, Alejandro Sanz Paris, Ana Zugasti Murillo, Ana Artero-Fullana, Alfonso Calañas Continente, M.ª Jesús Chinchetru, Katherine García Malpartida,
  Nutrición Hospitalaria.2022;[Epub]     CrossRef
• The Impact of Diabetes on the Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Systematic Review and Meta-Analysis
  Xiaoshuai Gao, Liang Zhou, Jianzhong Ai, Wei Wang, Xingpeng Di, Liao Peng, Banghua Liao, Xi Jin, Hong Li, Kunjie Wang
  Frontiers in Oncology.2021;[Epub]     CrossRef
• The Prognostic Value of Lymphovascular Invasion in Patients With Upper Tract Urinary Carcinoma After Surgery: An Updated Systematic Review and Meta-Analysis
  Lijin Zhang, Bin Wu, Zhenlei Zha, Hu Zhao, Jun Yuan, Yejun Feng
  Frontiers in Oncology.2020;[Epub]     CrossRef
• The impact of preoperative glycated hemoglobin levels on outcomes in oral squamous cell carcinoma
  Ze Yun Tay, Huang‐Kai Kao, Kuang‐Hsu Lien, Shao‐Yu Hung, Yenlin Huang, Ngan‐Ming Tsang, Kai‐Ping Chang
  Oral Diseases.2020; 26(7): 1449.     CrossRef

Citations

Citations to this article as recorded by  

• TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond
  Qitong Wu, Deeptashree Nandi, Dipali Sharma
  Cancer and Metastasis Reviews.2025;[Epub]     CrossRef
• Role of TRIM29 in disease: What is and is not known
  Kunying Lv, Qilong Li, Ning Jiang, Qijun Chen
  International Immunopharmacology.2025; 147: 113983.     CrossRef
• Lactate dehydrogenase A promotes nasopharyngeal carcinoma progression through the TAK1/NF-κB Axis
  Yingzi Li, Lanfang Chen, Qiaochong Zheng, Guanxin Liu, Mengjiao Wang, Shupei Wei, Tao Chen
  Molecular Biology Reports.2024;[Epub]     CrossRef
• Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50
  Min Wu, Meng-Meng Jin, Xiao-Hui Cao, Lei Zhao, Yong-Huai Li
  Current Cancer Drug Targets.2024; 24(4): 445.     CrossRef
• 20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65
  Qiang Ma, Fei Wu, Xiaohui Liu, Cuifang Zhao, Yang Sun, Yuanyuan Li, Wei Zhang, Hongge Ju, Yukun Wang
  Translational Oncology.2024; 45: 101958.     CrossRef
• The Role and Mechanism of TRIM Proteins in Gastric Cancer
  Wangxi Wu, Jinyu Yang, Tian Yu, Zhuoling Zou, Xuan Huang
  Cells.2024; 13(24): 2107.     CrossRef
• Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
  Junjie Gu, Jingyi Chen, Shuaixi Xiang, Xikun Zhou, Jing Li
  Journal of Advanced Research.2023; 54: 147.     CrossRef
• TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF‐kB/NLRP3 inflammasome pathway
  Xiaohong Xu, Zihan Qin, Ce Zhang, Xia Mi, Chi Zhang, Feihong Zhou, Junsheng Wang, Liexiang Zhang, Fei Hua
  Cell Biology International.2023; 47(6): 1126.     CrossRef
• Potential implications of protein kinase Cα in pathophysiological conditions and therapeutic interventions
  Rishi Kant Singh, Sanjay Kumar, Sandeep Kumar, Alok Shukla, Naveen Kumar, Anand Kumar Patel, Lokesh Kumar Yadav, Kaushalendra, Meera Antiwal, Arbind Acharya
  Life Sciences.2023; 330: 121999.     CrossRef
• TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation
  Yuanjian Chen, Jun Ma, Mingming Zhang
  Experimental Biology and Medicine.2023; 248(18): 1527.     CrossRef
• TRIM14 and TRIM29 as potential tumor markers for breast cancer diagnosis
  Mohammadreza Roshanazadeh, mojtaba rashidi, Arash sanaei, Hossein azizi dariuni, amirnader emami razavi, Maryam Adelipour
  Journal of Breast Disease.2023; 16(4): 4.     CrossRef
• TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer
  Huai-Yu Qiao, Qi Zhang, Jia-Mei Wang, Jing-Yi Jiang, Ling-Yue Huyan, Jing Yan, Chao Li, Hua-Qin Wang
  Cancer Letters.2022; 529: 85.     CrossRef
• NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway
  Feng Tang, Hua Yu, Xia Wang, Jiageng Shi, Zhizhuang Chen, Hao Wang, Ziyu Wan, Qiqi Fu, Xuan Hu, Yisha Zuhaer, Tao Liu, Zhonghua Yang, Jianping Peng
  Biochemical and Biophysical Research Communications.2022; 622: 101.     CrossRef
• Tripartite Motif Containing 26 is a Positive Predictor for Endometrial Carcinoma Patients and Regulates Cell Survival in Endometrial Carcinoma
  Tanmin Lu, Yu Wu
  Hormone and Metabolic Research.2022; 54(12): 859.     CrossRef
• TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients
  Mohammad Reza Roshanazadeh, Maryam Adelipour, Arash Sanaei, Hadi Chenane, Mojtaba Rashidi
  BMC Research Notes.2022;[Epub]     CrossRef
• Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer
  Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, Masaharu Murata, Jeong-Hun Kang
  Cancers.2022; 14(21): 5425.     CrossRef
• Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism
  Jing Han, Zitong Zhao, Nan Zhang, Yang Yang, Liying Ma, Li Feng, Xue Zhang, Jing Zuo, Zhisong Fan, Yudong Wang, Yongmei Song, Guiying Wang
  Aging.2021; 13(4): 5034.     CrossRef
• E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1
  Xueqiang Deng, Xiaowei Fu, Hong Teng, Lu Fang, Bo Liang, Rengui Zeng, Lian Chen, Yeqing Zou
  Journal of Translational Medicine.2021;[Epub]     CrossRef
• Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
  Yang Wang, Huaicheng Tan, Ting Yu, Xiaoxuan Chen, Fangqi Jing, Huashan Shi
  Frontiers in Immunology.2021;[Epub]     CrossRef
• TRIM29 in Cutaneous Squamous Cell Carcinoma
  Che-Yuan Hsu, Teruki Yanagi, Hideyuki Ujiie
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways
  Julie Girouard, Denise Belgorosky, Jovane Hamelin-Morrissette, Valerie Boulanger, Ernesto D'Orio, Djamel Ramla, Robert Perron, Lucie Charpentier, Céline Van Themsche, Ana Maria Eiján, Gervais Bérubé, Carlos Reyes-Moreno
  Biochemical Pharmacology.2020; 176: 113778.     CrossRef
• Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation
  Jia Sun, Jing Yan, Huai-Yu Qiao, Fu-Ying Zhao, Chao Li, Jing-Yi Jiang, Bao-Qin Liu, Xiao-Na Meng, Hua-Qin Wang
  Oncogene.2020; 39(3): 546.     CrossRef
• The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members
  Michael A. Mandell, Bhaskar Saha, Todd A. Thompson
  Frontiers in Pharmacology.2020;[Epub]     CrossRef

• Macrophage Membrane-Coated Nanoparticles Alleviate Hepatic Ischemia-Reperfusion Injury Caused by Orthotopic Liver Transplantation by Neutralizing Endotoxin

  
  Zhibing Ou, Hua Zhong, Liang Zhang, Minghua Deng, Wenfeng Zhang, Jingyuan Wang, Huaguo Feng, Jianping Gong, Chunmu Miao, Zhujun Yi
  International Journal of Nanomedicine.2020; Volume 15: 4125.     CrossRef
• TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis
  Fengyu Wang, Haili Wang, Lei Sun, Chengling Niu, Jie Xu
  American Journal of Physiology-Cell Physiology.2020; 319(2): C392.     CrossRef
• TRIM29 mediates lung squamous cell carcinoma cell metastasis by regulating autophagic degradation of E-cadherin
  Weifeng Xu, Beibei Chen, Dianshan Ke, Xiaobing Chen
  Aging.2020; 12(13): 13488.     CrossRef
• Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p
  Shunxiang Luo, Ming Shen, Hui Chen, Weiwei Li, Cong Chen
  Molecular Medicine Reports.2020;[Epub]     CrossRef
• Robust Sample-Specific Stability Selection with Effective Error Control
  Heewon Park, Makoto Yamada, Seiya Imoto, Satoru Miyano
  Journal of Computational Biology.2019; 26(3): 202.     CrossRef
• Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway
  Hao Shen, Jiawei Zhang, Yaodong Zhang, Qinchao Feng, Hongwei Wang, Gaochao Li, Wangjie Jiang, Xiangcheng Li
  Gene.2019; 698: 50.     CrossRef
• MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29
  Huimin Du, Qing Xu, Sheng Xiao, Zhenru Wu, Jianping Gong, Changan Liu, Guosheng Ren, Hao Wu
  Life Sciences.2019; 224: 1.     CrossRef
• ATDC contributes to sustaining the growth and invasion of glioma cells through regulating Wnt/β-catenin signaling
  Yidong Cao, Luoning Shi, Maode Wang, Juanru Hou, Yanqiang Wei, Changwang Du
  Chemico-Biological Interactions.2019; 305: 148.     CrossRef
• MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling
  Haili Tian, Xiaoqiang Wang, Jianfeng Lu, Weiping Tian, Peijie Chen
  Chemico-Biological Interactions.2019; 308: 244.     CrossRef
• Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling
  Gang Li, Meng Wang, Liangliang Ren, Hanzong Li, Qinghua Liu, Ying Ouyang, Lixin He, Fengyan Li
  Biomedicine & Pharmacotherapy.2019; 117: 109112.     CrossRef
• ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK‐3β/Wnt/β‐catenin signalling
  Weizhi Li, Hui Xue, Yingchao Li, Peijie Li, Fuquan Ma, Mengying Liu, Shuzhen Kong
  Clinical and Experimental Pharmacology and Physiology.2019; 46(9): 845.     CrossRef
• MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression
  Feng Li, Jing Liang, Lu Bai
  Biomedicine & Pharmacotherapy.2018; 103: 782.     CrossRef
• iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma
  Kun Wang, Zhen Chen, Lu Long, Ya Tao, Qiong Wu, Manlin Xiang, Yunlai Liang, Xulin Xie, Yuan Jiang, Zhiqiang Xiao, Yahui Yan, Shiyang Qiu, Bin Yi
  Cancer Biology & Therapy.2018; 19(9): 809.     CrossRef
• TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis
  Chao Liang, Huiyu Dong, Chenkui Miao, Jundong Zhu, Jie Wang, Pu Li, Jie Li, Zengjun Wang
  Oncotarget.2018; 9(15): 12323.     CrossRef
• Overexpression of sigma‑1 receptor in MCF‑7 cells enhances proliferation via the classic protein kinase C subtype signaling pathway
  Yuqi Wu, Xueyan Bai, Xiaoyang Li, Chang Zhu, Zachary Wu
  Oncology Letters.2018;[Epub]     CrossRef
• TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway
  Ye Sun, Bing Ji, Yifei Feng, Yue Zhang, Dongjian Ji, Chunyan Zhu, Sen Wang, Chuan Zhang, Dongsheng Zhang, Yueming Sun
  Oncology Reports.2017; 38(1): 43.     CrossRef
• TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway
  Jinkai Xu, Zongyu Li, Qinghua Su, Jun Zhao, Jiancang Ma
  Oncology Reports.2017; 37(3): 1555.     CrossRef
• Intravesicular administration of sodium hyaluronate ameliorates the inflammation and cell proliferation of cystitis cystica et glandularis involving interleukin-6/JAK2/Stat3 signaling pathway
  Yongliang Ni, Shaohua Zhao, Xiaoxuan Yin, Haixin Wang, Qianqian Guang, Guangxia Hu, Yi Yang, Shoubin Jiao, Benkang Shi
  Scientific Reports.2017;[Epub]     CrossRef
• High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial-mesenchymal transition in osteosarcoma
  Si-Xiang Zeng, Qing-Chun Cai, Chi-Hua Guo, Li-Qiang Zhi, Xing Dai, Dang-Feng Zhang, Wei Ma
  Oncology Reports.2017; 38(3): 1645.     CrossRef
• MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C
  Xuefeng He, Jigen Ping, Duangai Wen
  Experimental and Therapeutic Medicine.2017; 14(4): 3253.     CrossRef

Citations

Citations to this article as recorded by  

• Women 50 Years and Older With Negative Pap Test and Positive Human Papillomavirus Test for Genotypes Other Than 16 and 18—Follow-up Outcomes
  Farah S. Baban, Michael R. Henry, Margaret E. Long, Meredith A. VandeHaar, Grant M. Spears, Sarah M. Jenkins, Diva R. Salomao
  Journal of Lower Genital Tract Disease.2024; 28(1): 43.     CrossRef
• Cervical intraepithelial neoplasia in non-16/18 high-risk human papilloma virus positive/cytology negative women: An alternative approach in poor resource areas
  Fariba Yarandi, Elham Shirali, Elham Feizabad, Sara Ramhormoziyan, Soheila Sarmadi, Maryam SadrAmeli, Elham Arshadi
  Taiwanese Journal of Obstetrics and Gynecology.2023; 62(2): 299.     CrossRef
• Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer
  Fatema Alzahraa Samy Amin, Zeba Un Naher, P. Shaik Syed Ali
  Journal of Cancer Research and Clinical Oncology.2023; 149(10): 8077.     CrossRef
• Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications
  Daniel Sausen, Oren Shechter, Elisa Gallo, Harel Dahari, Ronen Borenstein
  Cancers.2023; 15(14): 3692.     CrossRef
• Association strength of E6 to E6AP/p53 complex correlates with HPV‐mediated oncogenesis risk
  Matheus Vitor Ferreira Ferraz, Isabelle Freire Tabosa Viana, Danilo Fernandes Coêlho, Carlos Henrique Bezerra da Cruz, Maíra de Arruda Lima, Madson Allan de Luna Aragão, Roberto Dias Lins
  Biopolymers.2022;[Epub]     CrossRef
• Diagnostic performance of immediate colposcopy among women with high‐risk human papillomavirus (HPV) other than HPV 16/18 and normal cytology
  Serdar Aydın, Hande Nur Öncü, Dilek Sema Arıcı
  Journal of Obstetrics and Gynaecology Research.2021; 47(2): 720.     CrossRef
• Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer
  Rachelle P. Mendoza, Tahmineh Haidary, Elmer Gabutan, Ying Yin Zhou, Zaheer Bukhari, Courtney Connelly, Wen-Ching Lee, Yi-Chun Lee, Raj Wadgaonkar, Raag Agrawal, M. A. Haseeb, Raavi Gupta
  Scientific Reports.2021;[Epub]     CrossRef
• Distribution of HPV genotypes among women with abnormal cytology results in Alberta, Canada
  Sabrina S Plitt, Ryan Kichuk, Sheena Geier, Trenton Smith, Felicia Roy, Alberto Severini, Carmen L Charlton
  Journal of the Association of Medical Microbiology and Infectious Disease Canada.2021; 6(2): 94.     CrossRef
• The Clinical Significance and Utility of HPV-DNA Testing in Korean Women with Atypical Glandular Cells in Cervical Pap Tests: An Analysis of 311 Cases at a Single Institution
  Tae-Kyu Jang, Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
  Cancer Investigation.2021; 39(10): 885.     CrossRef
• Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study
  Jaehyun Seong, Sangmi Ryou, JeongGyu Lee, Myeongsu Yoo, Sooyoung Hur, Byeong-Sun Choi
  Virology Journal.2021;[Epub]     CrossRef
• Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single-center study in China
  Zhiling Wang, Ting Liu, Yunjian Wang, Ying Gu, Hui Wang, Jingkang Liu, Baoxia Cui, Xingsheng Yang
  Infectious Agents and Cancer.2020;[Epub]     CrossRef
• Co-infection between genotypes of the human papillomavirus and Chlamydia trachomatis in Mexican women
  Marco A Escarcega-Tame, Marcela López-Hurtado, Marcos R Escobedo-Guerra, Elba Reyes-Maldonado, Graciela Castro-Escarpulli, Fernando M Guerra-Infante
  International Journal of STD & AIDS.2020; 31(13): 1255.     CrossRef
• Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach
  Giorgio Bogani, Antonino Ditto, Fabio Martinelli, Mauro Signorelli, Valentina Chiappa, Umberto Leone Roberti Maggiore, Francesca Taverna, Claudia Lombardo, Chiara Borghi, Cono Scaffa, Domenica Lorusso, Francesco Raspagliesi
  European Journal of Cancer Prevention.2019; 28(2): 81.     CrossRef
• Human papillomavirus genotype-specific risk in cervical carcinogenesis
  Kyeong A So, In Ho Lee, Ki Heon Lee, Sung Ran Hong, Young Jun Kim, Hyun Hee Seo, Tae Jin Kim
  Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
• Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women
  Eun Young Ki, Yoon Kyung Lee, Ahwon Lee, Jong Sup Park
  Yonsei Medical Journal.2018; 59(5): 662.     CrossRef
• Genetic variability in E6, E7 and L1 genes of Human Papillomavirus 62 and its prevalence in Mexico
  Cristina Artaza-Irigaray, María Guadalupe Flores-Miramontes, Dominik Olszewski, María Teresa Magaña-Torres, María Guadalupe López-Cardona, Yelda Aurora Leal-Herrera, Patricia Piña-Sánchez, Luis Felipe Jave-Suárez, Adriana Aguilar-Lemarroy
  Infectious Agents and Cancer.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Longitudinal study on quality of life following cervical cancer treatment in Botswana
  Surbhi Grover, Rohini K Bhatia, Salman Khan, Paseka Tladi, Lesego Gabaitiri, Memory Bvochora-Nsingo, Sebathu Chiyapo, Dawn Balang, Shalini Vinod, Mark N Polizzotto, Natalie Taylor, Karen Canfell, Nicola Zetola, Doreen Ramogola-Masire, Lilie L Lin, Erle Ro
  BMJ Global Health.2025; 10(3): e017206.     CrossRef
• The feasibility and acceptability of delivering and evaluating a physical activity intervention (ACCEPTANCE) for cervical cancer survivors
  Nessa Millet, Hilary J. McDermott, Fehmidah Munir, Charlotte L. Edwardson, Tatiana Plekhanova, Esther L. Moss
  Pilot and Feasibility Studies.2025;[Epub]     CrossRef
• Sexual quality of life between healthy women and women with gynecological cancer: Results of a hospital‐based case–control study in Türkiye
  Ekin Dila Topaloğlu Ören, Selin Kiziltaş
  Journal of Obstetrics and Gynaecology Research.2024; 50(3): 456.     CrossRef
• Quality of life in long-term cervical cancer survivors compared with healthy women and women with benign gynecological disorders
  Jorge Cea García, Inmaculada Rodríguez Jiménez, Francisco Márquez Maraver, Laura Ríos-Pena, M. Carmen Rubio Rodríguez
  European Journal of Obstetrics & Gynecology and Reproductive Biology.2024; 297: 78.     CrossRef
• Pre- and Post-Treatment Quality of Life Among Patients with Advanced Stage Cervical Cancer at Tikur Anbessa Specialized Hospital, Ethiopia
  Roza Teshome, Irene Yang, Edom Woldetsadik, Eshetu Girma, Melinda Higgins, Jessica Wells
  Cancer Management and Research.2024; Volume 16: 311.     CrossRef
• Female sexual function in long-term cervical cancer survivors compared with healthy women and women affected by benign gynecological disorders
  Jorge Cea García, Francisco Márquez Maraver, Inmaculada Rodríguez Jiménez, Laura Ríos-Pena, M. Carmen Rubio Rodríguez
  European Journal of Obstetrics & Gynecology and Reproductive Biology.2024; 299: 43.     CrossRef
• Prevalence of sexual dysfunction in women with cervical cancer: a systematic review and meta-analysis
  Maolin Qian, Lan Wang, Jiajun Xing, Xiao Shan, Juan Wu, Xiaoqin Liu
  Psychology, Health & Medicine.2023; 28(2): 494.     CrossRef
• Trends and future projections of cervical cancer‐related outcomes in Japan: What happens if the HPV vaccine program is not implemented?
  Atsuko Sakakibara, Takeo Nakayama, Hiroyuki Uchida, Youichi Odagiri, Yuri Ito, Toshiro Katayama, Yutaka Ueda, Toshihiro Higuchi, Koichi Terakawa, Kunihiko Matsui, Kikuko Miyazaki, Ikuo Konishi
  International Journal of Cancer.2023; 152(9): 1863.     CrossRef
• Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review
  Stefano Cianci, Mattia Tarascio, Martina Arcieri, Marco La Verde, Canio Martinelli, Vito Andrea Capozzi, Vittorio Palmara, Ferdinando Gulino, Salvatore Gueli Alletti, Giuseppe Caruso, Stefano Restaino, Giuseppe Vizzielli, Carmine Conte, Marco Palumbo, Alf
  Medicina.2023; 59(4): 704.     CrossRef
• Association between cervical cancer-related anxiety and depression symptoms and health-related quality of life: A Moroccan cross-sectional study
  Asmaa Azizi, Doha Achak, Amal Boutib, Samia Chergaoui, Elmadani Saad, Abderraouf Hilali, Amr S. Soliman, Ibtissam Youlyouz-Marfak, Abdelghafour Marfak
  Clinical Epidemiology and Global Health.2023; 22: 101328.     CrossRef
• Impacto del cáncer de cuello uterino en la sexualidad femenina
  Camilla R. Albæk-Jakobsen, Pere Fusté-Brull
  Medicina.2023; 24(2): 21.     CrossRef
• Sexual Behaviors and Intimate Relationships of Sexual Partners of Young Patients with Early-Stage Cervical Cancer: A Qualitative Study
  Mingyue Li, Dongyang Wang, Jiaxiang Huang, Shunlian Luan, Qinghua Wang
  International Journal of General Medicine.2023; Volume 16: 5377.     CrossRef
• Long-term Quality of Life and Sexual Function After Neoadjuvant Chemotherapy and Radical Surgery for Locally Advanced Cervical Cancer
  Innocenza Palaia, Giusi Santangelo, Giuseppe Caruso, Giorgia Perniola, Valentina Tibaldi, Ludovico Muzii, Pierluigi Benedetti Panici, Violante Di Donato
  The Journal of Sexual Medicine.2022; 19(4): 613.     CrossRef
• The Importance of Social Support, Optimism and Resilience on the Quality of Life of Cancer Patients
  Iván Ruiz-Rodríguez, Isabel Hombrados-Mendieta, Anabel Melguizo-Garín, María José Martos-Méndez
  Frontiers in Psychology.2022;[Epub]     CrossRef
• Relationship of sexual quality of life and mental well-being in undergraduate women in a Canadian university
  Niki Oveisi, Zeba Khan, Lori A. Brotto
  The Canadian Journal of Human Sexuality.2022; 31(3): 422.     CrossRef
• Longitudinal Health-Related Quality of Life Study among Cervical Cancer Patients Treated with Radiotherapy
  Małgorzata Pasek, Lilia Suchocka, Grażyna Osuch-Pęcak, Konrad Muzykiewicz, Ewa Iwańska, Helena Kaducakowa, Anna Goździalska, Magdalena Goździalska
  Journal of Clinical Medicine.2021; 10(2): 226.     CrossRef
• Sexual Function and the Role of Sexual Communication in Women Diagnosed with Cervical Cancer: A Systematic Review
  Magdalena Liberacka-Dwojak, Paweł Izdebski
  International Journal of Sexual Health.2021; 33(3): 385.     CrossRef
• Contribution of Sociodemographic, Clinical, and Psychological Variables to Quality of Life in Women with Cervical Cancer in the Follow-Up Phase
  Ana Clara Lopes, Rosário Bacalhau, Martim Santos, Marta Pereira, M. Graça Pereira
  Journal of Clinical Psychology in Medical Settings.2020; 27(3): 603.     CrossRef
• Health-related quality of life and associated factors among cervical cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia
  Liya Teklu Araya, Teferi Gedif Fenta, Beate Sander, Girma Tekle Gebremariam, Gebremedhin Beedemariam Gebretekle
  Health and Quality of Life Outcomes.2020;[Epub]     CrossRef
• Le retentissement du cancer utérin et ses traitements sur la sexualité
  A. Ghorbel, A. Yousfi, R. Abidi, S. Yahyaoui, S. Zaraa, K. Mahjoubi, A. Belaid, W. Gargouri, C. Nasr
  Sexologies.2020; 29(4): 186.     CrossRef
• Survey of the desire to have children and engage in sexual activity after trachelectomy among young Japanese women with early‐stage cervical cancer
  Hideaki Yahata, Kenzo Sonoda, Kaoru Okugawa, Hiroshi Yagi, Tatsuhiro Ohgami, Masafumi Yasunaga, Ichiro Onoyama, Eisuke Kaneki, Kazuo Asanoma, Kiyoko Kato
  Journal of Obstetrics and Gynaecology Research.2019; 45(11): 2255.     CrossRef
• Qualidade de vida e fatores associados em mulheres sobreviventes ao câncer do colo do útero
  Camila Soares Lima Corrêa, Isabel Cristina Gonçalves Leite, Anna Paula Silva Andrade, Simone Meira Carvalho, Ricardo Miranda Borges, Maximiliano Ribeiro Guerra
  HU Revista.2019; 43(4): 307.     CrossRef
• The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life
  Innocenza Palaia, Federica Tomao, Giusi Santangelo, Anna Di Pinto, Carolina Maria Sassu, Giorgia Perniola, Angela Musella, Violante Di Donato, Antonella Giancotti, Pierluigi Benedetti Panici
  Oncology.2019; 97(5): 306.     CrossRef
• Vaginal development and sexual functioning in young women after stem cell transplantation, chemotherapy, and/or radiotherapy for childhood hematological diseases
  Fausta Beneventi, Elena Locatelli, Margherita Simonetta, Chiara Cavagnoli, Raffaella Pampuri, Camilla Bellingeri, Irene De Maggio, Beatrice Ruspini, Santina Recupero, Giovanna Giorgiani, Arsenio Spinillo
  Bone Marrow Transplantation.2018; 53(9): 1157.     CrossRef
• Cross-cultural adaptation and validation of the Functional Assessment of Chronic Illness Therapy – Cervical Dysplasia (FACIT-CD) questionnaire for Serbian women
  Vesna Kesić, Radmila Sparić, Rafal Watrowski, Jelena Dotlić, Radomir Stefanović, Gorica Marić, Tatjana Pekmezović
  European Journal of Obstetrics & Gynecology and Reproductive Biology.2018; 226: 7.     CrossRef
• Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life
  Sati Akbaba, Jan Tobias Oelmann-Avendano, Tilman Bostel, Harald Rief, Nils Henrik Nicolay, Juergen Debus, Katja Lindel, Robert Foerster
  Radiology and Oncology.2018; 52(3): 320.     CrossRef
• Attitudes Regarding HPV Vaccinations of Children among Mothers with Adolescent Daughters in Korea
  Kyong-No Lee, Kylie Hae-Jin Chang, Seong-Sik Cho, Sung-Ho Park, Sung Taek Park
  Journal of Korean Medical Science.2017; 32(1): 130.     CrossRef
• Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study
  Nicoletta De Rosa, Giada Lavitola, Pierluigi Giampaolino, Ilaria Morra, Carmine Nappi, Giuseppe Bifulco
  BioMed Research International.2017; 2017: 1.     CrossRef
• Körperliche Beschwerden und psychosoziale Folgen nach einer Zervixkarzinomerkrankung
  Kristina Geue, Elisabeth Sowa, Susanne Kuhnt
  Der Onkologe.2016; 22(10): 780.     CrossRef

Citations

Citations to this article as recorded by  

• Multimodal treatments and the risk of breast cancer-related lymphedema: insights from a nationally representative cohort in South Korea
  Sung Hoon Jeong, Seong Min Chun, Miji Kim, Ye Seol Lee, Jisun Kim, Ja-Ho Leigh, Yoon-Hee Choi
  BMC Cancer.2025;[Epub]     CrossRef
• Efficacy of preoperative lymphoscintigraphy in predicting surgical outcomes of lymphaticovenous anastomosis in lower extremity lymphedema: Clinical correlations in gynecological cancer-related lymphedema
  Min Young Yoo, Kyong-Je Woo, Seo Young Kang, Byung Seok Moon, Bom Sahn Kim, Hai-Jeon Yoon, Andrea Giannini
  PLOS ONE.2024; 19(1): e0296466.     CrossRef
• Lymphatic remapping by long-term lymphoscintigraphy follow-up in secondary lymphedema after breast cancer surgery
  Garam Hong, Koeun Lee, Sangwon Han, Jae Yong Jeon
  Scientific Reports.2024;[Epub]     CrossRef
• The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10
  Shogo Nakamoto, Takayuki Iwamoto, Naruto Taira, Yukiko Kajiwara, Kengo Kawada, Daisuke Takabatake, Yuichiro Miyoshi, Shinichiro Kubo, Yoko Suzuki, Mari Yamamoto, Yutaka Ogasawara, Minami Hatono, Seiji Yoshitomi, Kyoko Hara, Asako Sasahara, Shozo Ohsumi, M
  Breast Cancer.2024; 31(5): 969.     CrossRef
• Taxanes and Breast Cancer‐Related Lymphedema
  Daniel Najafali, Charalampos Siotos, George Kokosis
  Journal of Surgical Oncology.2024;[Epub]     CrossRef
• A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction
  Anne Huang, Emma Koesters, Rebecca M. Garza, Summer E. Hanson, David W. Chang
  Journal of Surgical Oncology.2024;[Epub]     CrossRef
• The prevalence of arm lymphedema after radiation treatment in patients with breast cancer
  Kamonrat Sueangamiam, Kanisa Rongsriyam
  Journal of Radiotherapy in Practice.2023;[Epub]     CrossRef
• The Use of Ultrasound Imaging for Upper Extremity Lymphedema after Breast Cancer: A Systematic Review
  Elena Canales-Lachén, Ángel Asunsolo, Oscar J. Manrique, Javier Blázquez, Purificación Holguín, Andrés A. Maldonado
  Journal of Reconstructive Microsurgery.2023; 39(02): 102.     CrossRef
• Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies
  Aomei Shen, Qian Lu, Xin Fu, Xiaoxia Wei, Liyuan Zhang, Jingru Bian, Wanmin Qiang, Dong Pang
  Supportive Care in Cancer.2023;[Epub]     CrossRef
• Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study
  Xiaozhen Liu, Kewang Sun, Hongjian Yang, Lingli Xia, Kefeng Lu, Xuli Meng, Yongfeng Li
  BMC Cancer.2023;[Epub]     CrossRef
• Practical Approach to Establishing a Lymphedema Screening Program: Tips and Tricks
  Derly C. Munoz, Sarah S. Virk, Oluwadamilola T. Oladeru, Pamela Clevenger, Tracy L. Hollen, Mariam W. Hanna, Lisa R. P. Spiguel
  Current Breast Cancer Reports.2023; 15(3): 242.     CrossRef
• The impact of rehabilitation sport on breast cancer-related lymphoedema and quality of life
  Bettina Boeer, Anna Seller, Birgitt Schoenfisch, Ute krainick-Strobel, Andreas Dietrich, Sara Y. Brucker, Diethelm Wallwiener, Andreas Niess, Markus Hahn
  Archives of Gynecology and Obstetrics.2022; 307(5): 1529.     CrossRef
• The potential of gas plasma technology for targeting breast cancer
  Sander Bekeschus, Fariba Saadati, Steffen Emmert
  Clinical and Translational Medicine.2022;[Epub]     CrossRef
• Prediction of breast cancer-related lymphedema risk after postoperative radiotherapy via multivariable logistic regression analysis
  Jae Sik Kim, Jin Ho Kim, Ji Hyun Chang, Do Wook Kim, Kyung Hwan Shin
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Invited Commentary from the Authors of: Kuruvilla AS, et al. Risk Factors Associated With Postmastectomy Breast Cancer Lymphedema: Amulticenter Retrospective Analysis
  Annet S. Kuruvilla
  Annals of Plastic Surgery.2022; 89(6): 716.     CrossRef
• Development and validation of a nomogram to predict the risk of breast cancer-related lymphedema among Chinese breast cancer survivors
  Yan-fei Liu, Jun-E Liu, Yi Zhu, Yim Wah Mak, Hui Qiu, Li-hui Liu, Shen-shen Yang, Shao-hua Chen
  Supportive Care in Cancer.2021; 29(9): 5435.     CrossRef
• Eliminating the Burden of Lymphedema in Cancer Patients Requiring Nodal Dissections Using Prophylactic Immediate Lymphatic Reconstruction – A Case Report and Review of the Literature
  Abiye Mussie, Maria C. Medor, Sylia Mohand-Said, Andrea M. Ibrahim, Carolyn Nessim, Moein Momtazi
  Plastic Surgery Case Studies.2021;[Epub]     CrossRef
• Factors predicting one or two sentinel lymph nodes to be accepted for sentinel lymph node biopsy alone after neoadjuvant therapy in initially node-positive breast cancer patients
  Li-Wei Tsai, Yi-Hsuan Lee, Chiao Lo, Huang-Chun Lien, Ming-Yang Wang, I-Shiow Jan, Ruoh-Fang Yen, Fu-Chang Hu, Chiun-Sheng Huang
  Surgical Oncology.2021; 39: 101667.     CrossRef
• Sentinel Lymph Node Biopsy in T3 and T4b Breast Cancer Patients: Analysis in a Tertiary Cancer Hospital and Systematic Literature Review
  Idam de Oliveira-Junior, Eliana Aguiar Petri Nahas, Ana Cristina Cherem, Jorge Nahas-Neto, René Aloisio da Costa Vieira
  Breast Care.2021; 16(1): 27.     CrossRef
• Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema
  Ayako Nakagawa, Hiroshi Fujimoto, Takeshi Nagashima, Takafumi Sangai, Mamoru Takada, Takahito Masuda, Ryotaro Teranaka, Satoshi Ota, Jun Matsushima, Shinsuke Akita, Masayuki Ohtsuka
  Breast Cancer.2020; 27(1): 77.     CrossRef
• Lymphedema Signs, Symptoms, and Diagnosis in Women Who Are in Minority and Low-Income Groups and Have Survived Breast Cancer
  Ann Marie Flores, Jason Nelson, Lee Sowles, Rebecca G Stephenson, Kathryn Robinson, Andrea Cheville, Antoinette P Sander, William J Blot
  Physical Therapy.2020; 100(3): 487.     CrossRef
• Prevalence of obstructive sleep apnea syndrome in patients with lymphedema referred for complete decongestive therapy
  Côme Roux, Béatrice Villemur, Brigitte Giovannoni, Lucie Koeyemelk, Monique Mendelson, Meriem Benmerad, Marie Joyeux-Faure, Renaud Tamisier, Jean-Louis Pepin
  Journal of Vascular Surgery: Venous and Lymphatic Disorders.2020; 8(1): 137.     CrossRef
• The results of the intensive phase of complete decongestive therapy and the determination of predictive factors for response to treatment in patients with breast cancer related‐lymphedema
  Dilek Keskin, Meltem Dalyan, Sibel Ünsal‐Delialioğlu, Ülkü Düzlü‐Öztürk
  Cancer Reports.2020;[Epub]     CrossRef
• A scoring system for predicting the risk of breast cancer-related lymphedema
  Fenglian Li, Qian Lu, Sanli Jin, Quanping Zhao, Xueying Qin, Shuai Jin, Lichuan Zhang
  International Journal of Nursing Sciences.2020; 7(1): 21.     CrossRef
• Lymphedema and Lymphovenous Bypass: Perioperative Nursing Implications
  Lori A. Whitnell
  AORN Journal.2020; 111(2): 187.     CrossRef
• Who Will Continuously Depend on Compression to Control Persistent or Progressive Breast Cancer-Related Lymphedema Despite 2 Years of Conservative Care?
  Chul Jung, JaYoung Kim, Yu Jin Seo, Kyeong Joo Song, Ma. Nessa Gelvosa, Jin Geun Kwon, Changsik John Pak, Hyunsuk Peter Suh, Joon Pio Hong, Hwa Jung Kim, Jae Yong Jeon
  Journal of Clinical Medicine.2020; 9(11): 3640.     CrossRef
• Role of p53 as a prognostic marker in breast carcinoma and its correlation with tumor size, tumor grade and lymph node metastasis
  Alok Mohan, Bharat Jindal, Rajender Kumar Thakral, Vaseem Ansari, Veena K Sharma
  Indian Journal of Pathology and Oncology.2020; 7(3): 378.     CrossRef
• Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study
  I-Wen Penn, Yue-Cune Chang, Eric Chuang, Chi-Ming Chen, Chi-Feng Chung, Chia-Yu Kuo, Tien-Yow Chuang
  Supportive Care in Cancer.2019; 27(3): 991.     CrossRef
• Progressive resistance training to prevent arm lymphedema in the first year after breast cancer surgery: Results of a randomized controlled trial
  Gunn Ammitzbøll, Christoffer Johansen, Charlotte Lanng, Elisabeth Wreford Andersen, Niels Kroman, Bo Zerahn, Ole Hyldegaard, Merete Celano Wittenkamp, Susanne Oksbjerg Dalton
  Cancer.2019; 125(10): 1683.     CrossRef
• Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer – a long-term observation
  Julia Rupp, Catarina Hadamitzky, Christoph Henkenberens, Hans Christiansen, Diana Steinmann, Frank Bruns
  Radiation Oncology.2019;[Epub]     CrossRef
• Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis
  Fabiola Giudici, Elisabetta Petracci, Oriana Nanni, Cristina Bottin, Maurizio Pinamonti, Fabrizio Zanconati, Bruna Scaggiante, Aamir Ahmad
  PLOS ONE.2019; 14(6): e0218030.     CrossRef
• Introduction of the Lymphedema Action Plan (LeAP): Clinical Advancement in Proactive Lymphedema Care
  Renata Beaman
  Rehabilitation Oncology.2019; 37(3): 122.     CrossRef
• Profile of women with lymphedema after breast cancer treatment
  Thais de Oliveira Gozzo, Gabriela Aguado, Aniele Tomadon, Marislei Sanches Panobianco, Maria Antonieta Spinoso Prado
  Escola Anna Nery.2019;[Epub]     CrossRef
• Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for Prevention of Breast Cancer-Related Lymphedema—a Preliminary Report
  Juhi Agrawal, Sandeep Mehta, Ashish Goel, Pankaj Kumar Pande, Kapil Kumar
  Indian Journal of Surgical Oncology.2018; 9(3): 369.     CrossRef
• Progressive strength training to prevent LYmphoedema in the first year after breast CAncer – the LYCA feasibility study
  Gunn Ammitzbøll, Charlotte Lanng, Niels Kroman, Bo Zerahn, Ole Hyldegaard, Klaus Kaae Andersen, Christoffer Johansen, Susanne Oksbjerg Dalton
  Acta Oncologica.2017; 56(2): 360.     CrossRef
• Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema
  Wen Zhu, Dan Li, Xiaoqin Li, Jin Ren, Wenqi Chen, Hangang Gu, Yongqian Shu, Deqiang Wang
  Anti-Cancer Drugs.2017; 28(3): 350.     CrossRef
• P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
  Yunbao Pan, Yufen Yuan, Guoshi Liu, Yongchang Wei, William B. Coleman
  PLOS ONE.2017; 12(2): e0172324.     CrossRef
• Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel
  Sarah A. McLaughlin, Alicia C. Staley, Frank Vicini, Paul Thiruchelvam, Nancy A. Hutchison, Jane Mendez, Fiona MacNeill, Stanley G. Rockson, Sarah M. DeSnyder, Suzanne Klimberg, Michael Alatriste, Francesco Boccardo, Mark L. Smith, Sheldon M. Feldman
  Annals of Surgical Oncology.2017; 24(10): 2818.     CrossRef
• Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: A best practice guideline
  Nick Gebruers, Hanne Verbelen, Tessa De Vrieze, Lore Vos, Nele Devoogdt, Lore Fias, Wiebren Tjalma
  European Journal of Obstetrics & Gynecology and Reproductive Biology.2017; 216: 245.     CrossRef
• Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer
  Janine T. Hidding, Carien H. G. Beurskens, Philip J. van der Wees, Wilmy C. A. M. Bos, Maria W. G. Nijhuis-van der Sanden, Hanneke W. M. van Laarhoven
  Supportive Care in Cancer.2017;[Epub]     CrossRef
• Palliative surgery for giant mucinous carcinoma of the breast in an elderly patient: A rare case report
  Haruko Takuwa, Wakako Tsuji, Fumiaki Yotsumoto
  Molecular and Clinical Oncology.2017; 7(4): 609.     CrossRef
• Update December 2016
  Francine Blei
  Lymphatic Research and Biology.2016; 14(4): 240.     CrossRef

Citations

Citations to this article as recorded by  

• Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer
  Rachel Han, Sharon Nofech-Mozes, Dina Boles, Hannah Wu, Nikolina Curcin, Elzbieta Slodkowska
  International Journal of Surgical Pathology.2024; 32(2): 239.     CrossRef
• Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice
  Laura Lopez-Gonzalez, Alicia Sanchez Cendra, Cristina Sanchez Cendra, Eduardo David Roberts Cervantes, Javier Cassinello Espinosa, Tatiana Pekarek, Oscar Fraile-Martinez, Cielo García-Montero, Ana María Rodriguez-Slocker, Laura Jiménez-Álvarez, Luis G. Gu
  Medicina.2024; 60(1): 168.     CrossRef
• TP53R175H mutation promotes breast cancer cell proliferation through CORO1A–P38 MAPK pathway regulation
  Yali Su, Jiaxuan Zhao, Haoran Fu, Zeliang Liu, Panyan Du, Jianxia Zheng, Jinghua Wu, Jinghua Zhang
  Biochemical Pharmacology.2024; 221: 116047.     CrossRef
• TP53 and/or BRCA1 Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer
  Akiko Arimura, Kazuko Sakai, Kazuhisa Kaneshiro, Takafumi Morisaki, Saori Hayashi, Kimihisa Mizoguchi, Mai Yamada, Masaya Kai, Mayumi Ono, Kazuto Nishio, Masafumi Nakamura, Makoto Kubo
  Cancers.2024; 16(6): 1184.     CrossRef
• Exploration of newly synthesized deferasirox derivatives as potential anti-cancer agents via in-vitro and in-silico approaches
  Muhammad Zahid Ullah, Zahid Hussain, Syed Ahmad Shakir, Mahnoor Mahmood, Syeda Abida Ejaz, Mubashir Aziz, Ammara Fayyaz, Jamshed Iqbal, Amara Mumtaz
  International Journal of Biological Macromolecules.2024; 283: 137971.     CrossRef
• Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
  Zhijun Li, Yiqun Han, Jiayu Wang, Binghe Xu
  Journal of Personalized Medicine.2023; 13(2): 190.     CrossRef
• The role of p53 and ki67 in predicting clinical outcome in breast cancer patients
  Bhanu Prakash Lalkota, B.J Srinivasa, Mani V. Swamy, Diganta Hazarika, B.M Jeet, K Jyothi, Mithua Ghosh, Suhail M. Sayeed, Mohammad Nasiruddin, Radheshyam Naik
  Journal of Cancer Research and Therapeutics.2023; 19(2): 208.     CrossRef
• Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis
  Xing Chang, Zi Liu, Simeng Cao, Jiang Bian, Dayong Zheng, Nuo Wang, Qi Guan, Yingliang Wu, Weige Zhang, Zengqiang Li, Daiying Zuo
  Toxicology and Applied Pharmacology.2022; 436: 115883.     CrossRef
• Targeted gene next‐generation sequencing reveals genomic profile in a cohort of 46 Chinese patients with breast cancer
  Jie Yao, Qian Chen, Jun‐qi Zhu, Rui‐gang Cai
  The Journal of Gene Medicine.2022;[Epub]     CrossRef
• Effect of the elastin-derived peptides (VGVAPG and VVGPGA) on breast (MCF-7) and lung (A549) cancer cell lines in vitro
  Konrad A. Szychowski, Bartosz Skóra, Tadeusz Pomianek
  Biomedicine & Pharmacotherapy.2022; 151: 113149.     CrossRef
• p53 Missense Mutation is Associated with Immune Cell PD-L1 Expression in Triple-Negative Breast Cancer
  Ai-Yan Xing, Long Liu, Ke Liang, Bin Wang
  Cancer Investigation.2022; 40(10): 879.     CrossRef
• Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer
  Hyo-Jin Kim, Bo-Gyeong Seo, Eun-Chan Seo, Kwang-Min Lee, Cheol Hwangbo
  Current Issues in Molecular Biology.2022; 44(12): 5848.     CrossRef
• An integrative pan-cancer analysis of COPB1 based on data mining
  Heyan Chen, Kunlong Li, Yijun Li, Peilin Xie, Jianjun He, Huimin Zhang
  Cancer Biomarkers.2021; 30(1): 13.     CrossRef
• Sex differences in expression of immune elements emerge in children, young adults and mice with osteosarcoma
  Lauren J. Mills, Logan G. Spector, David A. Largaespada, Lindsay A. Williams
  Biology of Sex Differences.2021;[Epub]     CrossRef
• GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature
  Patrizia Querzoli, Massimo Pedriali, Rosa Rinaldi, Paola Secchiero, Paolo Giorgi Rossi, Elisabetta Kuhn
  Diagnostics.2021; 11(4): 604.     CrossRef
• Oncogenic and Tumor Suppressive Components of the Cell Cycle in Breast Cancer Progression and Prognosis
  Dharambir Kashyap, Vivek Kumar Garg, Elise N. Sandberg, Neelam Goel, Anupam Bishayee
  Pharmaceutics.2021; 13(4): 569.     CrossRef
• Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer
  Weikai Xiao, Guochun Zhang, Bo Chen, Xiaoqing Chen, Lingzhu Wen, Jianguo Lai, Xuerui Li, Min Li, Hao Liu, Jing Liu, Han Han-Zhang, Analyn Lizaso, Ning Liao
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Syndrome de Peutz–Jeghers et surveillance mammaire : les nouvelles recommandations à propos d’une observation
  M. Osada, P. Maniez, N. Taris, C. Mathelin
  Gynécologie Obstétrique Fertilité & Sénologie .2021; 49(10): 795.     CrossRef
• Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
  Reyhaneh Farghadani, Rakesh Naidu
  Cancers.2021; 13(14): 3427.     CrossRef
• Effect of Dickkopf-1 (Dkk-1) and SP600125, a JNK Inhibitor, on Wnt Signaling in Canine Prostate Cancer Growth and Bone Metastases
  Wachiraphan Supsavhad, Bardes B. Hassan, Jessica K. Simmons, Wessel P. Dirksen, Said M. Elshafae, Nicole A. Kohart, Aylin A. Demirer, Thomas J. Rosol
  Veterinary Sciences.2021; 8(8): 153.     CrossRef
• TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines
  Ashkan Shahbandi, Hoang D. Nguyen, James G. Jackson
  Trends in Cancer.2020; 6(2): 98.     CrossRef
• The novel TP53 3′-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection
  Feng Zeng, Jianfu Heng, Xinwu Guo, Yue Wang, Wenhan Wu, Lili Tang, Min Chen, Shouman Wang, Hongyu Deng, Jun Wang
  Breast Cancer Research and Treatment.2020; 180(1): 237.     CrossRef
• Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China
  Zongbi Yi, Fei Ma, Guohua Rong, Yanfang Guan, Chunxiao Li, Binghe Xu
  Cancer Communications.2020; 40(6): 260.     CrossRef
• Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer
  Gu Xiao, Devon Lundine, George K. Annor, Jorge Canar, Viola Ellison, Alla Polotskaia, Patrick L. Donabedian, Thomas Reiner, Galina F. Khramtsova, Olufunmilayo I. Olopade, Alexander Mazo, Jill Bargonetti
  Cancer Research.2020; 80(3): 394.     CrossRef
• Genomic analysis of racial differences in triple negative breast cancer
  Chang-Sheng Chang, Eiko Kitamura, Joan Johnson, Roni Bollag, Lesleyann Hawthorn
  Genomics.2019; 111(6): 1529.     CrossRef
• p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
  Hyeon Jeong Oh, Jeong Mo Bae, Xianyu Wen, Seorin Jung, Younghoon Kim, Kyung Ju Kim, Nam-Yun Cho, Jung Ho Kim, Sae-Won Han, Tae-You Kim, Gyeong Hoon Kang
  British Journal of Cancer.2019; 120(8): 797.     CrossRef
• Immunostaining for p53 and p16CDKN2A Protein Is Not Predictive of Prognosis for Dogs with Malignant Mammary Gland Neoplasms
  John S Munday, Harsha Ariyarathna, Danielle Aberdein, Neroli A Thomson
  Veterinary Sciences.2019; 6(1): 34.     CrossRef
• NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer
  Paul B. Mullan, Victoria Bingham, Paula Haddock, Gareth W. Irwin, Elaine Kay, Stephen McQuaid, Niamh E. Buckley
  BMC Cancer.2019;[Epub]     CrossRef
• Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
  Jing-ping Li, Xiang-mei Zhang, Zhenzhen Zhang, Li-hua Zheng, Sonali Jindal, Yun-jiang Liu
  Medicine.2019; 98(18): e15449.     CrossRef
• Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis
  Fabiola Giudici, Elisabetta Petracci, Oriana Nanni, Cristina Bottin, Maurizio Pinamonti, Fabrizio Zanconati, Bruna Scaggiante, Aamir Ahmad
  PLOS ONE.2019; 14(6): e0218030.     CrossRef
• Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00
  Elisabetta Munzone, Kathryn P. Gray, Caterina Fumagalli, Elena Guerini-Rocco, István Láng, Thomas Ruhstaller, Lorenzo Gianni, Roswitha Kammler, Giuseppe Viale, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Meredith M. Regan, Aron Goldhirsch, Massimo B
  Breast Cancer Research and Treatment.2018; 170(2): 351.     CrossRef
• Cold atmospheric plasma conveys selectivity on triple negative breast cancer cells both in vitro and in vivo
  Liangjian Xiang, Xiaoyu Xu, Shuo Zhang, Dongyan Cai, Xiaofeng Dai
  Free Radical Biology and Medicine.2018; 124: 205.     CrossRef
• Genetic Markers in Triple-Negative Breast Cancer
  Zuzana Sporikova, Vladimira Koudelakova, Radek Trojanec, Marian Hajduch
  Clinical Breast Cancer.2018; 18(5): e841.     CrossRef
• Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy‐treated triple negative breast cancer
  Soo Youn Bae, Seung Pil Jung, Se Kyung Lee, Jonghan Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam
  The Kaohsiung Journal of Medical Sciences.2018; 34(12): 663.     CrossRef
• Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
  Yanli Luo, Wentao Huang, Huizhen Zhang, Guang Liu
  Oncology Letters.2018;[Epub]     CrossRef
• P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
  Yunbao Pan, Yufen Yuan, Guoshi Liu, Yongchang Wei, William B. Coleman
  PLOS ONE.2017; 12(2): e0172324.     CrossRef
• Alcohol promotes migration and invasion of triple‐negative breast cancer cells through activation of p38 MAPK and JNK
  Ming Zhao, Erin W. Howard, Amanda B. Parris, Zhiying Guo, Qingxia Zhao, Xiaohe Yang
  Molecular Carcinogenesis.2017; 56(3): 849.     CrossRef
• Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
  Zongbi Yi, Fei Ma, Chunxiao Li, Rongrong Chen, Lifang Yuan, Xiaoying Sun, Xiuwen Guan, Lixi Li, Binliang Liu, Yanfang Guan, Haili Qian, Binghe Xu
  Scientific Reports.2017;[Epub]     CrossRef
• TP53 gene expression levels and tumor aggressiveness in canine mammary carcinomas
  Táya F. Oliveira, Tábata Maués, Mariana S. Ramundo, Agnes Marie S. Figueiredo, Marcela F. V. de Mello, Kênia B. El-Jaick, Maria de Lourdes G. Ferreira, Ana Maria R. Ferreira
  Journal of Veterinary Diagnostic Investigation.2017; 29(6): 865.     CrossRef
• Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer
  Jisela Dimas-González, Vilma Maldonado-Lagunas, José Díaz-Chávez, María Eugenia López-Arellano, José Muñoz-Camacho, Marco Antonio Terán-Porcayo, Alfredo Lagunas-Martínez
  Oncology Reports.2017; 37(5): 3026.     CrossRef
• Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing
  Xi-Xi Chen, Qian Zhong, Yang Liu, Shu-Mei Yan, Zhang-Hua Chen, Shan-Zhao Jin, Tian-Liang Xia, Ruo-Yan Li, Ai-Jun Zhou, Zhe Su, Yu-Hua Huang, Qi-Tao Huang, Li-Yun Huang, Xing Zhang, Yan-Na Zhao, Jin-Ping Yun, Qiu-Liang Wu, Dong-Xin Lin, Fan Bai, Mu-Sheng Z
  Nature Communications.2017;[Epub]     CrossRef
• Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes
  Ji-Yeon Kim, Eunjin Lee, Kyunghee Park, Woong-Yang Park, Hae Hyun Jung, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
  Oncotarget.2017; 8(17): 27997.     CrossRef
• miR-34a expression in human breast cancer is associated with drug resistance
  Zhi-Hua Li, Xueling Weng, Qiu-Yun Xiong, Jian-Hong Tu, An Xiao, Wei Qiu, Yu Gong, Er-Wei Hu, Songyin Huang, Ya-Li Cao
  Oncotarget.2017; 8(63): 106270.     CrossRef
• Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer
  Min Chong Kim, Jung Eun Choi, Soo Jung Lee, Young Kyung Bae
  Annals of Surgical Oncology.2016; 23(11): 3524.     CrossRef
• 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway
  Jingwen Xu, Mengting Han, Jiwei Shen, Qi Guan, Zhaoshi Bai, Binyue Lang, Huijuan Zhang, Zengqiang Li, Daiying Zuo, Weige Zhang, Yingliang Wu
  Cancer Letters.2016; 383(1): 9.     CrossRef

Citations

Citations to this article as recorded by  

• Effectiveness of post-mastectomy adjuvant chemotherapy for the treatment of patients with prognostic stage IB breast cancer: A SEER-based study
  HongMei Wang, Yi Peng, Jianbin Wu, ZhuangWei Chen, HuaLe Zhang
  Asian Journal of Surgery.2023; 46(9): 3634.     CrossRef
• Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
  Elizabeth M. Salvo, Abril Oliva Ramirez, Jenilee Cueto, Ernest H. Law, Aaron Situ, Chris Cameron, Imtiaz A. Samjoo
  The Breast.2021; 57: 5.     CrossRef
• Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer
  Zhen-Yu Wu, Young-jin Lee, Heejeong Kim, Jongwon Lee, Il Yong Chung, Jisun Kim, Saebyeol Lee, Byung-Ho Son, Sung-Bae Kim, Jae Ho Jeong, Gyungyub Gong, Sei-Hyun Ahn, BeomSeok Ko
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients
  Minsung Kim, Hanna Kim, Sei Hyun Ahn, Vafa Tabatabaie, Sung Wook Choi, Guiyun Sohn, Sae Byul Lee, Beom Seok Ko, Il Yong Chung, Jisun Kim, Jong Won Lee, Byung Ho Son, Hee Jeong Kim
  Breast Cancer Research and Treatment.2020; 180(3): 657.     CrossRef
• Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen
  Young-jin Lee, Zhen-Yu Wu, Hee jeong Kim, Jong Won Lee, Il Yong Chung, Jisun Kim, Sae Byul Lee, Byung Ho Son, Sung-Bae Kim, Jae Ho Jung, Gyungyub Gong, Sei-Hyun Ahn, BeomSeok Ko
  Journal of Breast Cancer.2020; 23(5): 553.     CrossRef
• Survival outcome of combined GnRH agonist and tamoxifen is comparable to that of sequential adriamycin and cyclophosphamide chemotherapy plus tamoxifen in premenopausal patients with early breast cancer
  Doonyapat Sa‑Nguanraksa, Thitikon Krisorakun, Wanee Pongthong, Pornchai O‑Charoenrat
  Molecular and Clinical Oncology.2019;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Prioritizing cases from a multi-institutional cohort for a dataset of pathologist annotations
  Victor Garcia, Emma Gardecki, Stephanie Jou, Xiaoxian Li, Kenneth R. Shroyer, Joel Saltz, Balazs Acs, Katherine Elfer, Jochen Lennerz, Roberto Salgado, Brandon D. Gallas
  Journal of Pathology Informatics.2025; 16: 100411.     CrossRef
• Mitomycin C in the treatment of early triple-negative locally advanced BRCA-associated breast cancer
  D. A. Enaldieva, P. V. Krivorotko, E. N. Imyanitov, R. V. Donskih, A. P. Sokolenko, V. O. Azaova, N. N. Amirov, Ya. Ig. Bondarchuk, V. E. Levcheko, D. G. Ulrikh, V. F. Semiglazov
  Medical alphabet.2024; (7): 13.     CrossRef
• Tissue- and Temporal-Dependent Dynamics of Myeloablation in Response to Gemcitabine Chemotherapy
  Lydia E. Kitelinger, Eric A. Thim, Sarah Y. Zipkowitz, Richard J. Price, Timothy N. J. Bullock
  Cells.2024; 13(16): 1317.     CrossRef
• Risk of locoregional recurrence after breast cancer surgery by molecular subtype—a systematic review and network meta-analysis
  Lily Nolan, Matthew G. Davey, Gavin G. Calpin, Éanna J. Ryan, Michael R. Boland
  Irish Journal of Medical Science (1971 -).2024; 193(6): 2965.     CrossRef
• Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical
  Kelly K. Hunt, Vera J. Suman, Hannah F. Wingate, A. Marilyn Leitch, Gary Unzeitig, Judy C. Boughey, Funda Meric-Bernstam, Matthew J. Ellis, John Olson
  Annals of Surgical Oncology.2023; 30(4): 2111.     CrossRef
• Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy
  Mary Mrdutt, Alexandra Heerdt, Varadan Sevilimedu, Anita Mamtani, Andrea Barrio, Monica Morrow
  Annals of Surgical Oncology.2022; 29(1): 484.     CrossRef
• Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol
  Ariane A. van Loevezijn, Marieke E. M. van der Noordaa, Marcel P. M. Stokkel, Erik D. van Werkhoven, Emma J. Groen, Claudette E. Loo, Paula H. M. Elkhuizen, Gabe S. Sonke, Nicola S. Russell, Frederieke H. van Duijnhoven, Marie-Jeanne T. F. D. Vrancken Pee
  Breast Cancer Research and Treatment.2022; 193(1): 37.     CrossRef
• De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study
  Sabine R de Wild, Linda de Munck, Janine M Simons, Janneke Verloop, Thijs van Dalen, Paula H M Elkhuizen, Ruud M A Houben, A Elise van Leeuwen, Sabine C Linn, Ruud M Pijnappel, Philip M P Poortmans, Luc J A Strobbe, Jelle Wesseling, Adri C Voogd, Liesbeth
  The Lancet Oncology.2022; 23(9): 1201.     CrossRef
• Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
  Anna Baranova, Mykola Krasnoselskyi, Volodymyr Starikov, Sergii Kartashov, Igor Zhulkevych, Vadym Vlasenko, Kateryna Oleshko, Olga Bilodid, Marina Sadchikova, Yurii Vinnyk
  Journal of Medicine and Life.2022; 15(2): 153.     CrossRef
• Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy
  Makoto Ishitobi, Naoko Matsuda, Mizuho Tazo, Sayuka Nakayama, Ryu Tokui, Tomoko Ogawa, Atsushi Yoshida, Yasuyuki Kojima, Takashi Kuwayama, Takahiro Nakayama, Hideko Yamauchi, Seigo Nakamura, Koichiro Tsugawa, Naoki Hayashi
  Annals of Surgical Oncology.2021; 28(5): 2545.     CrossRef
• Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study
  Janine M. Simons, Julien G. Jacobs, Joost P. Roijers, Maarten A. Beek, Leandra J. M. Boonman-de Winter, Arjen M. Rijken, Paul D. Gobardhan, Jan H. Wijsman, Eric Tetteroo, Joan B. Heijns, C. Y. Yick, Ernest J. T. Luiten
  Breast Cancer Research and Treatment.2021; 185(2): 441.     CrossRef
• Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery
  Matthew R. Woeste, Neal Bhutiani, Marilyn Donaldson, Kelly M. McMasters, Nicolás Ajkay
  Journal of Surgical Oncology.2021; 123(2): 439.     CrossRef
• Does Surgical Margin Width Remain a Challenge for Triple-Negative Breast Cancer? A Retrospective Analysis
  Eduard-Alexandru Bonci, Ștefan Țîțu, Alexandru Marius Petrușan, Claudiu Hossu, Vlad Alexandru Gâta, Morvarid Talaeian Ghomi, Paul Milan Kubelac, Teodora Irina Bonci, Andra Piciu, Maria Cosnarovici, Liviu Hîțu, Alexandra Timea Kirsch-Mangu, Diana Cristina
  Medicina.2021; 57(3): 203.     CrossRef
• Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment
  Hsu-Huan Chou, Wei-Shan Chung, Rong-Yao Ding, Wen-Ling Kuo, Chi-Chang Yu, Hsiu-Pei Tsai, Shih-Che Shen, Chia-Hui Chu, Yung-Feng Lo, Shin-Cheh Chen
  BMC Surgery.2021;[Epub]     CrossRef
• Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients
  Giuseppe Canavese, Corrado Tinterri, Franca Carli, Elsa Garrone, Stefano Spinaci, Angelica Della Valle, Erika Barbieri, Emilia Marrazzo, Paolo Bruzzi, Beatrice Dozin
  European Journal of Surgical Oncology.2021; 47(8): 1920.     CrossRef
• Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis
  Yujie Lu, Yiwei Tong, Jiahui Huang, Lin Lin, Jiayi Wu, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
  Cancer Management and Research.2021; Volume 13: 6279.     CrossRef
• De-escalation of axillary irradiation for early breast cancer – Has the time come?
  Elżbieta Senkus, Maria Joao Cardoso, Orit Kaidar-Person, Aleksandra Łacko, Icro Meattini, Philip Poortmans
  Cancer Treatment Reviews.2021; 101: 102297.     CrossRef
• Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival
  K. Wimmer, M. Bolliger, Z. Bago-Horvath, G. Steger, D. Kauer-Dorner, R. Helfgott, C. Gruber, F. Moinfar, M. Mittlböck, F. Fitzal
  Annals of Surgical Oncology.2020; 27(5): 1700.     CrossRef
• Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy
  Joseph Lin, Kuo-Juei Lin, Yu-Fen Wang, Ling-Hui Huang, Sam Li-Sheng Chen, Dar-Ren Chen
  BMC Cancer.2020;[Epub]     CrossRef

• Identifying Risk Factors for Regional Recurrence in Early-Stage Breast Cancer with pT1-2 and Negative Sentinel Lymph Node Biopsy

  
  Kai-yun You, Zhuo-fei Bi, Lin Ding, Yu-jia Ma, Yi-min Liu, He-rui Yao
  Cancer Management and Research.2020; Volume 12: 9211.     CrossRef
• Discordance between Primary Breast Cancer and Ipsilateral Breast Cancer Tumor Recurrence as a Function of Distance
  Sebastian M. Jud, Reinhard Hatko, Julius Emons, Bianca Lauterbach, Carolin C. Hack, Caroline Preuß, Werner Adler, Matthias W. Beckmann, Felix Heindl
  Journal of Clinical Medicine.2020; 9(12): 4033.     CrossRef
• A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types
  Patrick H. Dinkelborg, Meng Wang, Liliana Gheorghiu, Joseph M. Gurski, Theodore S. Hong, Cyril H. Benes, Dejan Juric, Rachel B. Jimenez, Kerstin Borgmann, Henning Willers
  Breast Cancer Research and Treatment.2019; 174(3): 605.     CrossRef
• The reciprocal influences of prognosis between two types of surgical interventions and early breast cancer patients with diverse luminal subtypes
  Lin He, Shengnan Zhao, Min Liu, Zhumin Su, Yuanzhong Ren, Yuhua Song
  Medicine.2019; 98(11): e14912.     CrossRef
• Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer
  Jin-Sun Ryu, Sung Hoon Sim, In Hae Park, Eun Gyeong Lee, Eun Sook Lee, Yun-Hee Kim, Youngmee Kwon, Sun-Young Kong, Keun Seok Lee
  Cancers.2019; 11(4): 574.     CrossRef
• Partial-Breast Irradiation: Review of Modern Trials
  Bindu Manyam, Chirag Shah, Thomas Julian, Frank Vicini
  Current Breast Cancer Reports.2019; 11(4): 277.     CrossRef
• AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019
  Marc Thill, Christian Jackisch, Wolfgang Janni, Volkmar Müller, Ute-Susann Albert, Ingo Bauerfeind, Jens Blohmer, Wilfried Budach, Peter Dall, Ingo Diel, Peter A. Fasching, Tanja Fehm, Michael Friedrich, Bernd Gerber, Volker Hanf, Nadia Harbeck, Jens Huob
  Breast Care.2019; 14(4): 247.     CrossRef
• The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation
  Chirag Shah, Frank Vicini, Simona F. Shaitelman, Jaroslaw Hepel, Martin Keisch, Douglas Arthur, Atif J. Khan, Robert Kuske, Rakesh Patel, David E. Wazer
  Brachytherapy.2018; 17(1): 154.     CrossRef
• Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy
  Janet K. Horton, Reshma Jagsi, Wendy A. Woodward, Alice Ho
  International Journal of Radiation Oncology*Biology*Physics.2018; 100(1): 23.     CrossRef
• Risk factors for locoregional disease recurrence after breast‐conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta‐analysis
  Antonios Valachis, Eleftherios P. Mamounas, Elizabeth A. Mittendorf, Naoki Hayashi, Makoto Ishitobi, Clara Natoli, Florian Fitzal, Isabel T. Rubio, Daniel G. Tiezzi, Hee‐Chul Shin, Stewart J. Anderson, Kelly K. Hunt, Naoko Matsuda, Shozo Ohsumi, Athina To
  Cancer.2018; 124(14): 2923.     CrossRef
• Margins in Breast-Conserving Surgery After Neoadjuvant Therapy
  Jungeun Choi, Alison Laws, Jiani Hu, William Barry, Mehra Golshan, Tari King
  Annals of Surgical Oncology.2018; 25(12): 3541.     CrossRef
• Critical review of axillary recurrence in early breast cancer
  Carlos A. Castaneda, Pamela Rebaza, Miluska Castillo, Henry L. Gomez, Miguel De La Cruz, Gabriela Calderon, Jorge Dunstan, Jose Manuel Cotrina, Julio Abugattas, Tatiana Vidaurre
  Critical Reviews in Oncology/Hematology.2018; 129: 146.     CrossRef
• Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy
  Seung Hyuck Jeon, Kyung Hwan Shin, Jin Ho Kim, Kyubo Kim, In Ah Kim, Kyung-Hun Lee, Tae-Yong Kim, Seock-Ah Im
  Breast Cancer Research and Treatment.2018; 172(3): 619.     CrossRef
• Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer
  Victor E. Chen, Erin F. Gillespie, Kaveh Zakeri, James D. Murphy, Catheryn M. Yashar, Sharon Lu, John P. Einck
  Advances in Radiation Oncology.2017; 2(2): 105.     CrossRef
• Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study
  Pauline Gillon, Nathan Touati, Christel Breton-Callu, Leen Slaets, David Cameron, Hervé Bonnefoi
  European Journal of Cancer.2017; 79: 226.     CrossRef
• Age, molecular subtypes and local therapy decision-making
  Anne Kuijer, Tari A. King
  The Breast.2017; 34: S70.     CrossRef
• Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer
  Cefan Zhou, Jing Yu, Ming Wang, Jing Yang, Hui Xiong, Huang Huang, Dongli Wu, Shimeng Hu, Yefu Wang, Xing-Zhen Chen, Jingfeng Tang
  Oncotarget.2017; 8(60): 101309.     CrossRef
• Prognostic significance of PLIN1 expression in human breast cancer
  Cefan Zhou, Ming Wang, Li Zhou, Yi Zhang, Weiyong Liu, Wenying Qin, Rong He, Yang Lu, Yefu Wang, Xing-Zhen Chen, Jingfeng Tang
  Oncotarget.2016; 7(34): 54488.     CrossRef

Citations

Citations to this article as recorded by  

• Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System
  Zhe Wang, Wei Chong, Huikun Zhang, Xiaoli Liu, Yawen Zhao, Zhifang Guo, Li Fu, Yongjie Ma, Feng Gu
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis
  Jinzhao Liu, Yifei Li, Weifang Zhang, Chenhui Yang, Chao Yang, Liang Chen, Mingjian Ding, Liang Zhang, Xiaojun Liu, Guozhong Cui, Yunjiang Liu
  Frontiers in Surgery.2022;[Epub]     CrossRef
• Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
  Yul Ri Chung, Ji Won Woo, Soomin Ahn, Eunyoung Kang, Eun-Kyu Kim, Mijung Jang, Sun Mi Kim, Se Hyun Kim, Jee Hyun Kim, So Yeon Park
  Scientific Reports.2021;[Epub]     CrossRef
• Using a novel T-lymph node ratio model to evaluate the prognosis of nonmetastatic breast cancer patients who received preoperative radiotherapy followed by mastectomy
  Yang Wang, Yuanyuan Zhao, Song Liu, Weifang Tang, Hong Gao, Xucai Zheng, Shikai Hong, Shengying Wang
  Medicine.2017; 96(42): e8203.     CrossRef
• The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes
  Xiang Li, Ruishan Zhang, Zhuangkai Liu, Shuang Li, Hong Xu
  Oncotarget.2017; 8(12): 20252.     CrossRef
• Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy
  Ji Hyun Chang, Wan Jeon, Kyubo Kim, Kyung Hwan Shin, Wonshik Han, Dong-Young Noh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang
  Journal of Breast Cancer.2016; 19(4): 394.     CrossRef

Citations

Citations to this article as recorded by  

• HISTOPATHOLOGICAL AND BIOLOGICAL BEHAVIOR OF BREAST CANCER IN ELDERLY KURDISH WOMEN
  Kamal Saeed, Shewaz Salih
  JOURNAL OF SULAIMANI MEDICAL COLLEGE.2023; 13(4): 11.     CrossRef
• Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry
  Junyup Kim, Seri Hong, Jae Jun Lee, Young-Joo Won, Eun Sook Lee, Han-Sung Kang, Seeyoun Lee, Jai Hong Han, Eun-Gyeong Lee, Heein Jo, Hyun Hee Kim, So-Youn Jung
  Breast Cancer Research and Treatment.2021; 187(3): 785.     CrossRef
• Survival outcomes in elderly Taiwanese women according to breast cancer subtype and lymph node status: A single-center retrospective study
  Kung-Hung Lin, Huan-Ming Hsu, Kuo-Feng Hsu, Chi-Hong Chu, Zhi-Jie Hong, Chun-Yu Fu, Yu-Ching Chou, Golshan Mehra, Ming-Shen Dai, Jyh-Cherng Yu, Guo-Shiou Liao, Jason Chia-Hsun Hsieh
  PLOS ONE.2021; 16(12): e0261258.     CrossRef
• Could lymph node evaluation be eliminated in nearly 50% of women with early stage ER/PR positive breast cancer?
  Juan Ruiz, Gerson Maldonado, Elizabeth Ablah, Hayrettin Okut, Jared Reyes, Karson Quinn, Patty L. Tenofsky
  The American Journal of Surgery.2020; 220(6): 1417.     CrossRef
• Overall survival of elderly patients with breast cancer is not related to breast-cancer specific survival: A single institution experience in Japan
  Haruko Takuwa, Wakako Tsuji, Fumiaki Yotsumoto
  Breast Disease.2018; 37(4): 177.     CrossRef
• Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting
  Chiara Mandoj, Laura Pizzuti, Domenico Sergi, Isabella Sperduti, Marco Mazzotta, Luigi Di Lauro, Antonella Amodio, Silvia Carpano, Anna Di Benedetto, Claudio Botti, Francesca Ferranti, Anna Antenucci, Maria Gabriella D’Alessandro, Paolo Marchetti, Silveri
  Journal of Translational Medicine.2018;[Epub]     CrossRef
• Do site and type of metastasis in breast cancer show a changing pattern with increased age? A cross comparison of clinicopathological characteristics between age groups
  Majid Akrami, Afrooz Sepahdar, Peyman Arasteh, Sedigheh Tahmasebi, Vahid Zangouri, Azam Askari, Babak Pezeshki, Abdolrasoul Talei
  World Journal of Surgical Oncology.2018;[Epub]     CrossRef
• Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice
  Jessemae L. Welsh, Tanya L. Hoskin, Courtney N. Day, Elizabeth B. Habermann, Matthew P. Goetz, Judy C. Boughey
  Annals of Surgical Oncology.2017; 24(10): 2881.     CrossRef
• Combination of 125I brachytherapy and chemotherapy for unresectable recurrent breast cancer
  Qixing Tan, Qinghong Qin, Weiping Yang, Bin Lian, Qinguo Mo, Changyuan Wei
  Medicine.2016; 95(44): e5302.     CrossRef

Citations

Citations to this article as recorded by  

• Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer
  Yaping Huang, Chengjie Ke, Jiaqin Cai, Xiaoxia Wei, Maohua Chen, Hong Sun
  Breast Cancer.2024; 31(5): 917.     CrossRef
• Cáncer de mama en el varón: estudio multicéntrico en Aragón durante 27 años
  Olga Dobato Portoles, Daniel Aparicio Lopez, Reyes Ibañez Carreras, Elena Aguirre Ortega, Beatriz Eizaguirre Zarza, Carmen García Mur, Aurora Carrasquer Puyal, María Pilar Cebollero Benito, Laura Isabel Comín Novella, Marta Allue Cabañuz, Fernando Martine
  Cirugía Española.2024; 102(10): 524.     CrossRef
• Observational Study of Men and Women with Breast Cancer in Terms of Overall Survival
  Vlad Bogdan Varzaru, Diana-Maria Anastasiu-Popov, Anca-Elena Eftenoiu, Roxana Popescu, Daliborca Cristina Vlad, Cristian Sebastian Vlad, Aurica Elisabeta Moatar, Daniela Puscasiu, Ionut Marcel Cobec
  Cancers.2024; 16(17): 3049.     CrossRef
• Male breast cancer: A multicenter study in Aragon over 27 years
  Olga Dobato Portoles, Daniel Aparicio Lopez, Reyes Ibañez Carreras, Elena Aguirre Ortega, Beatriz Eizaguirre Zarza, Carmen García Mur, Aurora Carrasquer Puyal, María Pilar Cebollero Benito, Laura Isabel Comín Novella, Marta Allue Cabañuz, Fernando Martine
  Cirugía Española (English Edition).2024; 102(10): 524.     CrossRef
• Male breast cancer: a 32-year retrospective analysis in radiation therapy referral center in northern Iran
  Mahboobeh Asgharian, Dariush Moslemi, Hossein-Ali Nikbakht, Mohammad-Ali Jahani, Ali Bijani, Hakimeh Mehdizadeh
  Annals of Medicine & Surgery.2024; 86(10): 5756.     CrossRef
• Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)
  Jieun Lee, Keun Seok Lee, Sung Hoon Sim, Heejung Chae, Joohyuk Sohn, Gun Min Kim, Kyung-Hee Lee, Su Hwan Kang, Kyung Hae Jung, Jae-ho Jeong, Jae Ho Byun, Su-Jin Koh, Kyoung Eun Lee, Seungtaek Lim, Hee Jun Kim, Hye Sung Won, Hyung Soon Park, Guk Jin Lee, S
  Cancer Research and Treatment.2023; 55(1): 123.     CrossRef
• Clinicopathological features and correlation analysis of male breast cancer
  Lei Xi, Jinxing Zhou, Yan Wu, Rong Rong
  Medicine.2023; 102(30): e34408.     CrossRef
• Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population‐based observational study
  Wentong Fang, Yue Huang, Xu Han, Jinghui Peng, Mingjie Zheng
  Cancer Medicine.2022; 11(3): 764.     CrossRef
• Comparison of short-term surgical outcomes between men and women with breast cancer: a retrospective study using nationwide inpatient data in Japan
  Takaaki Konishi, Michimasa Fujiogi, Nobuaki Michihata, Kojiro Morita, Hiroki Matsui, Kiyohide Fushimi, Masahiko Tanabe, Yasuyuki Seto, Hideo Yasunaga
  Breast Cancer Research and Treatment.2021; 186(3): 731.     CrossRef
• Ulcerated Nipple Nodule, Clinicopathologic Challenge: Answer
  Ahmad Adel, Mona R. E. Abdel-Halim, Yosra Abdel-Galeil
  The American Journal of Dermatopathology.2021; 43(6): 466.     CrossRef
• Genetic Landscape of Male Breast Cancer
  Fernando Augusto Batista Campos, Etienne Rouleau, Giovana Tardin Torrezan, Dirce Maria Carraro, José Claudio Casali da Rocha, Higor Kassouf Mantovani, Leonardo Roberto da Silva, Cynthia Aparecida Bueno de Toledo Osório, Solange Moraes Sanches, Sandrine M.
  Cancers.2021; 13(14): 3535.     CrossRef
• Treatment of male breast cancer: meta-analysis of real-world evidence
  A. P. Lin, T.-W. Huang, K.-W. Tam
  British Journal of Surgery.2021; 108(9): 1034.     CrossRef
• Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells
  Ana D. Pinzón-García, Ruben Sinisterra, Maria Cortes, Fredy Mesa, Sandra Ramírez-Clavijo
  PeerJ.2021; 9: e12124.     CrossRef
• Prognostic Factors in Male Breast Cancer: A Retrospective Nationwide Study in South Korea by the Study of SMARTSHIP Group
  Sungmin Park, Ho Hur, Ji Sung Lee, JaeSun Yoon, Sung Mo Hur, Il Yong Chung, Jong Won Lee, Hyun Jo Youn, Se Jeong Oh, Cheol Wan Lim, Jihyoun Lee
  Journal of Breast Cancer.2021; 24(6): 561.     CrossRef
• Meme Kanseri Cerrahisi Sonrası Lenfödem ve Uçak Seyahati
  Aysel GÜL, Dilek AYGİN
  İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi.2021; (15): 669.     CrossRef
• Italian Men Tested for BRCA1/2 Mutation: Psychological Distress during 6-Month Follow-Up
  F. Pellini, S. Mirandola, E. Granuzzo, S. Urbani, G. Piccinni Leopardi, G. P. Pollini
  Journal of Oncology.2020; 2020: 1.     CrossRef
• Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry
  Eun-Gyeong Lee, So-Youn Jung, Myong Cheol Lim, Jiwon Lim, Han-Sung Kang, Seeyoun Lee, Jai Hong Han, Heein Jo, Young-Joo Won, Eun Sook Lee
  Cancer Research and Treatment.2020; 52(3): 739.     CrossRef
• The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population‐based observational study
  Hong Pan, Kai Zhang, Ming Wang, Lijun Ling, Shui Wang, Wenbin Zhou
  Cancer.2020; 126(S16): 3830.     CrossRef
• Adjuvant Radiation Therapy for Male Breast Cancer—A Rare Indication?
  Tobias Forster, Clara Köhler, Rami El Shafie, Fabian Weykamp, Laila König, Nathalie Arians, Sebastian Adeberg, Laura Michel, Katharina Smetanay, Michael Golatta, Christof Sohn, Jörg Heil, Andreas Schneeweiss, Jürgen Debus, Juliane Hörner-Rieber
  Cancers.2020; 12(12): 3645.     CrossRef
• Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy
  Francesca Pellini, Eleonora Granuzzo, Silvia Urbani, Sara Mirandola, Marina Caldana, Davide Lombardi, Elena Fiorio, Marta Mandarà, Giovanni Paolo Pollini
  Breast Care.2020; 15(1): 14.     CrossRef
• Ultrasonographic and Mammographic Findings of Male Breast Disease
  Su Hong Kim, Young‐Seon Kim
  Journal of Ultrasound in Medicine.2019; 38(1): 243.     CrossRef
• Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study
  Paul Rogowski, Stephan Schönecker, Montserrat Pazos, Daniel Reitz, Michael Braun, Martin Pölcher, Claus Hanusch, Rachel Wuerstlein, Nadia Harbeck, Sven Mahner, Claus Belka, Stefanie Corradini
  Strahlentherapie und Onkologie.2019; 195(4): 289.     CrossRef
• Survival analysis for male ductal and lobular breast cancer patients with different stages
  Jizhao Wang, Yuchen Sun, Jingkun Qu, Huang Zuo, Xixi Zhao, Lin Liu, Jinteng Feng, Jiansheng Wang, Guangjian Zhang
  Future Oncology.2019; 15(2): 167.     CrossRef
• Clinical features of patients with male breast cancer in Shanxi province of China from 2007 to 2016
  Weigang Wang, Xiaoqin Xu, Baoguo Tian, Yan Wang, Lili Du, Ting Sun, Yanchun Shi, Xianwen Zhao, Yali Jia, Yanfeng Xi, Jiexian Jing
  Journal of Investigative Medicine.2019; 67(3): 699.     CrossRef
• Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database
  Jun Xie, Yao-Yu Ying, Bin Xu, Yan Li, Xian Zhang, Chong Li
  Therapeutic Advances in Medical Oncology.2019;[Epub]     CrossRef
• Different Patterns of Conditional Survival of Breast Cancer Patients by Age and Histologic Types: Evidence from the Korean Nationwide Registry
  So-Youn Jung, Kyu-Won Jung, Johyun Ha, Young-Joo Won, Young Ae Kim, Youngmee Kwon, Sun-Young Kong, Eun Sook Lee
  Cancer Epidemiology, Biomarkers & Prevention.2019; 28(7): 1169.     CrossRef
• Diagnostic Value of Fine-Needle Aspiration in Male Breast Lesions
  Raza S. Hoda, Ronald N. Arpin III, Ravi V. Gottumukkala, Kevin S. Hughes, Amy Ly, Elena F. Brachtel
  Acta Cytologica.2019; 63(4): 319.     CrossRef
• The endocrinology of male breast cancer
  Ian S Fentiman
  Endocrine-Related Cancer.2018; 25(6): R365.     CrossRef
• Magee Equation Recurrence Score Is Associated With Distal Metastatic Risk in Male Breast Carcinomas
  Yanjun Hou, Harrison S Moosavi, Lai Wei, Anil V Parwani, Xiaoxian (Bill) Li, Zaibo Li
  American Journal of Clinical Pathology.2018; 150(6): 491.     CrossRef
• Axillary lymph node metastasis as the first manifestation of male occult breast cancer
  Xinyu Wang, Liwen Fan, Wenxing Yan, Qi Zhang, Shunchao Bao, Ying Wang, Xin Bao, Linlin Liu
  Medicine.2018; 97(50): e13706.     CrossRef
• A review of estrogen receptor/androgen receptor genomics in male breast cancer
  Tesa M Severson, Wilbert Zwart
  Endocrine-Related Cancer.2017; 24(3): R27.     CrossRef
• Imaging the Male Breast
  Shruthi Ram, Shadi Aminololama-Shakeri
  Current Radiology Reports.2017;[Epub]     CrossRef
• Mammary gland tumors in a male Cocker Spaniel
  Soon-Chan Kwon, Dae-Young Yoo, Minho Ko, Kwon-Young Lee, Ho-Hyun Kwak, In-Chul Park, In-Koo Hwang, Jung-Hoon Choi, Jin-Young Chung
  Acta Veterinaria Scandinavica.2017;[Epub]     CrossRef
• Male occult breast cancer with axillary lymph node metastasis as the first manifestation
  Ruixin Xu, Jianbin Li, Yingjie Zhang, Hongbiao Jing, Youzhe Zhu
  Medicine.2017; 96(51): e9312.     CrossRef

Citations

Citations to this article as recorded by  

• Detection of Circulating Tumor Cells in Neuroblastoma and Its Clinical Application Progress
  哲蝶 周
  Advances in Clinical Medicine.2025; 15(02): 757.     CrossRef
• A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer
  Jinghui Hong, Mengxin Li, Yichang Chen, Ye Du, Dong Song
  Frontiers in Immunology.2024;[Epub]     CrossRef
• CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma
  Ran Zhuo, Zimu Zhang, Yanling Chen, Gen Li, Shibei Du, Xinyi Guo, Randong Yang, Yanfang Tao, Xiaolu Li, Fang Fang, Yi Xie, Di Wu, Yang Yang, Chun Yang, Hongli Yin, Guanghui Qian, Hairong Wang, Juanjuan Yu, Siqi Jia, Frank Zhu, Chenxi Feng, Jianwei Wang, Y
  Cancer Letters.2024; 591: 216882.     CrossRef
• A comprehensive overview of liquid biopsy applications in pediatric solid tumors
  Ferdinand W. Janssen, Nathalie S. M. Lak, Claudia Y. Janda, Lennart A. Kester, Michael T. Meister, Johannes H. M. Merks, Marry M. van den Heuvel-Eibrink, Max M. van Noesel, Jozsef Zsiros, Godelieve A. M. Tytgat, Leendert H. J. Looijenga
  npj Precision Oncology.2024;[Epub]     CrossRef
• T-Switch: A specificity-based engineering platform for developing safe and effective T cell therapeutics
  Nouran S. Abdelfattah, Tomasz Kula, Stephen J. Elledge
  Immunity.2024; 57(12): 2945.     CrossRef
• Minimal Infiltrative Disease Identification in Cryopreserved Ovarian Tissue of Girls with Cancer for Future Use: A Systematic Review
  Monika Grubliauskaite, M. E. Madeleine van der Perk, Annelies M. E. Bos, Annelot J. M. Meijer, Zivile Gudleviciene, Marry M. van den Heuvel-Eibrink, Jelena Rascon
  Cancers.2023; 15(17): 4199.     CrossRef
• Circulating tumor cells in neuroblastoma: Current status and future perspectives
  Ran Yang, Shan Zheng, Rui Dong
  Cancer Medicine.2023; 12(1): 7.     CrossRef
• Targeting of intracellular oncoproteins with peptide-centric CARs
  Mark Yarmarkovich, Quinlen F. Marshall, John M. Warrington, Rasika Premaratne, Alvin Farrel, David Groff, Wei Li, Moreno di Marco, Erin Runbeck, Hau Truong, Jugmohit S. Toor, Sarvind Tripathi, Son Nguyen, Helena Shen, Tiffany Noel, Nicole L. Church, Amber
  Nature.2023; 623(7988): 820.     CrossRef
• A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses
  Jia Li, Hao Qiao, Fei Wu, Shiyu Sun, Cong Feng, Chaofan Li, Wanjun Yan, Wei Lv, Huizi Wu, Mengjie Liu, Xi Chen, Xuan Liu, Weiwei Wang, Yifan Cai, Yu Zhang, Zhangjian Zhou, Yinbin Zhang, Shuqun Zhang
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Liquid biomarkers for the management of paediatric neuroblastoma: an approach to personalised and targeted cancer therapy
  Ernest Osei, Nidaa Al-Ani, Aladdin Al-Asady, Susan Dang
  Journal of Radiotherapy in Practice.2021; 20(2): 217.     CrossRef
• Construction of a novel methylation‐related prognostic model for colorectal cancer based on microsatellite status
  Lichao Cao, Erfei Chen, Hezi Zhang, Ying Ba, Bianbian Yan, Tong Li, Jin Yang
  Journal of Cellular Biochemistry.2021; 122(12): 1781.     CrossRef
• RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs
  Mark Yarmarkovich, Quinlen F. Marshall, John M. Warrington, Rasika Premaratne, Alvin Farrel, David Groff, Wei Li, Moreno di Marco, Erin Runbeck, Hau Truong, Jugmohit S. Toor, Sarvind Tripathi, Son Nguyen, Helena Shen, Tiffany Noel, Nicole L. Church, Amber
  Nature.2021; 599(7885): 477.     CrossRef
• Clinical Significance of Segmental Chromosomal Aberrations in Patients with Neuroblastoma: First Report in Korean Population
  Hana Lim, Meong Hi Son, Ju Kyung Hyun, Hee Won Cho, Hee Young Ju, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• The challenge of defining “ultra‐high‐risk” neuroblastoma
  Daniel A. Morgenstern, Rochelle Bagatell, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Lucas Moreno, Julie R. Park, Andrew D. Pearson, Gudrun Schleiermacher, Dominique Valteau‐Couanet, Wendy B. London, Meredith S. Irwin
  Pediatric Blood & Cancer.2019;[Epub]     CrossRef
• Opportunities and challenges of circulating biomarkers in neuroblastoma
  Ricky M. Trigg, Jacqui A. Shaw, Suzanne D. Turner
  Open Biology.2019;[Epub]     CrossRef
• Risk stratification of high‐risk metastatic neuroblastoma: A report from the HR‐NBL‐1/SIOPEN study
  Daniel A. Morgenstern, Ulrike Pötschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, Martin Elliot, Aleksandra Wieczorek, Geneviève Laureys, Per Kogner, Josef Malis, Ell
  Pediatric Blood & Cancer.2018;[Epub]     CrossRef
• Favorable prognostic role of tropomodulins in neuroblastoma
  Paola Bettinsoli, Giulia Ferrari-Toninelli, Sara Anna Bonini, Michela Guarienti, Davide Cangelosi, Luigi Varesio, Maurizio Memo
  Oncotarget.2018; 9(43): 27092.     CrossRef
• Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors
  Atif A. Ahmed, Lei Zhang, Naresh Reddivalla, Maxine Hetherington
  Pediatric Hematology and Oncology.2017; 34(3): 165.     CrossRef

Citations

Citations to this article as recorded by  

• ESTRO-SIOPE guideline: Clinical management of radiotherapy in atypical teratoid/rhabdoid tumors (AT/RTs)
  Beate Timmermann, Claire Alapetite, Karin Dieckmann, Rolf-Dieter Kortmann, Yasmin Lassen-Ramshad, John H. Maduro, Monica Ramos Albiac, Umberto Ricardi, Damien C. Weber
  Radiotherapy and Oncology.2024; 196: 110227.     CrossRef
• Tandem High-Dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors
  Hana Lim, Minji Im, Eun Seop Seo, Hee Won Cho, Hee Young Ju, Keon Hee Yoo, Sung Yoon Cho, Jong-Won Kim, Do Hoon Lim, Ki Woong Sung, Ji Won Lee
  Cancer Research and Treatment.2024; 56(2): 642.     CrossRef
• Focal versus craniospinal radiation for disseminated atypical teratoid/rhabdoid tumor following favorable response to systemic therapy
  Paul D. Aridgides, Anita Mahajan, Bree Eaton, Dongliang Wang, Beate Timmerman, Michael C. Früwald, Karolina Nemes, Jared Deck, Kai Yamasaki, Katja Von Hoff, Lucie Lafay‐Cousin, Alyssa Reddy, Andrea C. Lo
  Pediatric Blood & Cancer.2023;[Epub]     CrossRef
• Comparative treatment results of children with atypical teratoid/rhabdoid tumor of the central nervous system in the younger age group
  L. V. Olkhova, O. G. Zheludkova, L. S. Zubarovskaya, A. S. Levashov, A. Yu. Smirnova, Yu. V. Dinikina, Yu. V. Kushel, A. G. Melikyan, S. K. Gorelyshev, M. V. Ryzhova, Yu. Yu. Trunin, A. G. Gevorgyan, O. B. Polushkina, V. E. Popov, L. P. Privalova, N. B. Y
  Russian Journal of Pediatric Hematology and Oncology.2023; 10(1): 11.     CrossRef
• Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children: Case Reports and Literature Review
  Gengyin Guo, Jianfeng Zhuang, Keke Zhang, Zhizhen Zhou, Yanjun Wang, Zhen Zhang
  Frontiers in Surgery.2022;[Epub]     CrossRef
• Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years
  Meerim Park, Jung Woo Han, Seung Min Hahn, Jun Ah Lee, Joo-Young Kim, Sang Hoon Shin, Dong-Seok Kim, Hong In Yoon, Kyung Taek Hong, Jung Yoon Choi, Hyoung Jin Kang, Hee Young Shin, Ji Hoon Phi, Seung-Ki Kim, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Hong H
  Cancer Research and Treatment.2021; 53(2): 378.     CrossRef
• The results of multicenter treatment of atypical teratoid/rhabdoid tumors of the central nervous system in children under 3 years
  L. V. Olkhova, O. G. Zheludkova, L. S. Zubarovskaya, A. Yu. Smirnova, Yu. V. Dinikina, Yu. V. Kushel, A. G. Melikyan, S. K. Gorelyshev, M. V. Ryzhova, Yu. Yu. Trunin, E. I. Shults, A. G. Gevorgyan, S. V. Gorbatykh, A. N. Kislyakov, V. E. Popov, L. P. Priv
  Pediatric Hematology/Oncology and Immunopathology.2021; 20(2): 121.     CrossRef
• Effect of early radiotherapy initiation and high-dose chemotherapy on the prognosis of pediatric atypical teratoid rhabdoid tumors in different age groups
  Wan-Chin Yang, Hsiu-Ju Yen, Muh-Lii Liang, Hsin-Hung Chen, Yi-Yen Lee, Feng-Chi Chang, Shih-Chieh Lin, Tai-Tong Wong, Yu-Wen Hu, Yi-Wei Chen
  Journal of Neuro-Oncology.2020; 147(3): 619.     CrossRef
• Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors
  Lindsey M Hoffman, Elizabeth Anne Richardson, Ben Ho, Ashley Margol, Alyssa Reddy, Lucie Lafay-Cousin, Susan Chi, Irene Slavc, Alexander Judkins, Martin Hasselblatt, Franck Bourdeaut, Michael C Frühwald, Rajeev Vibhakar, Eric Bouffet, Annie Huang
  Neuro-Oncology.2020; 22(7): 944.     CrossRef
• Meta-Analysis of Treatment Modalities in Metastatic Atypical Teratoid/Rhabdoid Tumors in Children
  Reena M. Underiner, Mostafa Eltobgy, Joseph R. Stanek, Jonathan L. Finlay, Mohamed S. AbdelBaki
  Pediatric Neurology.2020; 108: 106.     CrossRef
• Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors
  Jane Koo, Stacy Silverman, Brandon Nuechterlein, Amy K. Keating, Michael R. Verneris, Nicholas K. Foreman, Jean M. Mulcahy Levy
  Bone Marrow Transplantation.2019; 54(10): 1605.     CrossRef
• Role of early and aggressive post-operative radiation therapy in improving outcome for pediatric central nervous system atypical teratoid/rhabdoid tumor
  Wan-Chin Yang, Hsiu-Ju Yen, Muh-Lii Liang, Hsin-Hung Chen, Yi-Yen Lee, Tai-Tong Wong, Yu-Wen Hu, Yi-Wei Chen
  Child's Nervous System.2019; 35(6): 1013.     CrossRef
• Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors
  Jung Yoon Choi, Hyoung Jin Kang, Kyung Taek Hong, Che Ry Hong, Yun Jeong Lee, June Dong Park, Ji Hoon Phi, Seung-Ki Kim, Kyu-Chang Wang, Il Han Kim, Sung-Hye Park, Young Hun Choi, Jung-Eun Cheon, Kyung Duk Park, Hee Young Shin
  International Journal of Clinical Oncology.2019; 24(12): 1515.     CrossRef
• The impact on outcomes by using thiotepa in tandem transplant for pediatric high-risk embryonal brain tumors
  Hsiu-Ju Yen, Ting-Yen Yu, Chih-Ying Lee, Giun-Yi Hung, Tzeon-Jye Chiou, Hsin-Hung Chen, Yi-Yen Lee, Muh-Lii Liang, Yi-Wei Chen
  Journal of the Chinese Medical Association.2019; 82(2): 148.     CrossRef
• Integration of a Personalized Molecular Targeted Therapy into the Multimodal Treatment of Refractory Childhood Embryonal Tumor with Multilayered Rosettes (ETMR)
  Lisa L.R. Hartman, Derrick M. Oaxaca, Benjamin Carcamo, Harry L. Wilson, Jeremy A. Ross, Elisa Robles-Escajeda, Robert A. Kirken
  Case Reports in Oncology.2019; 12(1): 211.     CrossRef
• Tandem High-dose Chemotherapy and Autologous Stem Cell Transplantation in Children with Brain Tumors : Review of Single Center Experience
  Ki Woong Sung, Do Hoon Lim, Hyung Jin Shin
  Journal of Korean Neurosurgical Society.2018; 61(3): 393.     CrossRef
• Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies
  Elizabeth Anne Richardson, Ben Ho, Annie Huang
  Journal of Korean Neurosurgical Society.2018; 61(3): 302.     CrossRef
• Surveillance imaging for high‐grade childhood brain tumors: What to do 10 years after completion of treatment?
  Maria Otth, Katrin Scheinemann
  Pediatric Blood & Cancer.2018;[Epub]     CrossRef
• Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents
  Ji Won Lee, Do Hoon Lim, Ki Woong Sung, Hyeong Jin Lee, Eun Sang Yi, Keon Hee Yoo, Hong Hoe Koo, Yeon-Lim Suh, Hyung Jin Shin
  Journal of Korean Medical Science.2017; 32(2): 195.     CrossRef
• Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature
  Mary Fossey, Haocheng Li, Samina Afzal, Anne-Sophie Carret, David D. Eisenstat, Adam Fleming, Juliette Hukin, Cynthia Hawkins, Nada Jabado, Donna Johnston, Tania Brown, Valerie Larouche, Katrin Scheinemann, Douglas Strother, Beverly Wilson, Shayna Zelcer,
  Journal of Neuro-Oncology.2017; 132(1): 155.     CrossRef
• Atypical teratoid/rhabdoid tumors in children treated with multimodal therapies: The necessity of upfront radiotherapy after surgery
  Jeongshim Lee, Dong‐Seok Kim, Jung Woo Han, Chang‐Ok Suh
  Pediatric Blood & Cancer.2017;[Epub]     CrossRef
• Protective Effects of Dihydromyricetin against •OH-Induced Mesenchymal Stem Cells Damage and Mechanistic Chemistry
  Xican Li, Jingjing Liu, Jian Lin, Tingting Wang, Jieyuan Huang, Yongqiang Lin, Dongfeng Chen
  Molecules.2016; 21(5): 604.     CrossRef
• Sarcandra glabra (Caoshanhu) protects mesenchymal stem cells from oxidative stress: a bioevaluation and mechanistic chemistry
  Jingjing Liu, Xican Li, Jian Lin, Yunrong Li, Tingting Wang, Qian Jiang, Dongfeng Chen
  BMC Complementary and Alternative Medicine.2016;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea
  Ryugyoung Lee, Minhee Ku, Nam Kyung Je
  Supportive Care in Cancer.2024;[Epub]     CrossRef
• Chemotherapy-Associated Nausea and Vomiting
  Kelvin Mogesa Manyega, Benjamin Nasara Joseph, Okunlola Charity Rotkangmwa, Maxwell P. Dapar
  Annals of African Medicine.2022; 21(2): 124.     CrossRef
• Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective
  Ashok K. Vaid, Sudeep Gupta, Dinesh C. Doval, Shyam Agarwal, Shona Nag, Poonam Patil, Chanchal Goswami, Vikas Ostwal, Sagar Bhagat, Saiprasad Patil, Hanmant Barkate
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Construção e avaliação de bundle frente ao extravasamento de antineoplásicos: estudo metodológico
  João Marcos Alves Melo, Patrícia Peres de Oliveira, Andrea Bezerra Rodrigues, Raíssa Silva Souza, Deborah Franscielle da Fonseca, Thaís Fonseca Gontijo, Edilene Aparecida Araújo da Silveira
  Acta Paulista de Enfermagem.2020;[Epub]     CrossRef
• A cost-utility analysis of risk model-guided versus physician’s choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach
  Kednapa Thavorn, Doug Coyle, Jeffrey S. Hoch, Lisa Vandermeer, Sasha Mazzarello, Zhou Wang, George Dranitsaris, Dean Fergusson, Mark Clemons
  Supportive Care in Cancer.2017; 25(8): 2505.     CrossRef

Citations

Citations to this article as recorded by  

• Usefulness of Indian Diabetes Risk Score in Predicting Treatment-Induced Hyperglycemia in Women Undergoing Adjuvant Chemotherapy for Breast Cancer
  Krishna Prasad, Sanath Hegde, Suresh Rao, Rhea Katherine D'souza, Thomas George, Sucharitha Suresh, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2025; 14(01): 004.     CrossRef
• Prognostic Factors for Hyperglycemia in Patients Receiving Chemotherapy
  Jiyeong Kim, Kyung Hee Lim
  Cancer Nursing.2025; 48(2): 112.     CrossRef
• Rethinking corticosteroids use in oncology
  Pierrick Martinez, Jean-Marc Sabatier
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Evaluation of the Efficacy and Safety of Palonosetron + Dexamethasone (1-day) + Fosaprepitant + Olanzapine (2.5 mg) in Patients with Lung Cancer Undergoing Carboplatin-based Chemotherapy
  Yuki Mikame, Yasunari Okuda, Makoto Shinada, Takahiro Saito, Naoto Kobayashi, Takako Yamashita, Masato Nakata, Daichi Arai, Mika Ohira, Izumi Tamura, Yasushi Imai
  Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences).2024; 50(10): 531.     CrossRef
• Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)
  Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura, Hitoshi Arioka, Hirotoshi Iihara, Mitsuhiro Sugawara, Hajime Morita, Ayako Mochizuki, Shuichi Nawata, Keisuke Mishima, Ayako Tsuboya, Tempei Miyaji, Kazunori Honda, Ayako Yokomizo, Naoya Hashimoto, Takes
  British Journal of Cancer.2024; 130(2): 224.     CrossRef
• A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-
  Daiki Tsuji, Shigeru Nakagaki, Itsuki Yonezawa, Kenichi Suzuki, Takashi Yokokawa, Yohei Kawasaki, Takumi Yamaguchi, Takashi Kawaguchi, Masahiro Hatori, Takuma Matsumoto, Yukio Sakata, Keisuke Yamamoto, Tomoyasu Nishimura, Yuki Kogure, Toshinobu Hayashi, M
  Investigational New Drugs.2024; 42(1): 44.     CrossRef
• Change in abdominal obesity after colon cancer surgery – effects of left-sided and right-sided colonic resection
  Younes Kays Mohammed Ali, Troels Gammeltoft Dolin, Janus Damm Nybing, Jakob Lykke, Frederik Hvid Linden, Erik Høgh-Schmidt, Thorkild I. A. Sørensen, Jesper Frank Christensen, Yousef J. W. Nielsen, Jim Stenfatt Larsen, Sten Madsbad, Julia Sidenius Johansen
  International Journal of Obesity.2024; 48(4): 533.     CrossRef
• Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study)
  Venkatraman Radhakrishnan, Kritthivasan Venkatakrishnan, Jayachandran Perumal Kalaiyarasi, Gangothri Selvarajan, Nizamudin Mahaboobasha, Paulson Vijaykumar Victor, Malarvizhi Anbazhagan, Deyva Manohari Sivanandam, Swaminathan Rajaraman
  JCO Global Oncology.2024;[Epub]     CrossRef
• Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
  Jung-Hwan Cho, Sunghwan Suh
  Endocrinology and Metabolism.2024; 39(2): 222.     CrossRef
• The impact of surgery and oncological treatment on risk of type 2 diabetes onset in patients with colorectal cancer: nationwide cohort study in Denmark
  Caroline Krag, Maria Saur Svane, Sten Madsbad, Susanne Boel Graversen, Jesper Frank Christensen, Thorkild IA Sørensen, Louise Lang Lehrskov, Tinne Laurberg
  eLife.2024;[Epub]     CrossRef
• Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Jap
  Ayako Yokomizo, Kazuhisa Nakashima, Arisa Iba, Kenji Okita, Makoto Wada, Keiko Iino, Tatsuo Akechi, Hirotoshi Iihara, Chiyo K. Imamura, Ayako Okuyama, Keiko Ozawa, Yong-Il Kim, Hidenori Sasaki, Eriko Satomi, Masayuki Takeda, Ryuhei Tanaka, Takako Eguchi N
  International Journal of Clinical Oncology.2024; 29(11): 1632.     CrossRef
• Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clin
  Kazuhisa Nakashima, Ayako Yokomizo, Michiyasu Murakami, Kenji Okita, Makoto Wada, Keiko Iino, Tatsuo Akechi, Hirotoshi Iihara, Chiyo K. Imamura, Ayako Okuyama, Keiko Ozawa, Yong-il Kim, Hidenori Sasaki, Eriko Satomi, Masayuki Takeda, Ryuhei Tanaka, Takako
  International Journal of Clinical Oncology.2024; 29(12): 1785.     CrossRef
• Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology
  Rupert Bartsch, Daniel Aletaha, Thorsten Fuereder, Matti Aapro, Francois R. Jornayvaz, Pierre-Olivier Lang, Denis Migliorini, Chantal Csajka, Marie-Bernadette Aretin, Vérène Dougoud-Chauvin
  Journal of Geriatric Oncology.2024; : 102077.     CrossRef
• Diabetes and cancer: Optimising glycaemic control
  Nalinie Joharatnam‐Hogan, Daniel L. Morganstein
  Journal of Human Nutrition and Dietetics.2023; 36(2): 504.     CrossRef
• Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)
  Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio, Elena Collovà, Federica Bertolini, Fausto Petrelli, Alessandra Cassano, Rita Chiari, Francesca Zanelli, Salvatore Pisconti, Isabella Vittimberga, Antonietta
  Scientific Reports.2023;[Epub]     CrossRef
• Diabetes and cancer co-management: patient-reported challenges, needs, and priorities
  Laura C. Pinheiro, Jacklyn Cho, Julia Rothman, Caroline Zeng, Micayla Wilson, Lisa M. Kern, Rulla M. Tamimi, Monika M. Safford
  Supportive Care in Cancer.2023;[Epub]     CrossRef
• Link between Blood Cell-Associated Inflammatory Indices and Chemotherapy-Induced Hyperglycemia in Women Affected with Breast Cancer: Clinical Studies
  Krishna Prasad, Suresh Rao, Sanath Kumar Hegde, Thomas George, Rhea Katherine D'souza, Sucharitha Suresh, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2023; 12(02): 118.     CrossRef
• Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer
  Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, Wai Yu, Raynald Samoa, Nora Ruel, Susan E. Yost, Hayley Lee, Sung Hee Kil, Joanne E. Mortimer
  Journal of Clinical Medicine.2023; 12(5): 1906.     CrossRef
• Dexamethasone-free antiemetic strategy for highly emetogenic chemotherapy: safety and efficacy-pilot study
  Vinod Sharma, Akash Kumar, Annie Baa, Sudhir Kirar, Atul Sharma, Sameer Bakhshi, Ajay Gogia, Prabhat Singh Malik, Sameer Rastogi, Atul Batra, Deepam Pushpam, Babita Kataria, Hari Sagiraju, Aparna Sharma, Vishwajeet Singh
  BMJ Supportive & Palliative Care.2023; 13(e3): e867.     CrossRef
• Identifying patients with diabetes in a day‐case systemic anti‐cancer therapy population: the Belfast Regional Oncology Centre experience
  Adam Waterworth, Ashleigh Hamilton, Philip Johnston, Anna Todd, Grainne Connolly, Ailish Nugent, Paula Scullin, Sarah McKenna, Sarah Lawless, Helen Wallace, Ian Wallace
  Practical Diabetes.2023; 40(3): 26.     CrossRef
• Dexamethasone-sparing regimens with NEPA (netupitant/palonosetron) for the prevention of chemotherapy-induced nausea and vomiting in older patients (>65 years) fit for cisplatin: A sub-analysis from a phase 3 study
  Luigi Celio, Rupert Bartsch, Matti Aapro
  Journal of Geriatric Oncology.2023; 14(6): 101537.     CrossRef
• Effects of Vitamin Intake on Blood Glucose in Cancer Patients Undergoing Chemotherapy: Quantitative and Descriptive Research
  Ji Yeong Kim, Kyung Hee Lim
  Korean Journal of Adult Nursing.2023; 35(2): 148.     CrossRef
• Effectiveness of Palonosetron, 1-Day Dexamethasone, and Aprepitant in Patients Undergoing Carboplatin-Based Chemotherapy
  Toshinobu Hayashi, Mototsugu Shimokawa, Koichi Matsuo, Masanobu Uchiyama, Kei Kawada, Takafumi Nakano, Takashi Egawa
  Oncology.2023; 101(9): 584.     CrossRef
• COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams
  Younes R. Younes, Susan Stockley, Lorna Keegan, Linda O’Donoghue, Elizabeth Yohannan, Liz Read, Jamie‐Leigh Williamson, John Peter, Kavitha Lakshmipathy, Vera Smout, Vidhu Nayyar, Julian Emmanuel, Sunil Zachariah, James Clark, Benjamin C. T. Field
  Diabetic Medicine.2022;[Epub]     CrossRef
• The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
  Mengjun Liang, Liping Xiong, Aihua Li, Jiafan Zhou, Yajuan Huang, Miaofang Huang, Xing Zhang, Hongrui Shi, Ning Su, Yi Wei, Zongpei Jiang
  BMC Nephrology.2022;[Epub]     CrossRef
• Insulin resistance and weight gain in women treated for early stage breast cancer
  Grace Makari-Judson, Richard Viskochil, Deborah Katz, Ruth Barham, Wilson C. Mertens
  Breast Cancer Research and Treatment.2022; 194(2): 423.     CrossRef
• Cytoprotective effect of genistein against dexamethasone-induced pancreatic β-cell apoptosis
  Kanchana Suksri, Namoiy Semprasert, Thawornchai Limjindaporn, Pa-thai Yenchitsomanus, Sirirat Kooptiwoot, Suwattanee Kooptiwut
  Scientific Reports.2022;[Epub]     CrossRef
• Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study
  Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio, Elena Collovà, Federica Bertolini, Fausto Petrelli, Alessandra Cassano, Rita Chiari, Francesca Zanelli, Salvatore Pisconti, Isabella Vittimberga, Antonietta
  BMC Cancer.2022;[Epub]     CrossRef
• Efficacy of the Dexamethasone-Sparing Triplet Regimen for Preventing Cisplatin-Induced Emesis: a Combined Analysis
  Luigi Celio, Erminio Bonizzoni, Elena Montani, Matti Aapro
  Future Oncology.2022; 18(30): 3389.     CrossRef
• How should rheumatologists manage glucocorticoid-induced hyperglycemia?
  Hiroyuki Nakamura, Yuichiro Fujieda, Akinobu Nakamura, Tatsuya Atsumi
  Modern Rheumatology.2021; 31(3): 519.     CrossRef
• A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapy
  Koung Jin Suh, Seonghae Yoon, Jin Won Kim, Seo Hyun Yoon, Ji-Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
  Journal of Geriatric Oncology.2021; 12(6): 922.     CrossRef
• Incidence and disease course of new-onset diabetes mellitus in breast and colorectal cancer patients undergoing chemotherapy: A prospective multicenter cohort study
  Eun Kyung Lee, Bokyung Koo, Yul Hwangbo, You Jin Lee, Ji Yeon Baek, Yong Jun Cha, Sun Young Kim, Sung Hoon Sim, Keun Seok Lee, In Hae Park, Hyewon Lee, Jungnam Joo, Sujeong Go, Seung Chul Heo, Min Kyong Moon
  Diabetes Research and Clinical Practice.2021; 174: 108751.     CrossRef
• Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study
  Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio, Elena Collovà, Federica Bertolini, Fausto Petrelli, Alessandra Cassano, Rita Chiari, Francesca Zanelli, Salvatore Pisconti, Isabella Vittimberga, Antonietta
  The Oncologist.2021; 26(10): e1854.     CrossRef
• Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations
  Fei Chen, Lanting Hao, Shiheng Zhu, Xinyuan Yang, Wenhao Shi, Kai Zheng, Tenger Wang, Huiran Chen
  Infectious Diseases and Therapy.2021; 10(4): 1907.     CrossRef
• Glycemic Excursion, Adverse Drug Reactions, and Self-Management in Diabetes Patients Undergoing Chemotherapy: A Literature Review
  Naoko Terao, Kumi Suzuki
  Asia-Pacific Journal of Oncology Nursing.2021; 8(6): 610.     CrossRef
• Patient-Centered Diabetes Care of Cancer Patients
  Anupam Kotwal, Yee-Ming M. Cheung, Grace Cromwell, Andjela Drincic, Houry Leblebjian, Zoe Quandt, Robert J. Rushakoff, Marie E. McDonnell
  Current Diabetes Reports.2021;[Epub]     CrossRef
• Quercetin modulates hyperglycemia by improving the pancreatic antioxidant status and enzymes activities linked with glucose metabolism in type 2 diabetes model of rats: In silico studies of molecular interaction of quercetin with hexokinase and catalase
  Sunday O. Oyedemi, Godswill Nwaogu, Chika I. Chukwuma, Olaoluwa T. Adeyemi, Motlalepula G. Matsabisa, Shasank S. Swain, Olayinka A. Aiyegoro
  Journal of Food Biochemistry.2020;[Epub]     CrossRef
• Side Effects of Adjuvant Chemotherapy and their Impact on Outcome in Elderly Breast Cancer Patients: A Cohort Study
  Valentina Zanuso, Vittorio Fregoni, Lorenzo Gervaso
  Future Science OA.2020;[Epub]     CrossRef
• Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
  Suresh Rao, Krishna Prasad, Soniya Abraham, Thomas George, Supreeth Kakkaje Chandran, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2020; 09(03): 130.     CrossRef
• Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes
  Moein Ala, Razieh Mohammad Jafari, Ahmad Reza Dehpour
  Current Diabetes Reviews.2020; 16(9): 984.     CrossRef
• Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin
  Hiroko Minatogawa, Naoki Izawa, Takashi Kawaguchi, Tempei Miyaji, Kazuhiro Shimomura, Honda Kazunori, Hirotoshi Iihara, Yasushi Ohno, Yusuke Inada, Hitoshi Arioka, Hajime Morita, Naoya Hida, Mitsuhiro Sugawara, Chikatoshi Katada, Shuichi Nawata, Hiroo Ish
  BMJ Open.2020; 10(12): e041737.     CrossRef
• Effect of high-dose dexamethasone on patients without diabetes during elective neurosurgery: a prospective study
  Majid Alabbood, Min Ling, Kenneth Ho
  Diabetology International.2019; 10(2): 109.     CrossRef
• Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma
  Saby George, Brian I. Rini, Hans J. Hammers
  JAMA Oncology.2019; 5(3): 411.     CrossRef
• GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION
  Al’bert Yu. Selimov, Lyudmila N. Eliseeva, Valeriya P. Kurinnaya, Sergei P. Oranskii
  Kuban Scientific Medical Bulletin.2019; 26(1): 209.     CrossRef
• Steroid-induced diabetes in cancer patients
  Gemma Dinn
  Journal of Prescribing Practice.2019; 1(12): 610.     CrossRef
• Hyperglycemia During Childhood Cancer Therapy: Incidence, Implications, and Impact on Outcomes
  Allison Grimes, Ashraf Mohamed, Jenna Sopfe, Rachel Hill, Jane Lynch
  JNCI Monographs.2019; 2019(54): 132.     CrossRef
• Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidence
  Luigi Celio, Erminio Bonizzoni, Emma Zattarin, Paolo Codega, Filippo de Braud, Matti Aapro
  BMC Cancer.2019;[Epub]     CrossRef
• Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy
  Yuka Ito, Takashi Tsuda, Hiroko Minatogawa, Sayaka Kano, Kentaro Sakamaki, Masahiko Ando, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, Sadatoshi Sugae, Ichiro Ohta, Hitoshi Arioka, Yutaka Tokuda, Kazutaka Narui, Ayak
  Journal of Clinical Oncology.2018; 36(10): 1000.     CrossRef
• Glucocorticoid‐induced diabetes among people without diabetes: a literature review
  Majid Alabbood, Min Ling, Kenneth Ho
  Practical Diabetes.2018; 35(2): 63.     CrossRef
• Metformin prevents metabolic side effects during systemic glucocorticoid treatment
  Eleonora Seelig, Stefanie Meyer, Katharina Timper, Nicole Nigro, Martina Bally, Ida Pernicova, Philipp Schuetz, Beat Müller, Marta Korbonits, Mirjam Christ-Crain
  European Journal of Endocrinology.2017; 176(3): 349.     CrossRef
• Central pancreatectomy: an oncologically safe option to treat metastases of other neoplasms of the mid-portion of the pancreas?
  Traian Dumitrascu, Andra Scarlat, Mihnea Ionescu, Irinel Popescu
  Annals of Hepato-Biliary-Pancreatic Surgery.2017; 21(2): 76.     CrossRef
• Outpatient management of steroid-induced hyperglycaemia and steroid-induced diabetes in people with lymphoproliferative disorders treated with intermittent high dose steroids
  Jennifer Vidler, Charlotte Rogers, Deborah Yallop, Stephen Devereux, Ellinor Wellving, Orla Stewart, Alison Cox, Katharine F. Hunt, Shireen Kassam
  Journal of Clinical & Translational Endocrinology.2017; 9: 18.     CrossRef
• Consumption of Fresh Yellow Onion Ameliorates Hyperglycemia and Insulin Resistance in Breast Cancer Patients During Doxorubicin-Based Chemotherapy: A Randomized Controlled Clinical Trial
  Farnaz Jafarpour-Sadegh, Vahid Montazeri, Ali Adili, Ali Esfehani, Mohammad-Reza Rashidi, Saeed Pirouzpanah
  Integrative Cancer Therapies.2017; 16(3): 276.     CrossRef

Citations

Citations to this article as recorded by  

• A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives
  Zhongyu Han, Yuanke Luo, Haoran Chen, Guochen Zhang, Luling You, Meiqi Zhang, Yumeng Lin, Lan Yuan, Shiyi Zhou
  Kidney Diseases.2024; 10(3): 224.     CrossRef
• Genotype–phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions
  Kenan Zhang, Wuping Yang, Kaifang Ma, Jianhui Qiu, Lei Li, Yawei Xu, Zedan Zhang, Chaojian Yu, Jingcheng Zhou, Yanqing Gong, Lin Cai, Kan Gong
  Journal of Medical Genetics.2023; 60(5): 477.     CrossRef
• Idiopathic interstitial pneumonia in a patient with von Hippel–Lindau syndrome: a first case
  Letizia Corinna Morlacchi, Umberto Zanini, Andrea Gramegna, Paola Faverio, Francesco Blasi, Fabrizio Luppi
  ERJ Open Research.2023; 9(6): 00504-2023.     CrossRef
• The Cross‐Link between Ferroptosis and Kidney Diseases
  Jingyu Wang, Yi Liu, Yaqing Wang, Li Sun, Ana Cipak Gasparovic
  Oxidative Medicine and Cellular Longevity.2021;[Epub]     CrossRef
• Prioritization of differentially expressed genes through integrating public expression data
  W. Xu, S. Li, Z. Zhang, J. Hu, Y. Zhao
  Animal Genetics.2019; 50(6): 726.     CrossRef

Citations

Citations to this article as recorded by  

• Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives
  Zaoqin Yu, Wei Li, Cheng Tian, Yan Cao, Chengliang Zhang
  Archives of Toxicology.2025; 99(3): 835.     CrossRef
• Treatment of Sinusoidal Obstruction Syndrome With Defibrotide in Pediatric Cancer Patients Following Nontransplant-associated Chemotherapy: A Case Report and Review of the Literature
  Marc R. Lawrence, Mylène Bassal, Raveena Ramphal, Donna L. Johnston
  Journal of Pediatric Hematology/Oncology.2022; 44(3): e788.     CrossRef
• Indispensable role of microbes in anticancer drugs and discovery trends
  Ridam Kapoor, Anamika Saini, Deepika Sharma
  Applied Microbiology and Biotechnology.2022; 106(13-16): 4885.     CrossRef
• Caspase inhibitor z-VAD-FMK increases the survival of hair cells after Actinomycin-D-induced damage in vitro
  Huimin Chang, Fei Sun, Keyong Tian, Weilong Wang, Ke Zhou, Dingjun Zha, Jianhua Qiu
  Neuroscience Letters.2020; 732: 135089.     CrossRef
• Adjuvant recombinant thrombomodulin therapy for hepatopathy induced by vincristine, actinomycin D, and cyclophosphamide in pediatric rhabdomyosarcoma: A case report
  Tetsuko Kobayashi, Maiko Noguchi, Hideki Nakayama, Reiji Fukano, Shouichi Ohga
  Molecular and Clinical Oncology.2019;[Epub]     CrossRef
• “Pre‐emptive strike”—the case for early treatment of hepatic sinusoidal obstruction syndrome with defibrotide
  Revathi Rajagopal, Marianne B. Phillips, Nicholas G. Gottardo
  Pediatric Blood & Cancer.2018;[Epub]     CrossRef
• Cyclophosphamide/dactinomycin/vincristine
  
  Reactions Weekly.2017; 1637(1): 75.     CrossRef